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ABSTRACT 
Mitochondrial oxidative phosphorylation is an efficient source of cellular energy. 
This pathway couples the oxidation of NADH and FADH2 to the establishment of an 
electrochemical gradient across the inner mitochondrial membrane to facilitate ATP 
generation. The respiratory chain is comprised of five complexes; however, these are not 
simple enzymes. Rather, they are highly intricate membrane-bound complexes. As such, 
the biogenesis of these complexes presents the cell with numerous problems. Thus, the 
cell expresses dozens of assembly factors that are required to support the biogenesis of 
individual complexes. In the end, this promotes cellular energy production and protects 
the cell from potentially damaging insults.  
Succinate dehydrogenase (SDH) or complex II is a member of the electron 
transport chain (ETC) and TCA cycle. It plays a central role in cellular energy generation 
and mutations in the genes encoding SDH subunits and assembly factors are associated 
with human disease, including cancer and neurodegeneration. This highly conserved 
family supports the maturation of SDHA/Sdh1, the catalytic subunit of SDH. As such, 
Sdh8 functions as an Sdh1-specific chaperone and prevents the spurious generation of 
reactive oxygen species during the assembly process. In Drosophila, Sdhaf4 is required to 
prevent neurodegeneration and maintain normal motility. In the end, this work has 
expanded our understanding of the SDH assembly pathway and provided novel insights 
into the development of SDH-deficient pathologies.  
iv 
In addition to the canonical cytosolic pathway, eukaryotic cells have maintained a 
mitochondrial fatty acid synthesis pathway (FASII). This pathway is homologous to 
prokaryotic fatty acid synthesis and utilizes a number of enzymes that interact transiently 
with the acyl carrier protein (ACP) to support elongation of nascent acyl chains. Herein, 
we describe a novel and unexpected role for ACP and FASII in the assembly and 
activation of the ETC. As such, FASII-dependent synthesis of ACP-bound acyl chains 
activates a network of complex-specific assembly factors to support the assembly of the 
ETC complexes and synthesis of their essential cofactors. In the end, FASII and ACP 
couple mitochondrial acetyl-CoA to ETC biogenesis.  
This dissertation is dedicated to my parents, who have always 
supported my education. 
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CHAPTER 1 
INTRODUCTION 
Uncharacterized mitochondrial proteins 
Mitochondria are dynamic organelles that play important roles in a number of 
cellular processes including metabolism, signal transduction, and apoptosis. Owing in 
part to its diverse roles within the cell, it has become increasingly clear that 
mitochondrial dysfunction is involved in the pathogenesis of a diverse array of human 
disease including diabetes, neurodegeneration, and cancer. Thus, mitochondrial function 
is essential for maintaining cellular homeostasis, while defects in these essential functions 
often manifest as disease. Because the influence of this organelle impacts both normal 
physiology and disease pathogenesis, considerable effort has been allocated to the 
complete characterization of the mitochondrial proteome (1, 2). Despite this effort, 
however, nearly a quarter of the mitochondrial proteins remain uncharacterized, including 
many genes that have maintained a high degree of conservation throughout eukaryotic 
evolution, implying involvement in an essential cellular process. Furthermore a high 
percentage of genes encoding mitochondrial proteins are predicted to be associated with 
inherited human disease. Thus, we predict that the interrogation of uncharacterized 
mitochondrial proteins will reveal important insights into normal cellular physiology as 
well as human disease.  
2 
In total, we identified 29 proteins or protein families to focus our initial 
investigation. This has lead to the characterization of numerous proteins and has 
expanded our understanding of mitochondrial biology considerably (3-9). This list 
initially focused strictly on proteins that remained completely uncharacterized. However, 
there remain numerous targets that have been studied but not in sufficient depth to 
provide a complete understanding of their function. Thus, it is likely that the 
mitochondrial proteome encodes a number of other genes that remain under-characterized 
and warrant further investigation. Using a combination of biochemical and genetic 
methods and taking advantage of the model system Saccharomyces cerrevisiae (budding 
yeast) we will seek to define the cellular role of these un- or under-characterized 
mitochondrial proteins.  
The electron transport chain 
While it is now abundantly clear that mitochondria are intimately involved in a 
vast array of cellular processes, this organelle is classically regarded as the 
compartmentalized site of oxidative phosphorylation (Figure 1-1). As such, the 
catabolism of glucose, fatty acids, and amino acids converge in the mitochondria as 
acetyl-CoA. This principal metabolite, which exclusively fuels cellular respiration, is 
oxidized by the tricarboxylic acid (TCA) cycle, providing the reducing equivalents 
(NADH and FADH2) that fuel the electron transport chain (ETC) This series of 
complexes then passes electrons through a number of redox active cofactors thereby 
generating a membrane potential across the inner mitochondrial membrane, which ATP 
synthase can exploit to generate adenosine triphosphate.  
3 
In mammals, the ETC is comprised of five membrane-bound protein complexes 
and two mobile electron carriers, which altogether consists of nearly 100 individual 
protein subunits, expressed from two distinct genomes. This machine of unrivaled 
complexity and elegance is capable of generating ~34 molecules of ATP from the 
oxidation of one molecule of glucose. Indeed the ETC can serve as an efficient source of 
cellular energy; however, it can also generate potentially deleterious byproducts that are 
capable of damaging the cell. Therefore, the cell has evolved numerous mechanisms to 
promote and regulate the assembly the ETC.  
ETC biogenesis does not happen spontaneously. Instead, the cell has evolved 
numerous mechanisms to support the assembly and activity of these complexes. In fact, 
the process of ETC biogenesis presents the cell with numerous problems the cell must 
overcome in order to maintain cellular energy homeostasis and redox balance. First, the 
cell must coordinate the synthesis and interaction of dozens of individual protein subunits 
in order to support the step-wise assembly of individual complexes. Furthermore, these 
individual subunits are translated from two distinct genomes in two distinct 
compartments that are separated by double membranes. This problem is exacerbated by 
the nature of the ETC complexes themselves. First, some subunits of these complexes are 
embedded in the IMM and, therefore, are hydrophobic and prone to aggregation prior to 
and during assembly. Furthermore, the complexes contain redox-active cofactors that can 
perform inappropriate reactions when they are not properly secluded within the native 
complex. As a result, the eukaryotic genome has maintained dozens of dedicated factors 
to assist the assembly of these complexes by facilitating cofactor insertion, preventing 
nonproductive interactions, and stabilizing assembly intermediates (10, 11). 
4 
Importantly, the threat imposed on the cell by the ETC does not end following 
biogenesis. In fact, the fully assembled ETC and its numerous redox-active cofactors are 
the primary source of reactive oxygen species (ROS) in the cell. Thus, it is not enough for 
the cell to simply assemble these complexes. Instead, it must work diligently to maintain 
the fidelity of these complexes such that energy generation can be maximized and ROS 
minimized. This is particularly problematic in times of nutrient imbalance when the 
reducing capacity of the ETC is high but electron flux is limited due to lack of substrate 
(12). Thus, the cell must be able to balance mitochondrial oxidative capacity with 
substrate availability in order to prevent the spurious leak of electrons and ROS. In the 
end, the ability to modulate the assembly and activity of the ETC in response to substrate 
availability will promote efficient energy production while minimizing the deleterious 
byproducts of oxidative phosphorylation.  
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Figure 1-1. The electron transport chain.  
Electrons derived from NADH and FADH2 are passed from complex I and complex II, 
respectively to coenzyme Q. Complex III takes the electrons from coenzyme Q and 
passes them to cytochrome c. Finally, complex IV uses the electrons to reduce oxygen to 
water. This movement of electrons is coupled to the pumping of electrons across the 
inner mitochondrial membrane. This establishes an electrochemical gradient that complex 











































PROTEIN-MEDIATED ASSEMBLY OF SUCCINATE DEHYDROGENASE 
AND ITS COFACTORS 
Jonathan G. Van Vranken, Un Na, Dennis R. Winge, and Jared Rutter 
Reprinted with permission from Critical Reviews in Biochemistry and Molecular 
Biology, vol. 50(2), pp. 168-68 
Copyright © 2014 with permission from Taylor & Francis Group 
This is an Accepted Manuscript of an article published by Taylor & Francis in Critical 











ISSN: 1040-9238 (print), 1549-7798 (electronic)
Editor: Michael M. Cox
Crit Rev Biochem Mol Biol, 2015; 50(2): 168–180
! 2014 Informa Healthcare USA, Inc. DOI: 10.3109/10409238.2014.990556
REVIEW ARTICLE
Protein-mediated assembly of succinate dehydrogenase and its
cofactors
Jonathan G. Van Vranken1, Un Na1,2, Dennis R. Winge1,2, and Jared Rutter1
1Department of Biochemistry and 2Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
Abstract
Succinate dehydrogenase (or complex II; SDH) is a heterotetrameric protein complex that links
the tribarboxylic acid cycle with the electron transport chain. SDH is composed of four nuclear-
encoded subunits that must translocate independently to the mitochondria and assemble into
a mature protein complex embedded in the inner mitochondrial membrane. Recently, it has
become clear that failure to assemble functional SDH complexes can result in cancer and
neurodegenerative syndromes. The effort to thoroughly elucidate the SDH assembly pathway
has resulted in the discovery of four subunit-specific assembly factors that aid in the maturation
of individual subunits and support the assembly of the intact complex. This review will focus on
these assembly factors and assess the contribution of each factor to the assembly of SDH.
Finally, we propose a model of the SDH assembly pathway that incorporates all extant data.
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Electron transport chain complex assembly
Mitochondrial ATP synthesis is dependent on the concerted
efforts of the electron transport chain (ETC), which couples
the generation of an electrochemical gradient to the oxidation
of NADH and FADH2 and the reduction of oxygen to water.
The ETC is composed of four multimeric complexes and two
mobile electron carriers (coenzyme Q and cytochrome c), all
of which are embedded in or associated with the inner
mitochondrial membrane (IMM). Electrons derived from the
oxidation of NADH by complex I or succinate from the
tricarboxylic acid (TCA) cycle by complex II (succinate
dehydrogenase; SDH) are passed along the ETC, coupled
with the pumping of protons and establishment of the proton
gradient across the IMM. In the end, controlled flow of
protons down this electrochemical gradient is utilized by
complex V (ATP synthase) to catalyze ATP synthesis.
The assembly of the ETC complexes presents the cell with
the problem of coordinating the synthesis and stepwise
interactions of individual subunits, transcribed and translated
from two distinct genomes in two distinct compartments, into
intricate membrane bound complexes. This problem is
exacerbated by the nature of the ETC complexes themselves.
First, some subunits are embedded in the IMM and, therefore,
are hydrophobic and prone to aggregation prior to and during
assembly. Furthermore, the complexes contain redox-active
cofactors that can perform inappropriate and deleterious
reactions when they are not properly secluded within the
native complex. As a result, a number of dedicated factors
assist the assembly of these complexes by facilitating cofactor
insertion, preventing non-productive interactions and stabiliz-
ing assembly intermediates (Diaz et al., 2011; Fernandez-
Vizarra et al., 2009). While mammalian ETC complexes I, III
and IV contain 44, 11 and 14 subunits, respectively, and
include proteins encoded by both mitochondrial and nuclear
genomes, complex II or SDH, is the product of just four
nuclear-encoded genes. Despite this somewhat simple qua-
ternary structure, it has been made clear recently that SDH,
like all ETC complexes, requires assembly factors for its
biogenesis.
Succinate dehydrogenase and human disease
The critical role of SDH in mitochondrial metabolism has
long been appreciated, however, it has more recently emerged
that mutations affecting SDH cause a number of human
diseases (Hoekstra & Bayley, 2013; Rutter et al., 2010;
Table 1). Interestingly, loss of function mutations in SDH core
subunits do not cause a single, common pathology, but rather
lead to a variety of disease phenotypes that can be grouped
into two categories – cancer and neurodegeneration. With
respect to SDH-deficient cancers and other tumor syndromes,
mutations in the core subunits are most commonly associated
with paraganglioma, pheochromocytoma, renal cell carcin-
oma (RCC) and WT gastrointestinal stromal tumors (WT-
GIST). Paragangliomas are neuro-endocrine tumors that
occur in cells of the neural crest and tend to be co-localized
with oxygen sensing tissues such as the carotid body, while
pheochromocytomas represent a related class of tumors that
affect the adrenal gland. These two tumors are most
Address for correspondence: Jared Rutter, Department of Biochemistry,
University of Utah School of Medicine, Salt Lake City, UT, USA.
E-mail: rutter@biochem.utah.edu
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commonly associated with mutations in SDHB, SDHC and
SDHD, however SDHA mutations have recently been
implicated in rare cases (Astuti et al., 2001; Baysal, 2000;
Burnichon et al., 2010; Peczkowska et al., 2008). Mutations
in SDHA, SDHB and SDHC have also been associated with
WT-GIST, a mesenchymal tumor of the digestive tract
(Janeway et al., 2011; Pantaleo et al., 2011, 2014). Finally,
the link between RCC and SDH dysfunction is supported by
the discovery of two families with inherited renal cell tumor
syndromes resulting from germline mutations in SDHB
(Vanharanta et al., 2004). Taken together, it is clear that
normal SDH activity serves to suppress tumors in humans. In
addition to the cancers described above, defects in SDH
activity also cause a variety of neurodegenerative disorders. In
fact, the classical presentation of patients with mutations
in SDHA is Leigh Syndrome, an early-onset, progressive
neurodegenerative disorder (Bourgeron et al., 1995).
SDHA mutations have also been associated with milder
forms of atrophy and myopathy (Bourgeron et al., 1995;
Horva´th et al., 2006). Although mutations in SDHC are rarely,
if ever, associated with neurologic disorders, SDHB mutations
have been shown to cause infantile leukodystrophy (Alston
et al., 2012) and SDHD mutations have recently been
identified in patients with progressive encephalomyopathy
(Jackson et al., 2014). Therefore, SDH activity not only
suppresses tumors but also supports normal neurologic
development and function. While it is fascinating that
mutations in all four subunits of SDH have been found to
cause one of the diseases described above, it is perhaps even
more interesting that numerous patients present with disease
accompanied by a loss of SDH activity, but have no mutations
of any of the core subunits (Jain-Ghai et al., 2013). These
genetic observations clearly implicate additional auxiliary
factors in the maintenance of cellular SDH activity.
Furthermore, this supports the notion that a thorough
characterization of the SDH assembly pathway will ultimately
lead to the discovery of new human disease alleles in the
genes that encode SDH assembly factors.
Enzymology and structure of succinate
dehydrogenase
Eukaryotic SDH is a heterotetrameric complex composed of
four nuclear-encoded subunits (Sun et al., 2005; Figure 1).
SDH is unique amongst eukaryotic ETC complexes in that it
functions as part of both the TCA cycle and the ETC and thus
couples two of the primary energy-harvesting pathways
within the cell. In addition to this distinction, SDH is the
only ETC complex that does not pump protons across the
IMM nor does it contain any proteins encoded by the
mitochondrial genome. In the context of the TCA cycle, SDH
catalyzes the oxidation of succinate to fumarate and uses the
electrons derived from this oxidation to catalyze the reduction
of ubiquinione to ubiquinol. These electrons are passed to
Complex III and then Complex IV, thereby contributing to the
establishment of the electrochemical gradient across the IMM
in support of ATP synthesis. The structure of SDH can be
characterized as a hydrophilic head that protrudes into the
Figure 1. Porcine succinate dehydrogenase
(PDB accession number: 1ZOY) embedded
in the mitochondrial inner membrane. SdhA
(purple ribbon); SdhB (blue ribbon); SdhC
(green ribbon); SdhD (brown ribbon); FAD
(green stick); FeS centers, [2Fe–2S],
[4Fe–4S], [3Fe–4S] from the bottom (red and
yellow sphere); Ubiquinone in the QP site
(red stick); Heme b (blue stick). (see
colour version of this figure at www.
informahealthcare.com/bmg).
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mitochondrial matrix attached to the IMM by a hydrophobic
membrane anchor (Sun et al., 2005; Yankovskaya et al., 2003;
Figure 1).
The membrane anchor domain of SDH consists of Sdh3
(SDHC in mammals) and Sdh4 (SDHD; Sun et al., 2005;
Yankovskaya et al., 2003) and serves as the site of ubiquinone
binding to connect this hydrophobic mobile electron carrier to
the hydrophilic domain of SDH (Figure 1). The hydrophilic
domain represents the catalytic core of SDH and is composed
of Sdh1 (SDHA in mammals) and Sdh2 (SDHB), each of
which contain the redox-active cofactors that facilitate the
transfer of electrons from succinate to ubiquinone (Sun et al.,
2005; Yankovskaya et al., 2003; Figure 1). Sdh1 contains a
covalently bound FAD cofactor adjacent to the succinate-
binding site (Figure 1). Sdh2 harbors the three Fe–S centers
that mediate electron transfer from the flavin cofactor to the
ubiquinone (Figure 1). The Fe–S clusters of Sdh2, which
consist of a 2Fe–2S center adjacent to the FAD site of Sdh1,
followed by a 4Fe–4S and finally a 3Fe–4S center proximal to
the ubiquinone binding site, serve essentially as a wire used to
transfer electrons through the complex (Figure 1). In addition
to its important role in the process of electron transfer, Sdh2
also serves as the interface linking the catalytic Sdh1 subunit
to the membrane bound Sdh3 and Sdh4 subunits (Sun et al.,
2005; Yankovskaya et al., 2003). Interestingly, recent reports
indicate that soluble Sdh1–Sdh2 dimers exist in the absence
of one or both of the membrane anchors (Kim et al., 2012).
This suggests that Sdh1 and Sdh2 are likely to dimerize prior
to membrane association, rather than sequentially docking
onto the membrane anchor.
The SDH enzymatic reaction begins with the binding of
succinate to the open state of Sdh1, which undergoes a
conformational change bringing succinate into close proxim-
ity with the covalently bound FAD cofactor. Oxidation of
succinate is coupled to the two-electron reduction of FAD.
Since the Fe–S centers of SDH are single electron carriers,
two successive single electron transfer steps are required to
re-oxidize FADH2 back to FAD. In the end, the two electrons
gained from the oxidation of succinate are used to reduce
ubiquinone to ubiquinol, which passes the electrons on to
Complex III.
Assembly of SDH
Until recent years, the process of SDH assembly remained
highly enigmatic and was primarily focused on the core SDH
subunits themselves (Cecchini et al., 2002; Lemire &
Oyedotun, 2002). Our newfound understanding of this process
has been facilitated by the discovery of proteins dedicated to
the maturation of individual subunits and the assembly of the
holo-complex. Importantly, the discovery of these factors has
revealed that SDH assembly is a tightly coordinated process
in which the concerted functions of core subunits, dedicated
assembly factors and other ancillary factors must coordinate
their various activities to achieve the step-wise assembly of
this membrane bound complex. Based on the knowledge
gained in recent years, it is possible to organize the process of
SDH assembly into discrete, subunit-specific events. These
events, which include cofactor insertion, stabilization of sub-
complex assembly intermediates and prevention of
deleterious solvent interactions, result in the maturation of
individual subunits and support the complete assembly of
SDH. In the subsequent sections, we will review the current
understanding of the SDH assembly pathway focusing, in
particular, on the factors that facilitate this process (Figure 3).
Sdh1 – the catalytic subunit
Architecture of Sdh1
Sdh1 catalyzes the oxidation of succinate to fumarate. The
crystal structure of porcine SDH has revealed that mammalian
SDHA assumes a Rossmann-type fold with four distinct
domains – an FAD binding domain (residues 52–267 and
355–439; human sequence), a capping domain (residues 268–
354), a helical domain (residues 440–537) and a C-terminal
domain (residues 548–616). The structure indicates the
presence of a covalent bond between FAD and His99
(His90 in yeast) with the FAD being further coordinated by
a number of additional residues, which form a well-ordered
hydrogen bonding network (Sun et al., 2005; Figure 1).
In addition to the native SDH, a co-crystal structure of SDH
bound to a competitive inhibitor, 3-nitropropionic acid (NPA)
was also determined and facilitated the mapping of the
putative succinate binding site, which, as expected, is directly
adjacent to the FAD. While the precise mechanism for
succinate oxidation by Sdh1 has not yet been elucidated, these
studies have provided valuable information as to the residues
involved in this reaction. The structure demonstrates that
the nitryl group of NPA interacts with the FMN group of FAD
as well as the main chain of Glu261 and the side chains
of Thr260 and His248 while the NPA carboxyl group is
anchored by the amide of Glu246, the guanidinium group
of Arg403 and the imidazole of His359 (Sun et al., 2005).
Biosynthesis and delivery of FAD
FAD is an essential cofactor of Sdh1 and the flavinylation of
Sdh1 is dependent on adequate FAD levels in the mitochon-
drial matrix. Therefore, the synthesis and maintenance of
free FAD pools in this compartment plays a vital role in
the maturation of Sdh1 (Kim & Winge, 2013). In yeast, the
biosynthesis of FAD and its delivery to mitochondria is
dependent on the activities of three proteins – riboflavin
kinase (Fmn1), FAD synthetase (Fad1) and a putative
mitochondrial FAD transporter (Flx1). FAD is derived from
dietary riboflavin (vitamin B2) and its conversion requires the
activities of two ATP-dependent enzymes, Fmn1 and Fad1.
Fmn1, the riboflavin kinase, phosphorylates the tricyclic
isoalloxazine ring yielding flavin mononucleotide (FMN;
Santos et al., 2000). Although a number of enzymes within
the cell use FMN as a cofactor, the majority of FMN is
subsequently adenylated and converted to FAD by the FAD
synthetase, Fad1 (Wu et al., 1995).
Flx1 belongs to the eukaryotic superfamily of IMM carriers
and has been described as a putative IMM FAD carrier, but the
published literature disagrees as to the exact molecular
function of Flx1 (Bafunno et al., 2004; Tzagoloff et al.,
1996). At any rate, cells lacking Flx1 exhibit low matrix FAD
concentrations and reduced activity of two matrix flavo-
proteins, SDH and lipoamide dehydrogenase, due to a defect in
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flavinylation of these two enzymes (Kim et al., 2012;
Tzagoloff et al., 1996). Therefore, while there is no known
direct link between Flx1 and Sdh1, it is clear that Flx1 plays an
important role in Sdh1 cofactor insertion as Sdh1 flavinylation
is severely compromised in flx1D cells. This decrease in
flavinylation also leads to the destabilization of Sdh1.
Interestingly, the flx1D defect in Sdh1 flavinylation can be
suppressed by the overexpression of Fad1 or Sdh5, a dedicated
SDH assembly factor that will be discussed in significant
detail in the subsequent section (Hao et al., 2009).
It is important to note that in mammalian cells, it is not clear
whether an Flx1 ortholog is required for SDH maturation. The
mammalian ortholog of the FAD1 gene, FLAD1, yields two
transcripts encoding two isoforms of FAD synthetase, one of
which is cytosolic and the other has a mitochondrial targeting
motif (Torchetti et al., 2010). Thus, mammalian cells might
synthesize FAD within the mitochondrial matrix perhaps
making any IMM carrier dispensable.
Sdh1 cofactor insertion
The first known step in the maturation of Sdh1, which is
imported into the mitochondrial matrix as an apo-protein, is
the insertion and covalent attachment of its FAD cofactor
(Robinson et al., 1994). Interestingly, succinate appears to be
an important allosteric effector of this process as it and
several other TCA cycle intermediates stimulate flavinylation
significantly in vitro (Brandsch & Bichler, 1989). Unlike
some bacterial Sdh1 orthologs, eukaryotic Sdh1 is not
competent to become flavinylated in the absence of other
proteins, which is typically interpreted to mean that the
flavinylation of Sdh1 is not autocatalytic (Kounosu, 2014;
Robinson & Lemire, 1996). As a result, simply maintaining
matrix FAD pools is not sufficient for Sdh1 flavinylation.
Early studies focused on this process revealed that there likely
exists a protein in the mitochondrial matrix required for
flavinylation of Sdh1 as the degree to which Sdh1 can be
flavinylated in vitro is proportional to the concentration of
isolated matrix fraction used in the assay (Robinson &
Lemire, 1996). This insight was subsequently validated by the
discovery of Sdh5.
Yeast Sdh5 was discovered in the course of studying
a collection of uncharacterized mitochondrial proteins with
a high degree of conservation throughout eukaryotes
(Hao et al., 2009). Deletion of SDH5 in yeast prevented
respiratory dependent growth and caused a dramatic reduction
in oxygen consumption – two phenotypes indicative of a
strong respiratory deficiency. In an attempt to better under-
stand this phenotype, an unbiased tandem affinity purification
was performed and it identified Sdh1 as the sole binding
partner of Sdh5. This result, consistent with a clear respira-
tory deficiency, strongly implicated Sdh5 in the maintenance
of SDH activity. This connection with SDH was further
strengthened by the observation that yeast cells lacking Sdh5
exhibited a complete loss of SDH activity and, in this regard,
essentially mirrored an sdh1D deletion strain. Despite these
phenotypic similarities, however, Sdh1 protein was still
clearly detectable, albeit at reduced levels, in an sdh5D
mutant strain and, interestingly, the SDH complex remained
intact (Hao et al., 2009; Kim et al., 2012).
Based on the above evidence, it is clear that Sdh5 is
required for maintaining SDH activity and that this function is
mediated through a direct physical interaction with Sdh1.
These data raised the possibility that the primary defect in
sdh5D cells might be failure to covalently flavinylate Sdh1,
resulting in a catalytically dead subunit. Indeed, direct
interrogation of Sdh1 flavinylation revealed a complete
failure to form the covalent bond between Sdh1 His90
and the FAD cofactor. This finding is consistent with
related studies that demonstrate flavinylation-deficient Sdh1
His90Ser mutants assemble into a catalytically inactive
SDH complex as do sdh5D mutants (Hao et al., 2009;
Robinson et al., 1994).
It is clear that Sdh5 is required for Sdh1 flavinylation but
through what mechanism? The first important clues resulted
from further interrogation of the nature of the Sdh1–Sdh5
interaction. BN-PAGE experiments demonstrated that Sdh5 is
not a member of the SDH holo-complex but rather migrates to
an approximate molecular weight of 90 kDa, consistent with
an Sdh1–Sdh5 dimer. Further investigation of this interaction
revealed that the formation of this complex is important in
maintaining the stability of both proteins. The steady-state
levels of Sdh1 are !50% reduced in an sdh5D mutant strain.
Conversely, deletion of SDH1 causes a near complete
destabilization of Sdh5, a result that strongly implicates
Sdh5 as a dedicated factor whose sole purpose is to act on
Sdh1. While Sdh1 protein is required to maintain the stability
of Sdh5, this relationship is not dependent on Sdh1 being
competent for flavinylation as substitution of Sdh1 His90 with
a Ser residue does not lead to destabilization of Sdh5. It is
important to note that only a minor fraction of Sdh1 in the
matrix is in association with Sdh5 at any given time.
Furthermore, deletion of SDH2 causes the steady-state level
of Sdh5 to increase, most likely due to an increase in the
fraction of Sdh1 that is bound to Sdh5. As this complex exists
independent of all other SDH subunits and accumulates in
strains that prevent SDH assembly, it is clear that the actions
of Sdh5 and the process of flavinylation are early steps in the
SDH assembly pathway (Hao et al., 2009; Kim et al., 2012).
Further insights into the role of Sdh5 in Sdh1 flavinylation
came from structural characterization of yeast Sdh5 by NMR
(Eletsky et al., 2012). No FAD was detected in purified
samples of Sdh5, nor did the addition of FAD to purified Sdh5
cause any perturbation in Sdh5 chemical shifts, suggesting
that Sdh5 does not act as a delivery vehicle that brings FAD to
apo-Sdh1 (Eletsky et al., 2012). The NMR studies revealed
that the Sdh5 core assumes a compact 5 a-helical bundle and
revealed a concentrated patch of conserved residues on the
surface of these a-helices, which is theorized to be the Sdh1
binding site (Eletsky et al., 2012)
While it is not yet possible to define the precise
mechanism by which Sdh5 supports Sdh1 flavinylation,
there is sufficient data to hypothesize as to the role of Sdh5
in this process. Biochemical studies have demonstrated that
Sdh5 does not directly bind FAD, thus it seems unlikely that
Sdh5 plays a role in physically delivering FAD to Sdh1.
While the Sdh1 binding site on Sdh5 has been defined in the
above NMR-based study, the region of Sdh1 that binds Sdh5
remains unknown. This information would provide insight
into the role of Sdh5 in Sdh1 flavinylation, but for now we are
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forced to theorize as to such details. It seems likely that Sdh5
binds adjacent to the FAD binding site on apo-Sdh1, which
could serve one or more of many possible roles. First, it could
facilitate the non-covalent insertion of FAD into the pocket,
which would enable subsequent autocatalytic covalent
flavinylation. Second, Sdh5 could act as a chaperone for
unflavinylated apo-Sdh1, thus supporting flavinylation by
stabilizing apo-Sdh1 in a flavinylation-competent conform-
ation. Finally, it is possible that Sdh5 might participate
directly in the covalent flavinylation reaction by providing
catalytic residues to this active site. Regardless of the precise
mechanism, it is clear that Sdh5 specifically binds to apo-
Sdh1 and is required for its covalent flavinylation (Figure 3).
Sdh8 is a chaperone for flavinylated Sdh1
Following Sdh5-dependent covalent flavinylation, Sdh1 is
destined to form a soluble dimer with Sdh2; however, there
remains a population of Sdh1 that exists in an unbound state
free from any other core subunits in the mitochondrial matrix.
It is likely that Sdh1 is present in excess to other core SDH
subunits within the mitochondrial matrix as deletion of Sdh1
destabilizes the remaining core subunits, Sdh2, Sdh3 and
Sdh4, while Sdh1 protein levels are maintained, albeit at a
reduced level, upon deletion of any of the other core subunits.
This free, flavinylated Sdh1 appears to be maintained in a
soluble, assembly-competent state by a newly discovered,
subunit-specific chaperone, Sdh8 (Figure 3).
SDH8 is conserved throughout eukaryotes and encodes a
small protein that is localized to the mitochondrial matrix
(Van Vranken et al., 2014). Yeast cells lacking Sdh8 exhibit
slow growth on non-fermentable carbon sources but are still
respiratory competent. The first observation that suggested a
role for Sdh8 in SDH assembly or activity was its
metabolomics phenotype. Yeast cells and Drosophila mutants
lacking Sdh8 (or its ortholog) exhibit a significant but subtle
block in the TCA cycle centered at SDH (i.e. an accumulation
of succinate and a depletion of fumarate and malate, the two
TCA cycle intermediates downstream of SDH). It is important
to note that the magnitude of succinate accumulation is much
less than a mutant lacking one of the four core subunits or
Sdh5, which exhibits a complete loss of SDH activity.
Consistent with this finding, sdh8D mutant yeast maintain
approximately 40% of wild-type SDH activity and abundance
of SDH holo-complexes. Interestingly, deletion of the
Drosophila ortholog, dSdhaf4, causes a much more severe
phenotype. These mutants accumulate significantly more
succinate and have a !90% decrease in SDH activity, while
assembled SDH complexes are nearly undetectable. Thus,
while Sdh8 clearly supports SDH biogenesis, it does not
appear to be absolutely required for assembling functional
SDH complexes as some level of SDH activity is maintained
in organisms lacking Sdh8 or its orthologs (Van Vranken
et al., 2014).
While metabolomics clearly implicated Sdh8 in enabling
SDH activity, the first evidence as to its particular function
came when Sdh1 was discovered to be its primary binding
partner. Further interrogation of the specificity of this
interaction revealed that Sdh8 bound to Sdh1 independent
of any other SDH core subunits and importantly, Sdh5. In
addition, it was determined that the Sdh1–Sdh8 interaction
depends on covalent flavinylation of Sdh1, as Sdh8 fails to
interact with Sdh1 in an sdh5D background and also fails to
interact with two covalent flavinylation-deficient Sdh1
mutants (H90S and H90A). BN-PAGE analysis further
confirmed that Sdh8 is not associated with the SDH
Figure 2. Iron-sulfur cluster synthesis and delivery to Sdh2. The tan box depicts the de novo synthesis of 2Fe–2S clusters within the ISU complex.
Clusters are formed on the Isu1 scaffold protein with sulfide ions provided by the Nfs1 cysteine desulfurase and Yah1 ferredoxin. It is not clear how
ferrous ions are delivered to the ISU complex. The preformed 2Fe–2S cluster is released from the scaffold complex through the actions of Hsp70 (Ssq1)
and DnaJ (Jac1) to a transfer complex consisting of GSH-bound Grx5. The GSH–Grx5 delivers 2Fe–2S clusters to the ISA complex for the subsequent
4Fe–4S cluster synthesis depicted in the blue box. However, it is elusive whether the GSH-Grx5 is also required for 2Fe–2S cluster delivery to recipient
proteins, in this case, Sdh2. It is also unknown whether the preformed 4Fe–4S clusters are directly delivered to Sdh2 or another factor is in need for this
delivery step. All arrows with solid lines indicate transfer of components of Fe–S clusters or pre-formed Fe–S clusters.
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holo-complex, but forms a stable subcomplex with Sdh1,
which hyper-accumulates in sdh2D and sdh4D backgrounds.
Consistent with this finding, Sdh8 steady-state protein levels
also increase in these conditions, presumably to occupy the
augmented pool of unbound and flavinylated Sdh1.
Furthermore, deletion of Sdh1 causes significant destabiliza-
tion of Sdh8, indicating that the stability of Sdh8 depends
upon its ability to form a complex with Sdh1. Taken
together, these data indicate that Sdh8 is a subunit-specific
chaperone that occupies flavinylated Sdh1 prior to the forma-
tion of the Sdh1–Sdh2-soluble dimer (Van Vranken et al.,
2014; Figure 3).
Why exactly does unbound Sdh1 require such a chaperone?
The first evidence came from assessing the steady-state levels
of SDH core subunits in the sdh8D mutant. While there was
little or no destabilization of Sdh1, the primary binding
partner of Sdh8, there was a marked decrease in the steady-
state abundance of Sdh2. This was accompanied by, and
probably a result of, a decrease in the Sdh1–Sdh2 soluble
dimer as assessed by co-immunoprecipitation. Although this
result is somewhat difficult to interpret, it suggests that the
interaction between Sdh1 and Sdh8 facilitates the formation
of the Sdh1–Sdh2 dimer by maintaining Sdh1 in a state that
is competent for Sdh2 binding. Therefore, in the absence of
Sdh8, Sdh1 does not interact as efficiently with Sdh2, which
is unstable on its own. Interestingly, studies focused on
Drosophila dSdhaf4 demonstrate that this assembly factor
is required for maintaining the stability of SdhA. Therefore,
it is possible that in higher eukaryotes Sdh8 orthologs support
the formation of the hydrophilic head by maintaining subunit
stability. Overall, this data suggests that the chaperone
activity of Sdh8 promotes SDH assembly by stabilizing
Sdh1 and maintaining it in an assembly-competent state prior
to interaction with Sdh2 (Van Vranken et al., 2014).
In addition to promoting formation of the Sdh1–Sdh2
dimer, Sdh8 might also function to prevent potentially
deleterious interactions of free and flavinylated Sdh1 with
the solvent. Indeed, studies focused on SDH have demon-
strated that impaired electron transport at the level of the FAD
can generate significant quantities of superoxide (Ishii et al.,
2005; Messner & Imlay, 2002; Yankovskaya et al., 2003).
Furthermore, previous studies in mammalian cells demon-
strate that silencing of SDHB (Sdh2 ortholog), but not SDHA
(Sdh1 ortholog) causes an increase in ROS levels (Guzy et al.,
2008; Ishii et al., 2005). This increase in oxidative stress
mediated by Sdh1 is thought to be dependent on the ability of
the exposed FAD cofactor to interact with the surrounding
solvent. In a phenomenon referred to as auto-oxidation, free
Sdh1 oxidizes succinate to fumarate independent of the SDH
holo-complex. This oxidation causes a reduction of the FAD
cofactor, which then reduces molecular oxygen to form
superoxide (Messner & Imlay, 2002). If Sdh8 functions to
prevent Sdh1 auto-oxidation then overexpression of Sdh1
should be toxic to sdh8D mutant cells. In fact, Sdh1
overexpression proved toxic to both WT and sdh8D mutant
cells; however, cells lacking Sdh8 were particularly sensitive
Figure 3. Model of the SDH assembly
pathway. Each SDH core subunit is trans-
lated in the cytosol and must be subsequently
translocated to the mitochondria. (1) Upon
mitochondrial import, apo-Sdh1 is rapidly
bound by the subunit-specific chaperone,
Sdh5, forming a dimeric complex that sup-
ports covalent attachment of the FAD cofac-
tor. (2) Following covalent flavinylation, the
Sdh1–Sdh5 dimer disintegrates resulting in a
pool of flavinylated Sdh1 that is unbound by
any other core subunits. This leads to the
formation of a complex comprised of Sdh1
and Sdh8, another subunit-specific chaper-
one. (3) The formation of this complex
supports the formation of the subsequent
Sdh1–Sdh2 soluble dimer and also prevents
the spurious production of superoxide by
flavinylated Sdh1. Meanwhile, apo-Sdh2
must also mature into a complex-competent
subunit. This process involves the insertion of
three Fe–S clusters generated by the ISU and
ISA complexes. (4) Following maturation of
Sdh2, it interacts with Sdh6 and Sdh7, which
serve to protect exposed Fe–S clusters during
the assembly process and (5) further associ-
ates with a mature Sdh1 subunit forming a
heterotetrameric assembly intermediate. (6)
Finally, the Sdh1–Sdh2 hydrophillic head
docks to the IMM via interactions with the
Sdh3–Sdh4 membrane anchor domain, which
may or may not pre-assemble at the IMM. In
the end, the concerted efforts of core sub-
units, dedicated assembly factors and other
ancillary factors facilitate the stepwise
assembly of SDH. (see colour version of this
figure at www.informahealthcare.com/bmg).
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to this stress. Furthermore, overexpression of Sdh8 was
capable of partially rescuing the toxicity associated with
overexpressed Sdh1. Additional studies demonstrated that
sdh8D mutant cells exhibited higher levels of oxidative stress
and that the growth phenotype associated with sdh8D mutant
cells was predominantly the result of oxidative stress rather
than respiratory deficiency. Indeed, while overexpression of
YAP1, a transcription factor involved in mediating oxidative
stress, is capable of rescuing the sdh8D growth phenotype it
fails to have any impact on the SDH deficiency of these cells
(Van Vranken et al., 2014). Therefore, Sdh8 might have two
important functions related to Sdh1. It appears to facilitate
assembly with Sdh2 and may also function to seclude the
FAD cofactor from the solvent, thus preventing spurious
oxidation (Van Vranken et al., 2014).
Sdh2 – the electron wire
Architecture of Sdh2
Sdh2 (SDHB in mammals) is the Fe–S cluster-containing
subunit of SDH. The crystal structure of porcine heart SDH
demonstrates that SDHB contains two distinct domains (Sun
et al., 2005; Figure 1). The N-terminal domain (residues
37–142; human sequence) consists of a single small a-helix
and a five-strand b-sheet. This domain harbors the FAD-
proximal 2Fe–2S center, which is ligated by Cys93, Cys98,
Cys101 and Cys113. The C-terminal domain (residues 142–
280) consists of six a-helices and harbors the 4Fe–4S and
3Fe–4S centers, which are coordinated by Cys186, Cys189,
Cys192 and Cys253 and Cys196, Cys243 and Cys249,
respectively. These three Fe–S centers essentially act as a
wire that carries electrons from FAD to ubiquinone. SDHB
also serves to connect the catalytic subunit, SDHA, with the
hydrophobic anchor domain. Both the N-terminal domain and
the C-terminal domain mediate the interaction with SDHA.
Meanwhile, the C-terminal domain is mainly responsible
for the interaction with the hydrophobic anchor domain.
Importantly, SDHB contributes several residues to the
ubiquinone-binding site, which otherwise is mediated by the
hydrophobic anchor domain. In this way, the terminal 3Fe–4S
center is poised adjacent to the ubiquinone to enable the final
electron transfer (Sun et al., 2005).
Iron–sulfur cluster biogenesis
The aforementioned Fe–S clusters are key cofactors required
for electron transfer from FAD to the QP site. Fe–S clusters
are preformed in the mitochondrial matrix on a scaffold
complex (ISU) consisting of four proteins, Nfs1, Isd11, Yfh1
and Isu1 (or Isu2; yeast nomenclature) (Lill et al., 2012;
Schmucker et al., 2011; Tsai & Barondeau, 2010). The sulfide
ions necessary for cluster biogenesis are provided by the Nfs1
cysteine desulfurase, along with its effector proteins Isd11
and Yfh1 (Pandey et al., 2012, 2013) and the Yah1 ferredoxin
reductant (Sheftel et al., 2010). Fe(II) and sulfide ions form
2Fe–2S clusters on the Isu1 (or Isu2) scaffold proteins prior to
transfer to client proteins. The preformed cluster is transferred
to the monothiol Grx5, an Fe–S shuttle protein, through the
binding of the DnaJ protein Jac1 to Isu1, which dissociates
the ISU complex (Majewska et al., 2013) and the recruitment
of the Hsp70 enzyme Ssq1. The cluster is released from Isu1
by the ATPase activity of Ssq1 (Ciesielski et al., 2012;
Majewska et al., 2013; Uzarska et al., 2013). Grx5, which is
pre-associated with Ssq1, transiently binds the 2Fe–2S cluster
together with glutathione (GSH) for subsequent transfer steps
(Banci et al., 2014; Johansson et al., 2011; Uzarska et al.,
2013). The human ortholog of Jac1 was shown to also
bind Fe–S client proteins, so Grx5-mediated cluster transfer
may occur in pre-bound complexes with client proteins
(Maio et al., 2014). Clusters consisting of 4Fe–4S and
perhaps 3Fe–4S stoichiometries are matured on a downstream
ISA scaffold complex consisting of Isa1, Isa2 and Iba57
(Gelling et al., 2008; Muhlenhoff et al., 2011; Sheftel et al.,
2012) and perhaps Nfu1 (Cameron et al., 2011; Lill et al.,
2012; Navarro-Sastre et al., 2011). Nfu1 is likely a targeting
factor to Fe–S client proteins in bacteria (Py et al., 2012).
Yeast depleted of ISU components or the Fe–S targeting
factors Grx5, ISA components and Nfu1 are impaired in SDH
activity (Jensen & Culotta, 2000; Muhlenhoff et al., 2011;
Rodriguez-Manzaneque et al., 2002). Mutations in human
orthologs of Isd11, Isu1, Iba57 or Nfu1 (Ajit Bolar et al.,
2013; Cameron et al., 2011; Crooks et al., 2012; Ferrer-
Cortes et al., 2013; Hall et al., 1993; Lim et al., 2013;
Navarro-Sastre et al., 2011) or RNAi depletion of Isa1, or Isa2
lead to compromised SDH function (Sheftel et al., 2012;
Figure 2).
Recently, mutations in a novel mitochondrial protein
BolA3 were shown to result in defects in similar respiratory
complexes and 2-oxoacid dehydrogenases as mutations in
Nfu1 (Baker et al., 2014; Cameron et al., 2011), suggesting
that BolA3 may likewise function in late stages of mitochon-
drial Fe–S biogenesis or transfer. BolA proteins typically
function with glutaredoxins (Li & Outten, 2012), therefore,
one prediction is that BolA3 has a role in conjunction
with Grx5.
Sdh2 cofactor insertion
The architecture of Sdh2 raises several questions regarding
cofactor insertion and maturation. Analogous to Sdh1, which
receives its FAD cofactor within the mitochondrial matrix,
Sdh2 receives its three Fe–S clusters in the matrix after
import (Figure 3). Based on the Fe–S biogenesis pathway
outlined above, one prediction is that the 2Fe–2S center in the
N-terminal domain of Sdh2 is received from the Grx5:GSH
complex, whereas the clusters in the C-terminal domain may
be populated by the late-stage targeting factors ISA and Nfu1.
Recently, Maio et al. (2014) reported that the mammalian
Jac1 ortholog HSC20, the Ssq1 ortholog HSPA9 and the Isu1
scaffold, ISCU, form a complex with SDHB. This SDHB
assembly intermediate was visualized on BN-PAGE after co-
immunoprecipitation of SDHB. SDH activity appeared to be
attenuated upon depletion of HSC20 or HSPA9 using siRNA
knock down. Therefore, the study suggested that cluster
transfer to SDHB occurs within this complex. In vitro
synthesized SDHB is readily imported into isolated mito-
chondria. Co-immunoprecipitation of the imported SDHB at
different time points revealed that the interaction of SDHA
with SDHB comes later than the formation of the HSC20/
HSPA9/ISCU/SDHB complex, indicating that cluster transfer
174 J. G. Van Vranken et al. Crit Rev Biochem Mol Biol, 2015; 50(2): 168–180
15 
may precede binding of SDHB to SDHA. However, the ISA
components and Nfu1 failed to be co-adsorbed with the
HSC20 pulldown. These results may imply that only the
2Fe–2S center is transferred within the HSC20/HSPA9/ISCU/
SDHB complex and a subsequent transfer step mediates
insertion of the C-terminal SDHB clusters. This process could
be either a zip-up from 2Fe–2S through 3Fe–4S or a zip-down
from 3Fe–4S through 2Fe–2S. Alternatively, SDHB may
remain associated with HSC20 during the insertion of the
4Fe–4S and 3Fe–4S centers, although the targeting factors
may not stably associate with the HSC20/HSPA9/ISCU/
SDHB complex (Maio et al., 2014).
It should be noted that reduced Cys thiolates are required
for Fe–S clusters to be assembled into Sdh2 as oxidized Cys
ligands cannot coordinate Fe–S clusters. However, it is
unknown whether cells depend on the thioredoxin/thioredoxin
reductase, glutathione/glutathione reductase or peroxiredoxin
to ensure the presence of thiolates for Fe–S coordination.
It is also intriguing how meta-stable Sdh2 intermediates are
protected specially from ROS after Fe–S cluster insertion.
It has been well known that Fe–S clusters are extremely
susceptible for damage upon exposure to oxygen (Imlay,
2006). Since 2Fe–2S and 3Fe–4S clusters are exposed to
solvent in Sdh2 prior to association with Sdh1 and the
membrane anchor domain, it is possible that specialized
chaperones are required to sequester these Fe–S clusters from
oxidative stressors present in the solvent.
In the following section, we discuss two recently reported
SDH assembly factors required for the maturation of Sdh2.
Sdh6 and Sdh7 are chaperone required for Sdh2
maturation
Sdh6 (SDHAF1 in human) is the first SDH assembly factor
reported. Mutations in human SDHAF1 compromise the
stable assembly of SDH, which leads to SDH deficiency
associated with infantile leukoencephalophaty (Ghezzi et al.,
2009, Ohlenbusch et al., 2012). Sdh6 is a small mitochondrial
matrix protein that belongs to the LYR motif protein family,
which is defined by the presence of a short
LX(L/A)YRXX(L/I)(R/K) motif. Previous studies showed
that the functions of several other LYR motif proteins are
related to Fe–S cluster metabolism. Ghezzi et al. reported that
yeast or human cells lacking wild-type Sdh6 (or its ortholog)
exhibited significantly reduced SDH activity, accompanied by
attenuation of SDH assembly (Ghezzi et al., 2009). They
suggested the possibility that Sdh6 is an assembly factor
required for the Fe–S containing subunit, Sdh2, based on the
fact that Sdh6 is an LYR motif protein. While prescient, this
hypothesis remained unproven as the biochemical data
supporting it were not yet available. We recently reported
that Sdh6 is indeed an assembly factor required for stable
Sdh2 maturation during SDH assembly (Na et al., 2014).
In yeast cells lacking Sdh6, Sdh2 steady-state levels were
significantly diminished, but Sdh1 steady-state levels and
covalent flavinylation remained unaffected. Moreover, Sdh6
appeared to accumulate in sdh3D or sdh4D cells lacking the
SDH membrane anchor domain where an Sdh1/Sdh2
subcomplex accumulated. Furthermore, immunoprecipitation
of Sdh6 in mitochondrial lysates from cells lacking Sdh4
resulted in co-precipitation of Sdh1 and Sdh2, but immuno-
precipitation of Sdh6 in WT or sdh2D mutants failed to yield
Sdh1 or Sdh2. Thus, these results suggested that Sdh6
interacts with an Sdh1/Sdh2 complex and the interface for the
interaction resides within Sdh2 (Figure 3). Indeed, Sdh6
overexpression in sdh1D mutants, in which Sdh2 is extremely
labile, increased Sdh2 accumulation, thus, corroborating the
postulate that Sdh6 acts on Sdh2 during SDH assembly.
Why does Sdh2 require the function of Sdh6 during
the process of SDH assembly? One possibility is that Sdh6
is a chaperone stabilizing Sdh2 prior to Sdh1 association.
However, Sdh2 overexpression failed to restore SDH activity
in sdh6D mutants. Thus, Sdh6 likely exerts its function on
Sdh2 maturation rather simply maintaining an apo-Sdh2 pool.
Unbiased high-copy genetic suppressor screening provided
a hint regarding Sdh6 function (Na et al., 2014). Yap1, a
transcription factor that increases expression of a repertoire
of genes required for oxidative stress tolerance was recovered
from this screen. Yap1 overexpression enhanced the respira-
tory growth of sdh6D mutants and restored SDH activity.
Conversely, artificially increased superoxide generation in the
presence of paraquat severely impaired the respiratory growth
of sdh6D cells. Moreover, Sdh2 protein levels under this
condition were dramatically decreased. Given that ROS levels
were not increased in sdh6D mutants, this exacerbated
phenotype with paraquat suggests that Sdh6 is important for
protecting Sdh2 from ROS-induced damage.
In the meantime, a genetic interaction between Sdh6 and
Acn9 (renamed Sdh7), another protein in the LYR motif
protein family, was observed. Sdh7 is also a small mitochon-
drial matrix protein, required for normal respiratory growth.
Overexpression of Sdh6 in sdh7D mutants slightly rescued the
respiratory growth defect although overexpression of Sdh7 in
sdh6D mutants failed to do so. Metabolite profiling suggested
an SDH deficiency in sdh7D mutant cells as succinate
accumulated in the mutants. BN-PAGE analysis and SDH
activity assay confirmed SDH deficiency with reduced SDH
complex levels in sdh7D mutants. Biochemical analysis of
sdh7D mutants suggested that Sdh7 function is similar to that
of Sdh6 (Na et al., 2014). Among the SDH structural
subunits, the steady-state levels of Sdh2 were the most
impaired in sdh7D mutants. Sdh7 exhibited increased abun-
dance and interaction with the Sdh1/Sdh2 subcomplex in cells
lacking the SDH membrane anchor. In addition, Yap1
overexpression restored SDH activity and paraquat supple-
ment markedly attenuated Sdh2 steady-state levels in sdh7D
cells. However, Sdh2 overexpression failed to restore SDH
activity in sdh7D cells. Thus, these results suggested that
Sdh7 is another assembly factor for protecting Sdh2 from
ROS damage. Deletion of the Drosophila melanogaster SDH7
ortholog, dSdhaf3, caused a dramatic SDH deficiency with
muscular and neuronal defects that are reminiscent of
neurodegeneration observed in humans with mutations in
SDHAF1 (Na et al., 2014).
It is clear that Sdh6 and Sdh7 support the assembly of SDH
under normal physiological conditions, although their defi-
ciencies do not result in total ablation of SDH biogenesis.
This might be due to a theoretical bypass pathway that can
substitute for Sdh6 and Sdh7 functions. Otherwise, the
importance of these two assembly factors is limited with
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passive roles for Sdh2 maturation under certain circum-
stances. Our study shows that iron salt supplementation
enhances the respiratory growth of sdh6D cells and sdh7D
cells. It has been shown that ROS-inactivated aconitase under
aerobic conditions regains activity following iron salt supple-
mentation (Kennedy et al., 1983). The active site of aconitase
harbors a 4Fe–4S cluster, which loses one Fe atom upon
exposure to superoxide, resulting in inactivation. Increased
concentration of iron salts facilitates re-insertion of Fe(II) ion
back into the damaged 3Fe–4S center, leading to reactivation
of aconitase. Therefore, it is possible that Sdh6 and Sdh7
are involved in shielding the aforementioned solvent-exposed
Fe–S centers from ROS until an Sdh1/Sdh2 complex is fully
assembled with Sdh3 and Sdh4. A recent study on Fe–S
cluster insertion to SDHB has revealed that SdhB (Sdh2) can
be expressed as two separate domains in vivo and SDHAF1
(Sdh6) interacts with the C-terminal domain of SdhB, but
not with the N-terminal domain (Maio et al., 2014). The
C-terminal domain harbors 4Fe–4S and 3Fe–4S centers
(Sun et al., 2005). Therefore, it is possible that Sdh6 is
required for protecting the solvent-exposed 3Fe–4S center
from ROS damage. However, there is no data suggesting how
Sdh7 would exert its protection on Sdh2.
The origin of the damaging ROS is unclear, but a likely
source is either the 2-oxoacid dehydrogenases including
2-oxoglutarate dehydrogenase and pyruvate dehydrogenase or
the respiratory complexes (Quinlan et al., 2014). However,
it is also possible that ROS generated intrinsically within an
Sdh1/Sdh2 subcomplex might play a role. Like flavinylated
monomeric Sdh1, an Sdh1/Sdh2 subcomplex is also compe-
tent to catalyze succinate oxidation (Lemire & Oyedotun,
2002; Nihei et al., 2001). It is expected that the electrons
extracted from succinate oxidation can travel to Fe–S centers.
Once the electrons reach the solvent-exposed surface via Fe–S
centers, the electrons can react with oxygen to generate local
ROS that can damage Fe–S centers in the vicinity. Therefore,
one alternative role of Sdh6 and Sdh7 might be that they
interact with an Sdh1/Sdh2 complex to inhibit the electron
transfer to Fe–S centers within the subcomplex.
It has also been suggested that Sdh6 may be directly
involved in the process for Fe–S insertion into Sdh2 based on
the observation that the SDH assembly factor SDHAF1
(Sdh6) was recovered in the immunoadsorption of HSC20
(Maio et al., 2014). It remains unclear, however, whether
SDHAF1 is a dedicated Fe–S targeting factor for SDHB since
no additional evidence is available to show that Sdh6 has an
active role in Fe–S cluster formation.
Sdh3 and Sdh4 – the hydrophobic anchor
Architecture of the hydrophobic anchor
The SDH membrane anchor consists of an Sdh3–Sdh4
heterodimer and an intercalated heme b moiety. The structure
of mammalian SDH demonstrates that SDHC contains four
total helices while SDHD contains five (Sun et al., 2005;
Figure 1). The N-terminal helix of SDHD is localized to the
mitochondrial matrix and interacts with SDHB to promote
membrane localization of the hydrophilic dimer. Each subunit
contributes two transmembrane helices to the formation of a
four-helix bundle, which comprises the core of the membrane
anchor, while the remaining transmembrane helix from each
subunit flanks the core. The remaining helices from each
subunit protrude from the membrane and arrange in antipar-
allel fashion in the IMS essentially capping the transmem-
brane core. In addition to the helical arrangement of this
domain, the structure reveals that SDHC and SDHD coord-
inate a heme b cofactor at the interface of the core four-helix
bundle, which interacts with the porphyrin ring. Each subunit
contributes a conserved histidine residue that coordinates
the heme iron while two arginine residues, one from
SDHC and one from SDHD, as well as another histidine
residue from SDHC interact with the heme propionate groups
(Sun et al., 2005).
The membrane anchor domain contains the site of
ubiquinone binding and reduction, which ultimately facilitates
electron transfer from succinate to subsequent ETC com-
plexes (Sun et al., 2005). In fact, this domain contains two
ubiquinone binding sites that are distinguished by their
disparate affinities for ubiquinone (Oyedotun & Lemire,
2001; Silkin et al., 2007). The high-affinity site (QP-proximal)
lies on the matrix-proximal side of the IMM and is the
dominant ubiquinone binding site (Figure 1). The QP site is
composed of residues from SDHC, SDHD and SDHB
including the terminal 3Fe–4S cluster of SDHB (Sun et al.,
2005). The second binding site (QD-distal) lies closer to the
IMS side of the IMM and is a lower affinity site. This site is
composed entirely of residues from SDHD (Sun et al., 2005).
Ubiquinone reduction occurs in two stepwise single electron
transfers, in contrast to the two-electron reduction of FAD.
Importantly, the QP site stabilizes the partially reduced
semiquinone intermediate and facilitates full reduction of
ubiquinone to ubiquinol, thereby preventing the generation
of reactive oxygen species (ROS; Yankovskaya et al., 2003).
Assembly of the hydrophobic anchor
With respect to assembly of the hydrophobic anchor, there
remain more questions than answers. Sdh3 and Sdh4 are
translated in the cytosol and imported to mitochondria
through the TOM complex. They may then be transferred to
the TIM23 complex in the IMM and laterally released to the
final destination like other a-helical transmembrane IMM
proteins (Dudek et al., 2013). Unfortunately, membrane
insertion represents the bulk of our knowledge regarding
assembly of this dimer and thus many questions remain.
Do Sdh3 and Sdh4 folding and subsequent dimer formation
require a chaperone? How is the Sdh3–Sdh4 assembly
intermediate stabilized prior to formation of the holo-
complex? Although little is known about this process, it is
intriguing that stable Sdh3/Sdh4 dimerization requires the
hydrophilic domain as deletion of either Sdh1 or Sdh2 causes
near complete loss of both Sdh3 and Sdh4 (Kim et al., 2012;
Na et al., 2014). Thus, it appears that biogenesis of the
hydrophobic anchor is in some manner connected to the rest
of the assembly process.
Perhaps the most intriguing question regarding the hydro-
phobic anchor relates to the heme b cofactor. In fact, it is
unclear whether heme b is actually required for the electron
transfer from FAD to ubiquinone in the QP site. The heme b
lies further away from the 3Fe–4S (13.3 A˚) than the QP site
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does (7.6 A˚; Sun et al., 2005; Yankovskaya et al., 2003).
Moreover, the redox potential of heme b (!185mV) is much
lower than the 3Fe–4S (+60mV) in SDH (Ha¨gerha¨ll, 1997).
Therefore, these two barriers would make the electron transfer
from 3Fe–4S to heme b thermodynamically unfavorable
compared to the direct electron transfer to ubiquinone
(+113mV). In fact, SDH complexes lacking heme b (from
yeast cells expressing Sdh3 H106A and Sdh4 C78A heme-
ligand mutants) appeared to be able to catalyze succinate-
dependent quinone reduction (Oyedotun et al., 2007).
It should be noted, however, that the heme b is important
for the structural integrity of the membrane anchor domain
in mammalian cells. SDH and SDHD steady-state levels were
decreased in cells expressing SDHC His-ligand mutants
(H127A or H127Y) in the absence of wild-type SDHC
(Lemarie et al., 2011).
Regardless of its precise function, the heme b cofactor is
present in SDH across all species, suggesting its importance
in either electron transfer or complex stability. However, it is
not yet known how Sdh3 and Sdh4 are assembled with heme b
in the IMM. Does an assembly factor deliver and/or insert the
heme b into a pre-existing Sdh3/Sdh4 dimer? It has been
shown that several assembly factors, including Coa1, Coa2
and Shy1, are required for proper heme insertion into the
complex IV subunit Cox1 in the IMM (Atkinson et al., 2010;
Mashkevich et al., 1997; Pierrel et al., 2007, 2008).
Therefore, one might expect that an assembly factor is
required for SDH hemylation. Overall, studies addressing the
assembly of this domain represent an important next step in
understanding SDH biogenesis.
Conclusion
Prior to the discovery of the assembly factors reviewed herein,
it was difficult to fully appreciate the complexity of the SDH
assembly pathway. This is perhaps best illustrated by the fact
that at least four and quite possible more, dedicated assembly
factors are required for the maturation of the two soluble
subunits alone. This does not even consider the process of
assembling the Sdh3–Sdh4 hydrophobic domain. In the end,
the assembly of SDH does not happen spontaneously, but is
rather the result of a highly intricate and stepwise process
facilitated by the concerted efforts of a number of accessory
assembly factors.
These discoveries have dramatically increased our under-
standing of the assembly process and allow us to propose a
more complete model of the SDH assembly pathway (Ghezzi
et al., 2009; Hao et al., 2009; Na et al., 2014; Van Vranken
et al., 2014; Figure 3). Following cytosolic translation, Sdh1
and Sdh2 are imported into the mitochondrial matrix as apo-
proteins. Each of these subunits must subsequently mature in
a process that is facilitated by subunit-specific assembly
factors. Upon import, Sdh1 must be flavinylated and is bound
by Sdh5, which enables this process. Although the precise
mechanism remains poorly defined, Sdh5 most likely main-
tains apo-Sdh1 in a confirmation that facilitates insertion and
covalent binding of FAD. Once Sdh1 has been covalently
flavinylated, Sdh5 is released and holo-Sdh1 binds another
subunit-specific chaperone, Sdh8. Sdh8 appears to serve dual
roles in the process of assembly. First, Sdh8 prevents the
generation of superoxide by Sdh1 through limiting the
spurious reduction of oxygen. In addition to this, Sdh8 also
appears to facilitate the formation of the Sdh1–Sdh2 soluble
dimer. Like Sdh1, apo-Sdh2 must also mature prior to
complex formation. The initial step in the maturation of this
subunit is the insertion of the three Fe–S clusters generated
by the ISU and ISA complexes. At this point, both Sdh1 and
Sdh2 have matured into holo-proteins and can proceed
through the assembly process. Sdh2 comes into association
with two additional chaperones, Sdh6 and Sdh7 as it forms a
soluble complex with Sdh1, thereby displacing Sdh8 and
generating a heterotetrameric assembly intermediate. This
intermediate, which is facilitated by Sdh6 and Sdh7, serves to
protect surface-exposed Fe–S clusters and possibly prevents
the spurious generation of superoxide by the redox active
Sdh1–Sdh2 dimer. Finally, the Sdh1–Sdh2 dimer is bound by
the Sdh3–Sdh4 hydrophobic domain, which may or may not
be pre-assembled in the IMM, bringing the hydrophilic head
in close association with the IMM and forming the active
holo-complex (Figure 3).
In general, the contribution of subunit-specific assembly
factors to the process of SDH assembly can be organized into
three distinct functions. First, they mediate the insertion of
essential cofactors. All ETC complexes utilize cofactors to
perform the redox chemistry necessary to oxidize and reduce
substrates and transfer electrons. Therefore, the maturation
of individual subunits and subsequent assembly of active
complexes is dependent on the post-translational insertion of
essential redox-active cofactors. This is highlighted by the
fact that eukaryotic genomes have maintained a specific Sdh1/
SDHA flavinylation factor, which is absolutely required for
the covalent attachment of FAD to this subunit. It remains to
be determined whether Sdh6 or Sdh7 also has an active role in
the insertion of one or more of the Fe–S clusters in Sdh2.
Second, assembly factors act as subunit-specific chaper-
ones that stabilize individual subunits and assembly inter-
mediates. The process of SDH, and more generally, ETC
assembly, relies on the step-wise assembly of potentially
dozens of individual subunits translated from two different
genomes to form a single intricately constructed complex. As
the structures of individual subunits are optimized to exist and
function in the context of fully assembled complexes, it is not
surprising that individual subunits and sub-complexes require
chaperones to maintain stability during assembly. In terms of
SDH assembly, this has been validated by discovery of
specific factors that mediate the stability of both individual
subunits and multimeric assembly intermediates. Indeed,
work in Drosophila has demonstrated that the fly ortholog of
Sdh8 is required for stabilization of holo-SdhA. Furthermore,
the requirement for stabilizing holo-assembly intermediates is
more manifested in the case of assembly intermediates
containing oxidatively labile cofactors such as Fe–S centers.
Sdh6 and Sdh7 appear to specifically bind and stabilize the
Sdh1–Sdh2 soluble dimer prior to membrane association via
Sdh3/Sdh4.
Third, assembly factors serve to prevent spurious and
potentially deleterious interactions between individual redox-
active subunits and the surrounding solvent. As a result of the
unique chemistry enabled by their cofactors, individual ETC
complex subunits are potentially toxic when not secluded
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within a fully assembled complex. Indeed, the cell contains
numerous protein complexes that need to be assembled in an
organized fashion; however, dedicated assembly factors are
much more common for those complexes in which individual
subunits contain redox-active cofactors. This is highlighted by
the role of Sdh8 as a chaperone for covalently flavinylated
Sdh1. In isolation, flavinylated Sdh1 is capable of oxidizing
succinate, which results in the spurious generation of
superoxide upon reduction of molecular oxygen. By occupy-
ing free Sdh1, Sdh8 serves to minimize these deleterious
chemical reactions, thus protecting the matrix from ROS.
Sdh6 and Sdh7, which specifically bind the potentially redox-
active Sdh1–Sdh2 dimer, could potentially mediate similar
protection as Sdh8.
In addition to providing valuable insights into the SDH
assembly pathway the recent discovery of SDH assembly
factors has also facilitated a greater understanding of SDH-
deficient pathologies (Table 1). The literature has many
reports of patients with SDH deficiencies; however, it is clear
that only a subset of these cases can be explained by
mutations in the genes encoding the four core subunits. With
the discovery of a number of proteins intimately involved in
the SDH assembly pathway, this disparity may now start to be
resolved. Indeed, it is now clear that loss of function
mutations in SDH assembly factors are capable of causing
the same pathologies as the core subunits themselves.
Analogous to mutations in SDHA, mutations in SDHAF1,
the human ortholog of SDH6, were discovered as a cause of
leukoencephalopathy, a neurodegenerative disorder similar to
Leigh Syndrome (Ghezzi et al., 2009). Furthermore, muta-
tions in SDHAF2, the human ortholog of SDH5, were shown
to be the causative lesion in at least two families with familial
paraganglioma syndrome, mirroring the physiological conse-
quences of core subunit mutations (Hao et al., 2009).
Currently, there are no published reports describing human
mutations in SDHAF3 (SDH7) or SDHAF4 (SDH8); however,
these genes have only recently been implicated in the SDH
assembly pathway. We suspect that, in time, mutations in
these genes will ultimately be discovered in patients with
SDH-deficient pathologies, thus further clarifying the con-
nection between succinate dehydrogenase and human disease.
Declaration of interest
The authors report no declaration of interest.
References
Ajit Bolar N, Vanlander AV, Wilbrecht C, et al. (2013). Mutation of the
iron-sulfur cluster assembly gene IBA57 causes severe myopathy and
encephalopathy. Hum Mol Genet 22:2590–602.
Alston CL, Davison JE, Meloni F, et al. (2012). Recessive germline
SDHA and SDHB mutations causing leukodystrophy and isolated
mitochondrial complex II deficiency. J Med Gen 49:569–77.
Astuti D, Latif F, Dallol A, et al. (2001). Gene mutations in the succinate
dehydrogenase subunit SDHB cause susceptibility to familial
pheochromocytoma and to familial paraganglioma. Am J Hum
Genet 69:49–54.
Atkinson A, Khalimonchuk O, Smith P, et al. (2010). Mzm1 influences a
labile pool of mitochondrial zinc important for respiratory function.
J Biol Chem 285:19450–9.
Bafunno V, Giancaspero TA, Brizio C, et al. (2004). Riboflavin uptake
and FAD synthesis in Saccharomyces cerevisiae mitochondria:
involvement of the Flx1p carrier in FAD export. J Biol Chem 279:
95–102.
Baker II PR,, Friederich MW, Swanson MA, et al. (2014). Variant non
ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and
the novel gene GLRX5. Brain 137:366–79.
Banci L, Brancaccio D, Ciofi-Baffoni S, et al. (2014). [2Fe-2S] cluster
transfer in iron-sulfur protein biogenesis. Proc Natl Acad Sci USA
111:6203–8.
Baysal BE. (2000). Mutations in SDHD, a mitochondrial complex II
gene, in hereditary paraganglioma. Science 287:848–51.
Bourgeron T, Rustin P, Chretien D, et al. (1995). Mutation of a nuclear
succinate dehydrogenase gene results in mitochondrial respiratory
chain deficiency. Nat Genet 11:144–9.
Brandsch R, Bichler V. (1989). Covalent cofactor binding to flavoen-
zymes requires specific effectors. Eur J Biochem 182:125–8.
Burnichon N, Briere JJ, Libe R, et al. (2010). SDHA is a
tumor suppressor gene causing paraganglioma. Hum Mol Genet 19:
3011–20.
Cameron JM, Janer A, Levandovskiy V, et al. (2011). Mutations in iron-
sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal
deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase
enzymes. Am J Hum Genet 89:486–95.
Cecchini G, Schroder I, Gunsalus RP, Maklashina E. (2002). Succinate
dehydrogenase and fumarate reductase from Escherichia coli.
Biochim Biophys Acta 1553:140–57.
Ciesielski SJ, Schilke BA, Osipiuk J, et al. (2012). Interaction of
J-protein co-chaperone Jac1 with Fe-S scaffold Isu is indispensable
in vivo and conserved in evolution. J Mol Biol 417:1–12.
Crooks DR, Jeong SY, Tong WH, et al. (2012). Tissue specificity of a
human mitochondrial disease: differentiation-enhanced mis-splicing
of the Fe-S scaffold gene ISCU renders patient cells more sensitive to
oxidative stress in ISCU myopathy. J Biol Chem 287:40119–30.
Diaz F, Kotarsky H, Fellman V, Moraes CT. (2011). Mitochondrial
disorders caused by mutations in respiratory chain assembly factors.
Semin Fetal Neonatal Med 16:197–204.
Dudek J, Rehling P, van der Laan M. (2013). Mitochondrial protein
import: common principles and physiological networks. BBA-Mol
Cell Res 1833:274–85.
Eletsky A, Jeong M-Y, Kim H, et al. (2012). Solution NMR structure of
yeast succinate dehydrogenase flavinylation factor Sdh5 reveals a
putative Sdh1 binding site. Biochemistry 51:8475–7.
Fernandez-Vizarra E, Tiranti V, Zeviani M. (2009). Assembly of the
oxidative phosphorylation system in humans: what we have learned by
studying its defects. Biochim Biophys Acta 1793:200–11.
Ferrer-Cortes X, Font A, Bujan N, et al. (2013). Protein expression
profiles in patients carrying NFU1 mutations. Contribution to the
pathophysiology of the disease. J Inherit Metab Dis 36:841–7.
Gelling C, Dawes IW, Richhardt N, et al. (2008). Mitochondrial Iba57p
is required for Fe/S cluster formation on aconitase and activation of
radical SAM enzymes. Mol Cell Biol 28:1851–61.
Ghezzi D, Goffrini P, Uziel G, et al. (2009). SDHAF1, encoding a LYR
complex-II specific assembly factor, is mutated in SDH-defective
infantile leukoencephalopathy. Nat Genet 41:654–6.
Guzy RD, Sharma B, Bell E, et al. (2008). Loss of the SdhB, but Not the
SdhA, subunit of complex II triggers reactive oxygen species-
dependent hypoxia-inducible factor activation and tumorigenesis.
Mol Cell Biol 28:718–31.
Ha¨gerha¨ll C. (1997). Succinate:quinone oxidoreductases. variations on a
censerved theme. Biochim Biophys Acta 1320:107–41.
Hall RE, Henriksson KG, Lewis SF, et al. (1993). Mitochondrial
myopathy with succinate dehydrogenase and aconitase deficiency.
Abnormalities of several iron-sulfur proteins. J Clin Invest 92:2660–6.
Hao HX, Khalimonchuk O, Schraders M, et al. (2009). SDH5, a gene
required for flavination of succinate dehydrogenase, is mutated in
paraganglioma. Science 325:1139–42.
Hoekstra AS, Bayley J-P. (2013). The role of complex II in disease.
Biochim Biophys Acta Bioenergetics 1827:543–51.
Horva´th R, Abicht A, Holinski-Feder E, et al. (2006). Leigh syndrome
caused by mutations in the flavoprotein (Fp) subunit of succinate
dehydrogenase (SDHA). J Neurol Neurosurg Psychiatry 77:74–6.
Imlay JA. (2006). Iron-sulphur clusters and the problem with oxygen.
Mol Microbiol 59:1073–82.
Ishii T, Yasuda K, Akatsuka A, et al. (2005). A mutation in the SDHC
gene of complex II increases oxidative stress, resulting in apoptosis
and tumorigenesis. Cancer Res 65:203–9.
178 J. G. Van Vranken et al. Crit Rev Biochem Mol Biol, 2015; 50(2): 168–180
19 
Jackson CB, Nuoffer J-M, Hahn D, et al. (2014). Mutations in SDHD
lead to autosomal recessive encephalomyopathy and isolated mito-
chondrial complex II deficiency. J Med Genet 51:170–5.
Jain-Ghai S, Cameron JM, Al Maawali A, et al. (2013). Complex II
deficiency – a case report and review of the literature. Am J Med
Genet A 161A:285–94.
Janeway KA, Kim SY, Lodish M, et al. (2011). Defects in succinate
dehydrogenase in gastrointestinal stromal tumors lacking KIT and
PDGFRA mutations. Proc Natl Acad Sci USA 108:314–18.
Jensen LT, Culotta VC. (2000). Role of Saccharomyces cerevisiae
ISA1and ISA2 in iron homeostasis. Mol Cell Biol 20:3918–27.
Johansson C, Roos AK, Montano SJ, et al. (2011). The crystal structure
of human GLRX5: iron-sulfur cluster co-ordination, tetrameric
assembly and monomer activity. Biochem J 433:303–11.
Kennedy MC, Emptage MH, Dreyer JL, Beinert H. (1983). The role of
iron in the activation-inactivation of aconitase. J Biol Chem 258:
11098–105.
Kim HJ, Jeong MY, Na U, Winge DR. (2012). Flavinylation and
assembly of succinate dehydrogenase are dependent on the C-terminal
tail of the flavoprotein subunit. J Biol Chem 287:40670–9.
Kim HJ, Winge DR. (2013). Emerging concepts in the flavinylation of
succinate dehydrogenase. Biochim Biophys Acta 1827:627–36.
Kounosu A. (2014). Analysis of covalent flavinylation using thermo-
stable succinate dehydrogenase from Thermus thermophilus and
Sulfolobus tokodaii lacking SdhE homologs. FEBS Lett 588:1058–63.
Lemarie A, Huc L, Pazarentzos E, et al. (2011). Specific disintegration
of complex II succinate: ubiquinone oxidoreductase links pH changes
to oxidative stress for apoptosis induction. Cell Death Differ 18:
338–49.
Lemire BD, Oyedotun KS. (2002). The Saccharomyces cerevisiae
mitochondrial succinate: ubiquinone oxidoreductase. Biochim
Biophys Acta 1553:102–16.
Li H, Outten CE. (2012). Monothiol CGFS glutaredoxins and BolA-like
proteins: [2Fe-2S] binding partners in iron homeostasis. Biochemistry
51:4377–89.
Lill R, Hoffmann B, Molik S, et al. (2012). The role of mitochondria in
cellular iron-sulfur protein biogenesis and iron metabolism. Biochim
Biophys Acta 1823:1491–508.
Lim SC, Friemel M, Marum JE, et al. (2013). Mutations in LYRM4,
encoding iron-sulfur cluster biogenesis factor ISD11, cause deficiency
of multiple respiratory chain complexes. Hum Mol Genet 22:4460–73.
Maio N, Singh A, Uhrigshardt H, et al. (2014). Cochaperone binding to
LYR motifs confers specificity of iron sulfur cluster delivery. Cell
Metab 19:445–57.
Majewska J, Ciesielski SJ, Schilke B, et al. (2013). Binding of the
chaperone Jac1 protein and cysteine desulfurase Nfs1 to the iron-
sulfur cluster scaffold Isu protein is mutually exclusive. J Biol Chem
288:29134–42.
Mashkevich G, Repetto B, Glerum DM, et al. (1997). SHY1, the yeast
homolog of the mammalian SURF-1 gene, encodes a mitochondrial
protein required for respiration. J Biol Chem 272:14356–64.
Messner KR, Imlay JA. (2002). Mechanism of superoxide and hydrogen
peroxide formation by fumarate reductase, succinate dehydrogenase,
and aspartate oxidase. J Biol Chem 277:42563–71.
Muhlenhoff U, Richter N, Pines O, et al. (2011). Specialized function
of yeast Isa1 and Isa2 proteins in the maturation of mitochondrial
[4Fe-4S] proteins. J Biol Chem 286:41205–16.
Na U, Yu W, Cox JE, et al. (2014). The LYR factors SDHAF1 and
SDHAF3 mediate maturation of the iron-sulfur subunit of succinate
dehydrogenase. Cell Metab 20:253–66.
Navarro-Sastre A, Tort F, Stehling O, et al. (2011). A fatal mitochondrial
disease is associated with defective NFU1 function in the maturation
of a subset of mitochondrial Fe-S proteins. Am J Hum Genet 89:
656–67.
Nihei C, Nakayashiki T, Nakamura K, et al. (2001). Abortive assembly
of succinate-ubiquinone reductase (complex II) in a ferrochelatase-
deficient mutant of Escherichia coli. Mol Genet Genomics 265:
394–404.
Ohlenbusch A, Edvardson S, Skorpen J, et al. (2012).
Leukoencephalopathy with accumulated succinate is indicative of
SDHAF1 related complex II deficiency. Orphanet J Rare Dis 7:69.
Oyedotun KS, Lemire BD. (2001). The Quinone-binding sites of
the Saccharomyces cerevisiae succinate-ubiquinone oxidoreductase.
J Biol Chem 276:16936–43.
Oyedotun KS, Sit CS, Lemire BD. (2007). The Saccharomyces
cerevisiae succinate dehydrogenase does not require heme for
ubiquinone reduction. Biochim Biophys Acta 1767:1436–45.
Pandey A, Golla R, Yoon H, et al. (2012). Persulfide formation on
mitochondrial cysteine desulfurase: enzyme activation by a eukaryote-
specific interacting protein and Fe-S cluster synthesis. Biochem J 448:
171–87.
Pandey A, Gordon DM, Pain J, et al. (2013). Frataxin directly stimulates
mitochondrial cysteine desulfurase by exposing substrate-binding
sites, and a mutant Fe-S cluster scaffold protein with frataxin-
bypassing ability acts similarly. J Biol Chem 288:36773–86.
Pantaleo MA, Astolfi A, Indio V. (2011). SDHA loss-of-function
mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors
identified by massively parallel sequencing. J Natl Cancer Inst 103:
983–7.
Pantaleo MA, Astolfi A, Urbini M, et al. (2014). Analysis of all
subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydro-
genase complex in KIT/PDGFRA wild-type GIST. Eur J Hum Genet
22:32–9.
Peczkowska M, Cascon A, Prejbisz A, et al. (2008). Extra-adrenal and
adrenal pheochromocytomas associated with a germline SDHC
mutation. Nat Clin Pract End Met 4:111–15.
Pierrel F, Bestwick ML, Cobine PA, et al. (2007). Coa1 links the Mss51
post-translational function to Cox1 cofactor insertion in cytochrome c
oxidase assembly. EMBO J 26:4335–46.
Pierrel F, Khalimonchuk O, Cobine PA, et al. (2008). Coa2 is an
assembly factor for yeast cytochrome c oxidase biogenesis that
facilitates the maturation of Cox1. Mol Cell Biol 28:4927–39.
Py B, Gerez C, Angelini S, et al. (2012). Molecular organization,
biochemical function, cellular role and evolution of NfuA, an atypical
Fe-S carrier. Mol Microbiol 86:155–71.
Quinlan CL, Goncalves RL, Hey-Mogensen M, et al. (2014). The 2-
oxoacid dehydrogenase complexes in mitochondria can produce
superoxide/hydrogen peroxide at much higher rates than complex I.
J Biol Chem 289:8312–25.
Robinson KM, Lemire BD. (1996). Covalent attachment of FAD to the
yeast succinate dehydrogenase flavoprotein requires import into
mitochondria, presequence removal, and folding. J Biol Chem 271:
4055–60.
Robinson KM, Rothery RA, Weiner JH, Lemire BD. (1994). The
covalent attachment of FAD to the flavoprotein of Saccharomyces
cerevisiae succinate dehydrogenase is not necessary for import and
assembly into mitochondria. Eur J Biochem 222:983–90.
Rodriguez-Manzaneque MAT, Tamarit J, Bellı´ G, et al. (2002). Grx5 is a
mitochondrial glutaredoxin required for the activity of iron/sulfur
enzymes. Mol Biol Cell 13:1109–21.
Rutter J, Winge DR, Schiffman JD. (2010). Succinate dehydrogenase –
assembly, regulation and role in human disease. Mitochondrion 10:
393–401.
Santos MAA, Jime´nez A, Revuelta J. (2000). Molecular characterization
of FMN1, the structural gene for the monofunctional flavokinase of
Saccharomyces cerevisiae. J Biol Chem 275:28618–24.
Schmucker S, Martelli A, Colin F, et al. (2011). Mammalian frataxin: an
essential function for cellular viability through an interaction with a
preformed ISCU/NFS1/ISD11 iron-sulfur assembly complex. PLoS
One 6:e16199.
Sheftel AD, Stehling O, Pierik AJ, et al. (2010). Humans possess two
mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in
steroidogenesis, heme, and Fe/S cluster biosynthesis. Proc Natl Acad
Sci USA 107:11775–80.
Sheftel AD, Wilbrecht C, Stehling O, et al. (2012). The human
mitochondrial ISCA1, ISCA2, and IBA57 proteins are required for
[4Fe-4S] protein maturation. Mol Biol Cell 23:1157–66.
Silkin Y, Oyedotun KS, Lemire BD. (2007). The role of Sdh4p Tyr-89 in
ubiquinone reduction by the Saccharomyces cerevisiae succinate
dehydrogenase. Biochim Biophys Acta 1767:143–50.
Sun F, Huo X, Zhai Y, et al. (2005). Crystal structure of mitochondrial
respiratory membrane protein complex II. Cell 121:1043–57.
Torchetti EM, Brizio C, Colella M, et al. (2010). Mitochondrial
localization of human FAD synthetase isoform 1. Mitochondrion 10:
263–73.
Tsai CL, Barondeau DP. (2010). Human frataxin is an allosteric switch
that activates the Fe-S cluster biosynthetic complex. Biochemistry 49:
9132–9.
DOI: 10.3109/10409238.2014.990556 Protein-mediated assembly of succinate dehydrogenase 179
20 
Tzagoloff A, Jang J, Glerum DM, Wu M. (1996). FLX1 codes for a
carrier protein involved in maintaining a proper balance of flavin
nucleotides in yeast mitochondria. J Biol Chem 271:7392–7.
Uzarska MA, Dutkiewicz R, Freibert SA, et al. (2013). The
mitochondrial Hsp70 chaperone Ssq1 facilitates Fe/S cluster transfer
from Isu1 to Grx5 by complex formation. Mol Biol Cell 24:
1830–41.
Van Vranken JG, Bricker DK, Dephoure N, et al. (2014). SDHAF4
promotes mitochondrial succinate dehydrogenase activity and pre-
vents neurodegeneration. Cell Metab 20:241–52.
Vanharanta S, Buchta M, Mcwhinney SR, et al. (2004). Early-onset renal
cell carcinoma as a novel extraparaganglial component of SDHB-
associated heritable paraganglioma. Am J Hum Genet 74:153–9.
Wu M, Repetto B, Glerum DM, Tzagoloff A. (1995). Cloning and
characterization of FAD1, the structural gene for flavin adenine
dinucleotide synthetase of Saccharomyces cerevisiae. Mol Cell Biol
15:264–71.
Yankovskaya V, Horsefield R, Tornroth S, et al. (2003). Architecture of
succinate dehydrogenase and reactive oxygen species generation.
Science 299:700–4.
180 J. G. Van Vranken et al. Crit Rev Biochem Mol Biol, 2015; 50(2): 168–180
CHAPTER 3 
SDHAF4 PROMOTES MITOCHONDRIAL SUCCINATE DEHYDROGENASE 
ACTIVITY AND PREVENTS NEURODEGENERATION 
Jonathan G. Van Vranken, Daniel K. Bricker, Noah Dephoure, Steven P. Gygi, James E. 
Cox, Carl S. Thummel, and Jared Rutter 
Reprinted with permission from Cell Metabolism, vol. 20, pp. 241-52 











Jonathan G. Van Vranken,1,5 Daniel K. Bricker,2,5 Noah Dephoure,3 Steven P. Gygi,3 James E. Cox,4 Carl S. Thummel,2,*
and Jared Rutter1,*
1Department of Biochemistry
2Department of Human Genetics
University of Utah School of Medicine, Salt Lake City, UT 84112, USA
3Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA
4Metabolomics Core Research Facility, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
5Co-first authors
*Correspondence: carl.thummel@genetics.utah.edu (C.S.T.), rutter@biochem.utah.edu (J.R.)
http://dx.doi.org/10.1016/j.cmet.2014.05.012
SUMMARY
Succinate dehydrogenase (SDH) occupies a central
place in cellular energy production, linking the tricar-
boxylic cycle with the electron transport chain. As
a result, a subset of cancers and neuromuscular
disorders result from mutations affecting any of the
four SDH structural subunits or either of two known
SDH assembly factors. Herein we characterize an
evolutionarily conserved SDHassembly factor desig-
nated Sdh8/SDHAF4, using yeast, Drosophila, and
mammalian cells. Sdh8 interacts specifically with
the catalytic Sdh1 subunit in the mitochondrial ma-
trix, facilitating its associationwith Sdh2 and the sub-
sequent assembly of the SDH holocomplex. These
roles for Sdh8 are critical for preventing motility
defects and neurodegeneration in Drosophila as
well as the excess ROS generated by free Sdh1.
These studies provide insights into the mechanisms
by which SDH is assembled and raise the possibility
that some forms of neuromuscular disease may be
associated with mutations that affect this SDH as-
sembly factor.
INTRODUCTION
Mitochondria are dynamic organelles that are essential for
many cellular processes including metabolism, signal transduc-
tion, and apoptosis. Consistent with these broad cellular func-
tions, mitochondrial dysfunction is associated with a wide range
of human diseases, including diabetes, neurodegeneration, and
cancer. These important roles have led to comprehensive char-
acterization of themitochondrial proteome, identifyingmore than
1,000 nuclear-encoded proteins (Sickmann et al., 2003; Pa-
gliarini et al., 2008). In spite of these efforts, however, manymito-
chondrial proteins remain uncharacterized, including proteins
that are conserved throughout eukaryotic evolution. We are
studying this subset of proteins as part of a systematic effort
to comprehensively understand mitochondrial physiology.
Herein, we describe the function of one of these evolutionarily
conserved proteins and demonstrate that it is essential for
proper succinate dehydrogenase (SDH) complex assembly
and activity in yeast, flies, and mammalian cells.
SDH is unique in that it functions in both the tricarboxylic acid
(TCA) cycle and the electron transport chain (ETC), wherein it is
referred to as Complex II. SDH links the oxidation of succinate
to fumarate in the TCA cycle with the reduction of ubiquinone
to ubiquinol in the ETC, which contributes to the establishment
of the mitochondrial membrane potential and ATP synthesis.
SDH is a heterotetrameric protein complex that is embedded
in the inner mitochondrial membrane (IMM), with its cat-
alytic domain facing the mitochondrial matrix. The complex is
anchored to the IMM by two integral membrane proteins, Sdh3
(SDHC in humans) and Sdh4 (SDHD). The Sdh3/Sdh4 dimer
binds the peripheral membrane protein Sdh2 (SDHB), which
tethers the catalytic Sdh1 (SDHA) subunit to the complex.
Sdh1 harbors a covalently bound FAD cofactor that is required
for the oxidation of succinate (Robinson et al., 1994). The two
electrons that result from succinate oxidation are channeled
through the three iron-sulfur clusters in Sdh2 to ubiquinone,
which interacts with SDH via the Sdh3/Sdh4 membrane anchor
(Rutter et al., 2010).
The assembly of complexes like SDH presents the cell with the
problem of coordinating the synthesis and stepwise interactions
of individual subunits to form an intricate membrane-bound
complex. This problem is exacerbated in the case of ETC com-
plexes, as individual subunits contain redox-active cofactors
that can perform inappropriate and deleterious reactions when
they are not properly secluded within the native complex. As a
result, a number of dedicated factors assist the assembly of
these complexes by facilitating cofactor insertion, preventing
nonproductive interactions, and stabilizing assembly intermedi-
ates. While the importance of assembly factors for Complexes I
and IV are well established (Ferna´ndez-Vizarra et al., 2009; Diaz
et al., 2011), dedicated SDH assembly factors have only recently
begun to emerge with the discovery of SDHAF1 (Sdh6 in yeast)
and SDHAF2 (Sdh5; Ghezzi et al., 2009; Hao et al., 2009). Human
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patients with loss-of-function mutations in SDHAF1 or SDHAF2
display reduced SDH complex levels and activity and present
with infantile leukoencephalopathy and neuroendocrine tumors,
respectively (Ghezzi et al., 2009; Hao et al., 2009). This is consis-
tent with the spectrum of diseases that associate with mutations
affecting the core subunits of SDH—SDHA, SDHB, SDHC, and
SDHD (Rutter et al., 2010) and with a series of additional dis-
eases that are characterized by loss of SDH activity, but which
lack mutations in known SDH genes (Jain-Ghai et al., 2013).
Disruption of the yeast orthologs for SDHAF1 or SDHAF2
(SDH6 or SDH5) prevents respiratory-dependent growth, with
a clear defect in SDH activity. While the precise mechanism by
which Sdh6 supports SDH biogenesis has remained elusive,
Sdh5 was shown to be required for the covalent attachment
of the FAD cofactor to Sdh1 (Ghezzi et al., 2009; Hao et al.,
2009). The current model proposes that Sdh1 is flavinated by
Sdh5 and binds iron-sulfur-loaded Sdh2, which then docks
onto the preassembled membrane-bound Sdh3-Sdh4 dimer to
form the holocomplex (Rutter et al., 2010). We hypothesized
that the complexity of this assembly process likely necessitates
the action of additional dedicated assembly factors and that the
genes encoding these factors may contribute to the currently
idiopathic SDH-associated genetic diseases.
With the goal of discovering new human disease genes and
gaining a better understanding of SDH assembly and activity,
we have focused on our ongoing functional elucidation of un-
characterized mitochondrial proteins. These studies led us to
identify an evolutionarily conserved SDH assembly factor,
Ybr269, which we have renamed Sdh8 in yeast and SDHAF4 in
higher organisms. Utilizing yeast, flies, and mammalian cells,
we have defined the molecular function of the SDHAF4 protein
family in SDH assembly and an important role for SDHAF4 in
metazoan physiology.
RESULTS
Yeast Sdh8 Is a Conserved Mitochondrial Matrix Protein
Required for Maximal SDH Activity
Sdh8 is a small protein of approximately 15 kDa that belongs to
a pan-eukaryotic protein family, which we have named the
SDHAF4 family (Figure S1A available online). N- and C-terminal
Sdh8 fusion proteins were unable to complement the phenotype
of an sdh8D mutant strain and were therefore deemed to be
nonfunctional. Efficient rescue was seen, however, when either
a tandem affinity tag (His6HA3) or GFP was fused into a pre-
dicted unstructured region within Sdh8, between residues N82
and S83. These constructs, which were subsequently named
Sdh8-His6HA3 and Sdh8-GFP, respectively, were expressed un-
der the control of the native SDH8 promoter and terminator and
determined to be fully functional (See Figures 1A and S1E). As
expected, we found that Sdh8 localizes exclusively to mitochon-
dria and determined it to be a soluble matrix protein (Figures
S1B–S1D). To begin to assess the role of Sdh8 in mitochondrial
function, an sdh8D mutant was established in two strains
(BY4741 and W303), both of which were used for key experi-
ments to control for genetic background. While sdh8D mutants
grew normally in glucose medium, growth was impaired on glyc-
erol and acetate, demonstrating a defect in mitochondrial respi-
ration (Figures 1A and S1E). Interestingly, the growth impairment
was exacerbated on acetate-containing medium, which is a hall-
mark of mutants that affect SDH activity. Consistent with this
possibility, metabolomic analysis of sdh8D mutants revealed
an apparent block in the TCA cycle at SDH, with an accumulation
of succinate and depletion of the two TCA cycle intermediates
downstream of SDH: fumarate and malate (Figures 1B and
S1F–S1H). We also measured the enzymatic activity of SDH in
mitochondria harvested from wild-type (WT) and sdh8D cells.
SDH activity in sdh8D cells was decreased 60% relative to WT
(Figure 1C), while malate dehydrogenase (MDH) activity was un-
affected (Figure 1D). Finally, the steady-state level of the SDH
holocomplex was assessed by blue native polyacrylamide gel
electrophoresis (BN-PAGE). Mitochondria purified from either
WT or sdh8D cells were solubilized in digitonin, resolved by
BN-PAGE, and probed by immunoblot. We observed a marked
decrease in assembled SDH and demonstrated that re-expres-
sion of Sdh8-His6HA3 (see Supplemental Information) in sdh8D
cells was sufficient to rescue the defect in SDH assembly (Fig-
ures 1E and S1I). Taken together, these data demonstrate that
Sdh8 is required for the stability and activity of SDH.
As a first step toward determining if its function is conserved
across eukaryotic species, the human and Drosophila orthologs
of SDH8 (SDHAF4 and dSdhaf4, respectively) were expressed in
the sdh8Dmutant under the control of the native SDH8 promoter
and terminator. Both orthologs complement the sdh8D growth
defects (Figure 1F), suggesting that the role of Sdh8 in SDH
assembly is an evolutionarily conserved feature of the SDHAF4
family.
Mammalian SDHAF4 Is Required for Maximal SDH
Activity
To assess a possible role for mammalian SDHAF4 in SDH func-
tion, we transfected C2C12 mouse myoblasts with a nontarget-
ing control siRNA (control) or either of two siRNAs targeting
mouse SDHAF4 (si1 and si2). Knockdown of SDHAF4 mRNA
was confirmed (Figure 2A), and mitochondria were harvested
from cells transfected with control, si1, and si2 siRNAs. Immuno-
blot of the isolated mitochondria revealed that depletion of
SDHAF4 did not affect the steady-state abundance of SDHA or
SDHB (Figure S2A). We detected, however, a decrease in SDH
enzymatic activity in SDHAF4 knockdown cells (Figure 2B) with
no significant change in MDH activity (Figure S2B). In addition,
cells transfected with si1 or si2 showed a reproducible and spe-
cific decrease in steady-state SDH complexes as assayed by
BN-PAGE of amagnitude similar to that seen in SDH activity (Fig-
ure 2C). We conclude that SDHAF4 is required for the proper as-
sembly and activity of SDH in both yeast and mammalian cells.
Drosophila Sdhaf4 Is Required for Maximal SDH Activity
To further define the function of Sdh8 in a multicellular organism,
we extended our analysis to Drosophila. Three null alleles were
generated in the Drosophila ortholog of SDH8 (CG7224) that
we have renamed Drosophila Sdhaf4 (dSdhaf4) (Figure S3A).
Similar to our findings in yeast, metabolomic analysis of dSdhaf4
mutants compared to genetically matched controls revealed a
significant accumulation of succinate and depletion of malate
and fumarate (Figure 3A). Acetyl-CoA was also elevated, while
citrate and isocitrate were reduced in the mutants (Figure 3A).
These effects may be due to a reduction in oxaloacetate that is
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Figure 1. Yeast Sdh8 Is a Conserved Mitochondrial Matrix Protein Required for Maximal SDH Activity and Assembly
(A) Ten-fold serial dilutions of WT yeast transformed with an empty vector (EV) or sdh8D mutants transformed with either EV or a plasmid expressing
SDH8-His6HA3, all in a BY4741 background.
(B) GC/MS was used to measure the abundance of metabolites in WT and sdh8D yeast (BY4741 background. n = 6 biological replicates. ****p < 0.0001;
**p < 0.005; *p < 0.05).
(C and D) (C) SDH and (D) MDH enzyme assays were performed on mitochondrial extracts of WT, sdh8D, and sdh1D strains, normalized to total protein (±SEM.
n = 3 biological replicates. **p < 0.005).
(E) WT and sdh8D mitochondria were solubilized in digitonin, fractionated by BN-PAGE, and analyzed by immunoblotting to detect Atp2 (complex V), Cor1/2
(complex III), Cox3 (complex IV), Sdh1 (complex II), or Porin.
(F) Ten-fold serial dilutions of the indicated strains were grown as in (A). SDHAF4 and dSdhaf4 are the human andDrosophila orthologs of SDH8, respectively, and
were each expressed under the control of the endogenous SDH8 promoter and terminator.
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required for the formation of citrate from acetyl-CoA. Consistent
with this, aspartate, which is interconvertible with oxaloacetate,
is depleted in dSdhaf4 mutants (Figure S3C). Similar changes
were observed upon metabolomic analysis of flies carrying a
dSdhaf4 TALEN-induced allele over an independently derived
imprecise excision, indicating that these results remain constant
across genetic backgrounds (Figures S3B and S3C). Consistent
with this metabolomic profile, dSdhaf4 mutant mitochondria
displayed an 85% reduction in SDH activity (Figure 3B) while
citrate synthase (CS) activity was unaffected (Figure 3C). Based
on these data, we conclude that, like yeast sdh8D mutants,
dSdhaf4 mutants have a specific impairment in SDH function.
Drosophila Sdhaf4 Is Required for the Stability of SdhA
and SdhB
The decrease in SDH activity in dSdhaf4mutants is greater than
that seen in yeast sdh8D mutants, suggesting that there might
be a more profound effect on the steady-state level of SDH.
Consistent with this, the SDH holocomplex was undetectable
by BN-PAGE, whereas the levels of Complex V were unaffected
(Figure 4A). This lack of SDH holocomplex was accompanied by
an apparent reduction in the stability of the SdhA and SdhB sub-
units in dSdhaf4mutants (Figures 4B, S4A, and S4B). In contrast,
dSdhaf4 heterozygous mutants displayed similar SDH activity
to controls (Figure S4C), and dSdhaf4 overexpression had no
effect on SDH activity or SDH subunit protein levels (Figures
S4D and S4E).
The reduced levels of SDH subunits in the dSdhaf4 mutant
suggest that wemight see genetic interactions between dSdhaf4
alleles and mutations in SDH subunit-encoding genes. Consis-
tent with this, we found that dSdhaf4 mutant flies heterozygous
for a strong loss-of-function mutation in SdhA or homozygous
for a hypomorphic mutation in SdhB displayed reduced viability
compared to controls (Figures 4C and S4F). This genetic interac-
tion is specific for SDH subunit-encoding genes, as dSdhaf4
mutants heterozygous for a null allele of CoVa (Mandal et al.,
2005) displayed normal viability (Figure 4C). Taken together,
these biochemical and genetic studies indicate that dSdhaf4 is
required for SDH assembly and activity.
dSdhaf4Mutants Display Neurodegeneration,
Early-Adult Lethality, and Sensitivity to Oxidative Stress
Consistent with their metabolic defects, dSdhaf4 mutants
died significantly earlier than controls, with a median lifespan
of 12 days compared to a median lifespan of 69 days for control
flies (Figure 5A). Interestingly, these mutants also displayed two
phenotypes that are hallmarks of mitochondrial dysfunction:
bang sensitivity and erect wings (Figures 5B, 5C, S5A, and
S5B) (Greene et al., 2003; Fergestad et al., 2006). In addition,
dSdhaf4 mutant retinas displayed a marked disorganization of
retinal architecture (Figure 5D, asterisks), consistent with the
known association between bang sensitivity and neurodegener-
ation (Celotto et al., 2006a; Gnerer et al., 2006; Liu et al.,
2007). The photoreceptors were also highly vesicularized (Fig-
ure 5D, arrows) (Kiselev et al., 2000), with aberrant mitochondrial
morphology (Figure 5D, arrowheads). The bang sensitivity of
dSdhaf4 mutants can be rescued by specific expression of WT
dSdhaf4 in neurons, suggesting that it is associatedwith the neu-
rodegeneration (Figures 5E, S5C, and S5D). Moreover, global
expression of human Sdhaf4 in dSdhaf4 mutants partially
rescued the bang-sensitivity of these animals, providing further
evidence of a conserved function for Sdhaf4 (Figures 5E, S5C,
and S5D). Taken together, these results demonstrate that
dSdhaf4 is required in neurons to maintain tissue architecture
and function.
Defects in mitochondrial ATP production and reactive oxygen
species (ROS) homeostasis have been previously shown to
cause neurodegenerative phenotypes similar to those observed
in dSdhaf4 mutants (Fergestad et al., 2006; Liu et al., 2007;
Celotto et al., 2012). Since loss of dSdhaf4 does not appear to
affect steady state ATP levels (Figures 3A and S3B), we hypoth-
esized that dSdhaf4 may be required to protect against ROS
toxicity. Consistent with this, dSdhaf4 mutants were highly sen-
sitive to oxidative stress induced by hyperoxia (Figure 5F) but
showed no sensitivity to starvation, which is unassociated with
ROS production (Figure S5E). These data suggest a connection
between the role of dSdhaf4 in SDH assembly and oxidative
stress resistance.
Yeast Sdh8 Is a Chaperone for Soluble and Covalently
Flavinated Sdh1
Data from three distinct eukaryotic systems indicate that the
SDHAF4 protein family plays an evolutionarily conserved role
in SDH assembly and activity. Turning back to yeast, we sought
to understand the mechanism by which Sdh8 supports SDH
biogenesis. To identify proteins interacting with Sdh8, we per-
formed a large-scale HA immunoprecipitation from either WT
or Sdh8-His6HA3 containing mitochondria. The final eluates
were resolved by SDS-PAGE, revealing a band of !70 kDa
that was present only in the Sdh8-His6HA3 immunoprecipitation.
Figure 2. Mammalian SDHAF4 Is Required for Maximal SDH Activity
(A) C2C12 cells were transfected with either a control nontargeting siRNA or
either of two siRNAs directed against SDHAF4 (si1 and si2), and SDHAF4
mRNA abundance was assayed by quantitative RT-PCR and normalized to
tubulin mRNA (±SEM. n = 3 biological replicates. ***p < 0.0005).
(B) SDH enzyme activity was measured in mitochondria harvested from
C2C12 cells treated as in (A) (±SEM. n = 3 biological replicates. ***p < 0.0005;
*p < 0.05).
(C) Mitochondria extracted from C2C12 cells treated as in (A) were solubilized
in digitonin, fractionated by BN-PAGE, and analyzed by immunoblotting for
ATP5A (complex Vmonomers [CVI] or dimers [CVII], QCR2 [complex III], VDAC,
or SDHA [complex II]).
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Using mass spectrometry, we found that this band contained
Sdh1, the catalytic subunit of SDH (Figure S6A). The putative
Sdh8/Sdh1 interaction was confirmed by immunoprecipitation
of Sdh8 followed by identification of Sdh1 in the eluate using
an Sdh1-specific antibody (Figure 6A, lanes 1 and 6 versus 2
and 7). Interestingly, it appears that Sdh2 is not a member of
this complex as it is undetectable in the eluate (Figure 6A).
Since Sdh8 binds Sdh1 independent of Sdh2, we hypothe-
sized that Sdh8 may be acting as a chaperone for a free soluble
Figure 3. Drosophila Sdhaf4 Is Required for
SDH Activity
(A) Either LC/MS (acetyl-CoA, succinyl-CoA, ATP,
AMP, NAD, NADH, NADP, and NADPH) or GC/MS
(citrate, isocitrate, alpha-ketoglutarate, succinate,
fumarate, and malate) was used to measure the
abundance of metabolites in trans-heterozygous
dSdhaf41/2 (dSdhaf4!) mutants compared to
genetically matched w1118 controls (dSdhaf4+).
Eight to twelve biological replicates from two
independent experiments were combined per
genotype.
(B and C) (B) SDH or (C) CS enzymatic activity was
measured in extracts from mitochondria isolated
from either control or dSdhaf4 mutant flies
(±SEM. n = 4–6 biological replicates. **p < 0.01 and
***p < 0.001). Two independent experiments were
performed with similar results.
pool of Sdh1 in the mitochondrial matrix.
If this is true, then deletion of SDH2 might
shift Sdh1 to a free soluble form, which
would increase the demand for Sdh8
function. Consistent with this possibility,
sdh2D mutant mitochondria exhibit
an accumulation of Sdh8-His6HA3 (Fig-
ure 6B, lane 1 versus 3), while sdh1D
mutant mitochondria exhibit a depletion
of Sdh8-His6HA3 (Figure 6B, lane 1 versus
2). Furthermore, this accumulation of
Sdh8-His6HA3 results in enhanced Sdh1-
Sdh8 association in the sdh2D mutant
(Figure 6A, lanes 2 and 7 versus 3 and 8)
despite an approximately 2-fold decrease
in steady-state Sdh1 levels (Figure 6B,
lane 1 versus 3).
Although the stability of Sdh8 depends
on Sdh1, Sdh1 abundance is unaffected
by the deletion of SDH8 (Figure 6B, lane
1 versus 4). However, Sdh2 levels are
reduced in an sdh8D mutant, likely due
to decreased Sdh1 competence for inter-
action with Sdh2 (Figure 6B, lane 1 versus
4). This is further supported by the obser-
vation that the formation of the Sdh1-
Sdh2 soluble dimer, which is readily
apparent in a mutant lacking the Sdh4
membrane anchor, is impaired in an
sdh8D mutant (Figure S6F). Interpretation
of this experiment is complicated by the
decreased Sdh2 steady-state level in the sdh8D mutant, but
the data are most consistent with the hypothesis that Sdh8 is
required to maintain Sdh1 in a state that is fully competent to
bind Sdh2 and assemble in the SDH holocomplex.
Sdh1 is known to be covalently flavinated at H90 in a reaction
that requires the activity of Sdh5 (Hao et al., 2009). Initially, we
found that deletion of SDH8 does not impact the flavination of
Sdh1 (Figure S6B). We reasoned, however, that Sdh8 might
act specifically on the flavinated form of free Sdh1. Accordingly,
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we immunoprecipitated Sdh8-His6HA3 from mitochondria that
express WT Sdh1, Sdh1H90A, or Sdh1H90S, which are Sdh1 mu-
tants that cannot covalently bind FAD. Indeed, Sdh1H90A and
Sdh1H90S both failed to copurify with Sdh8-His6HA3 (Figures
6A, lanes 2 and 7 versus 4 and 9, and S6C), even in the absence
of Sdh2 (Figure 6A, lanes 3 and 8 versus 5 and 10). In further sup-
port of this hypothesis, we found that Sdh1 failed to interact with
Sdh8-His6HA3 in sdh5Dmutant cells (Figure S6D), which lack co-
valent Sdh1 flavination (Figure S6B) (Hao et al., 2009). Further-
more, Sdh8-His6HA3 was destabilized in the sdh5D mutant as
was observed for the sdh1Dmutant (Figure S6E, lane 1 versus 6).
Finally, Sdh8-His6HA3 is not present in the SDH holocomplex,
as assayed by BN-PAGE (Figure 6C, lane 1). We also observed
that deletion of SDH2 or SDH4, which ablates the SDH holocom-
plex, causes the emergence of a subcomplex of !150 kDa,
which lacks Sdh2 but clearly contains both Sdh1 and Sdh8 (Fig-
ure 6C, lanes 2 and 5). This is not coincidental comigration as
loss of either Sdh1 or Sdh8 causes this subcomplex to disappear
from sdh2D and sdh4D mutant strains (Figure 6C, lanes 3, 4, 6,
and 7). The Sdh1-Sdh8 subcomplex can also be detected in
WT cells, albeit at lower steady-state levels than in sdh2D and
sdh4Dmutants (Figure S6G). Taken together, these data demon-
strate that Sdh8 interacts specifically with flavo-Sdh1, indepen-
dent of other components of the SDH complex, and its stability
depends upon this interaction.
Sdh8 Protects the Cell from Oxidative Stress
The data presented thus far demonstrate that Sdh8 acts as a
chaperone for Sdh1 to promote formation of the Sdh1-Sdh2
dimer. We found that overexpression of Sdh1 does not rescue
the growth defects of sdh8D mutants but, rather, is toxic to
both WT and sdh8D cells on respiratory carbon sources, with
the sdh8D mutant being particularly sensitive (Figures 7A and
S7A). This observation raises the possibility that free Sdh1 is
toxic and that Sdh8 may alleviate this toxicity. To test this, we
co-overexpressed Sdh8 with Sdh1 and observed a significant
rescue of the Sdh1 toxicity in WT cells (Figure 7B). We conclude
that, in addition to promoting assembly of the Sdh1-Sdh2 dimer,
Sdh8 also prevents the toxicity associated with free Sdh1.
In considering possible mechanisms for toxicity of free Sdh1,
we hypothesized that the exacerbated sdh8D phenotype on ac-
etate compared to glycerol medium (Figure 1A) may be the result
of increased oxidative stress. This is consistent with previous re-
ports using acetate to trigger ROS-dependent cell death in yeast
(Carmona-Gutierrez et al., 2010), as well as the sensitivity of
dSdhaf4 mutant to hyperoxia (Figure 5F). In support of this
hypothesis, we found that the sdh8Dmutant is profoundly hyper-
sensitive to paraquat in glycerol media relative to WT cells (Fig-
ure 7C). To test this hypothesis directly, we sought to quantify
the levels of ROS in the sdh8Dmutant. We observed a significant
decrease in aconitase activity in sdh8D cells, consistent with an
accumulation of ROS in the mutant strain (Figure 7D). We also
established a system for measuring the redox state of yeast
mitochondria using a mitochondrially targeted redox-sensitive
GFP construct (mito-roGFP) (McFaline-Figueroa et al., 2011;
Vevea et al., 2013). This construct has been engineered to
contain two surface exposed cysteines that are capable of form-
ing a disulfide bond. Mito-roGFP exhibits two excitation peaks at
!400nm and !480nm with a single emission peak at !510nm.
Oxidation of the surface-exposed cysteines promotes excitation
at 400 nm, while reduction of these residues favors excitation at
480 nm (Figures S7B and S7C) (McFaline-Figueroa et al., 2011;
Vevea et al., 2013). Thus, the excitation ratio of mito-roGFP is
a measure of the redox state of yeast mitochondria in live cells.
To quantify the redox state of the matrix, we transformed WT
cells, sdh8D cells, and sdh8D cells expressing Sdh8-His6HA3
with mito-roGFP (Figure S7D). Cells were grown in the presence
of 2% acetate and analyzed by flow cytometry. Consistent with
the aconitase activity data, we observed an increase in the ratio
of oxidized/reduced mito-roGFP in the sdh8D strain that was
fully rescued by re-expressing Sdh8-His6HA3 (Figures 7E and
7F). If this impaired growth of the sdh8D mutant is the result of
the elevated ROS seen in these cells, then overexpression of
genes involved in ROS detoxification might suppress the growth
phenotype. Consistent with this, overexpression of YAP1, a tran-
scription factor that stimulates the expression of many genes
Figure 4. Drosophila Sdhaf4 Is Required for SdhA and SdhB Stability
(A) Mitochondrial extracts from either w1118 controls (dSdhaf4+) or dSdhaf41/2
mutants (dSdhaf4") were fractionated by BN-PAGE and analyzed by immu-
noblotting to detect Atpa (Complex V) or SdhB (Complex II).
(B) Total protein from mitochondria isolated from either control or dSdhaf4
mutant flies was resolved using SDS-PAGE, followed by immunoblotting to
detect SdhA, SdhB, or Atpa.
(C) Flies carrying either control or dSdhaf4 mutant chromosomes over a bal-
ancer chromosome were crossed to flies carrying a strong loss-of-function
allele for either SdhA or Cytochrome c oxidase Va subunit (CoVa) over a bal-
ancer. The resulting progeny were scored for the absence or presence of the
marker linked to the balancer chromosome. The proportion of the expected
progeny that eclosed, based on Mendelian ratios of the indicated genotypes,
is shown. (±SEM. n = number of progeny assayed from each cross. ***p <
0.001 (Student’s t test).
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important for oxidative stress defense (including TRR1, TRX2,
GSH1, and GLR1), as well as the mitochondrial superoxide
dismutase SOD2, completely or partially rescued the growth
phenotype of sdh8D cells (Figures 7G and S7E). Interestingly,
despite a profound ability to rescue the growth phenotype asso-
ciated with sdh8D cells, YAP1 overexpression has no effect on
SDH activity (Figure 7H), SDH assembly (Figure S7F), or Sdh2
steady-state levels (Figure S7G). Thus, we conclude that the
ability of YAP1 to rescue the sdh8D mutant phenotype is not
related to SDH activity and likely due to an amelioration of oxida-
tive stress in the mutant cells.
DISCUSSION
The critical role of SDH in primary cellular metabolism is reflected
by the variety of diseases associated with its dysfunction. Unlike
other ETC complexes, which require multiple factors for their
assembly, only two factors, SDHAF1 and SDHAF2, have been
identified to date that are required for the assembly of the SDH
holocomplex within the IMM (Ghezzi et al., 2009; Hao et al.,
2009). Herein we use three distinct eukaryotic model systems,
yeast, Drosophila, and mammalian cells, to demonstrate that
the SDHAF4 protein family consists of evolutionarily conserved
SDH assembly factors. We show that Sdh8 binds directly to fla-
vinated Sdh1, blocking the generation of excess ROS and facil-
itating its interaction with Sdh2 and the subsequent assembly of
the SDH holocomplex. These functions for SDHAF4 appear to
be conserved in metazoans and suggest a role for this factor in
disease, as Drosophila Sdhaf4 mutants display muscular and
neuronal dysfunction as well as neurodegeneration.
Yeast sdh8D and Drosophila Sdhaf4 mutants exhibit the
classic metabolomic phenotype of SDH deficiency, with an
apparent block in the TCA cycle that results in an accumulation
of succinate and a depletion of fumarate and malate, the two
TCA cycle intermediates downstream of SDH. Consistent with
these effects, the yeast and fly mutants display a reduction in
the steady-state levels of the SDH holocomplex and reduced
SDH enzyme activity, indicating an important role for SDHAF4
in SDH stability and activity. siRNA-mediated knockdown of
SDHAF4 in mammalian cells leads to similar defects. Moreover,
Figure 5. Drosophila Sdhaf4 Mutants
Display Neurodegenerative Phenotypes,
Early-Adult Lethality, and Sensitivity to
Oxidative Stress
(A) The number of surviving w1118 control
(dSdhaf4+) or dSdhaf41/2 mutant (dSdhaf4!)
females maintained on standard laboratory food
at normoxia was assayed at 2–4 day intervals.
Each data point is the percentage of surviving
flies ±SEM, with at least 110 flies assayed per
genotype.
(B) Control or dSdhaf4 mutant females aged
6–8 hr, 2–4 days, or 8–12 days were vortexed for
15 s, and the percentage of paralyzed flies
was counted as described (Ganetzky and Wu,
1982). (±SEM. n > 32 flies per age per genotype.
**p < 0.01 and ***p < 0.001 [ANOVA].)
(C) The length of time required for the dSdhaf4
mutant flies in (A) to recover from paralysis is
presented as a bar graph, with the number of
paralyzed dSdhaf4 mutants analyzed from each
age group depicted above the bar.
(D) Cross-sections of compound eyes from 8- to
12-day-old control or dSdhaf4 mutant flies visual-
ized by transmission electron microscopy. Arrows
point to aberrant vesicularization of dSdhaf4
mutant photoreceptors, arrowheads point to
mitochondria, and asterisks denote vacuoles.
(E) control or dSdhaf4 mutant flies at 8–12 days of
age carrying either the ubiquitous Daughterless-
Gal4 (Da-GAL4) driver, the pan-neuronal Elav-
Gal4 driver, or no driver, in the presence or
absence of either a UAS-dSdhaf4 transgene or a
UAS-human Sdhaf4 (hSdhaf4) transgene, were
vortexed as in (A). Note that UAS-dSdhaf4 alone
has leaky dSdhaf4 activity since it partially res-
cues in the absence of a GAL4 driver. (±SEM. n =
15–40. ***p < 0.001 [ANOVA].)
(F) Control or dSdhaf4mutant females at 2–4 days
of age were transferred to 100% oxygen, and the
number of surviving animals was counted each
day. The median lifespan after transfer to hyperoxia is 9 days for controls and 1 day for dSdhaf4 mutants. Data are shown as the percentage of surviving
flies ±SEM. At least 40 flies were assayed per genotype. p values for both survival curves ([A] and [F]) were calculated using a log rank test.
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expression of either fly or human SDHAF4 is sufficient to rescue
the growth defects of an sdh8D mutant yeast strain. Taken
together, these results demonstrate that the central requirement
for SDHAF4 in SDH assembly has been conserved through evo-
lution, from yeast to mammals.
Our biochemical studies in yeast provide a mechanistic
context for understanding the role of SDHAF4 in SDH assembly.
An unbiased proteomic analysis of Sdh8-associated proteins
revealed a physical interaction between Sdh8 and Sdh1, the
catalytic subunit of SDH. We confirmed the specificity of this
interaction by coimmunoprecipitation and demonstrated that
an Sdh1-Sdh8 subcomplex of !150 kDa can be detected in
unstressed WT cells, albeit at very low levels. Increased levels
of this subcomplex, however, become readily detectable upon
genetic disruption of the SDH complex through deletion of either
Sdh2 or Sdh4. Taken together, these results support the model
that Sdh8 interacts with a soluble pool of Sdh1 prior to the for-
mation of the Sdh1-Sdh2 soluble dimer and assembly of the
holocomplex. Moreover, Sdh8 interacts specifically with the fla-
vinated form of Sdh1, indicating that this association follows
Sdh1 flavination by Sdh5/SDHAF2 (Hao et al., 2009). This model
is consistent with the localization of Sdh8 to the matrix where
it can readily access free flavo-Sdh1, which is subsequently
tethered to the IMM through its association with Sdh2 and the
membrane-bound Sdh3/Sdh4 dimer.
We observed that Sdh8 stability directly relates to its asso-
ciation with Sdh1, further supporting the centrality of its role
as an Sdh1 chaperone. Thus, deletion of Sdh1 leads to a dra-
matic reduction in Sdh8 levels while deletion of Sdh2, which
causes greatly increased availability of free Sdh1, leads to an in-
crease in Sdh8. Although Sdh1 protein levels are unperturbed
in sdh8D cells, we observed considerable destabilization of
Sdh2, which is consistent with impaired formation of Sdh1-
Sdh2 dimers. Therefore, we hypothesize that the occupation of
free Sdh1 by Sdh8 facilitates the formation of Sdh1-Sdh2
dimers. This dimer fails to form efficiently in the absence of
Sdh8, and Sdh2 is destabilized as it is in mutants lacking Sdh1
altogether.
Interestingly, the loss of SDHAF4 appears to havemore severe
consequences in Drosophila than in yeast or mammalian cells.
dSdhaf4 mutants display a profound reduction in SDH enzyme
activity, destabilization of both SdhA and SdhB, and a significant
loss of SDH holocomplexes. In contrast, yeast sdh8D mutants
and C2C12 mouse myoblasts treated with SDHAF4 siRNA
maintain !40%–50% of WT SDH activity and preserve a similar
fraction of assembled SDH holocomplexes. While yeast sdh8D
mutants have relatively normal levels of Sdh1, dSdhaf4 mutants
have greatly reduced levels of SdhA, which probably underlies
the nearly complete loss of SDH holocomplexes. It is possible
that yeast and mammalian cells express an additional SDHA
chaperone that can function in the absence of SDHAF4, main-
taining the levels of SDHA to support holocomplex assembly. It
is also possible that growth in rich culture medium provides a
buffer against oxidative stress in yeast that is not present in the
more complex Drosophila system. Identification of the mecha-
nism that underlies this discrepancy, however, will require further
study of SDH assembly in both yeast and flies. Regardless, it is
important to note that dSdhaf4mutants retain some SDH activity
(!15%) and that this is sufficient to support limited viability,
albeit with both muscular (erect wings) and behavioral (neuro-
degeneration) dysfunction. In contrast, SdhA null mutants are
lethal, demonstrating that a further reduction in SDH activity
cannot be tolerated (Mast et al., 2008). Thus, while the SDHAF4
protein family is clearly involved in SDH stability and activity, it
Figure 6. Yeast Sdh8 Is a Cochaperone for
Unbound and Covalently Flavinated Sdh1
(A) Sdh8-His6HA3 was immunoprecipitated from
digitonin-solubilized mitochondria isolated from
the yeast strains described as follows: lanes 1 and
6, WT cells; lanes 2 and 7, sdh8D cells expressing
Sdh8-His6HA3; lanes 3 and 8, sdh2D sdh8D
cells expressing Sdh8-His6HA3; lanes 4 and 9,
sdh1D sdh8D cells expressing Sdh8-His6HA3
and Sdh1H90A; and lanes 5 and 10, sdh1D
sdh2D sdh8D cells expressing Sdh8-His6HA3 and
Sdh1H90A.
(B) Mitochondrial lysates isolated from the
following strains were fractionated by SDS-PAGE.
Lane 1, sdh8D cells expressing Sdh8-His6HA3;
lane 2, sdh1D sdh8D cells expressing Sdh8-
His6HA3; lane 3, sdh2D sdh8D cells expressing
Sdh8-His6HA3; lane 4, sdh8D cells; lane 5, sdh2D
sdh8D cells (BY4741 background). Steady-state
protein abundance was assessed by immunoblot
using antibodies against Sdh1, Sdh2, and HA
(Sdh8-His6HA3).
(C) Mitochondria isolated from the following yeast
strains were solubilized in digitonin and fraction-
ated by BN-PAGE: lane 1, sdh8D cells expressing
Sdh8-His6HA3; lane 2, sdh2D sdh8D cells expressing Sdh8-His6HA3; lane 3, sdh1D sdh2D sdh8D cells expressing Sdh8-His6HA3; lane 4, sdh2D sdh8D; lane 5,
sdh4D sdh8D cells expressing Sdh8-His6HA3; lane 6, sdh1D sdh4D sdh8D cells expressing Sdh8-His6HA3; and lane 7, sdh4D sdh8D cells. Immunoblotting was
used to detect Atp2 (complex V) as a control and complexes containing Sdh1, Sdh2, and HA (Sdh8-His6HA3). SDH complex (!232 kDa), Sdh1-Sdh8 subcomplex
(!150 kDa).
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does not appear to be an absolute requirement, as some level of
SDH activity remains in the absence of the respective SDHAF4
ortholog in all three model systems.
Our demonstration that Sdh8 acts through Sdh1 to facilitate
formation of the Sdh1/Sdh2 dimer, and subsequently the SDH
holocomplex, further emphasizes the importance of dedicated
chaperones for ETC complex assembly. We propose that this
unique demand might relate to the need to protect the redox-
active cofactors present in many ETC complex subunits (Mess-
ner and Imlay, 2002). Prior to assembly, these cofactors are
exposed to solvent and are, therefore, susceptible to damaging
chemical reactions. The susceptibility of free cofactors to
damaging chemical reactions is exemplified by our data sug-
gesting that free flavinated Sdh1 is toxic and that this toxicity
is alleviated by Sdh8. Overexpression of Sdh1 causes growth
defects in WT cells, but this phenotype is exacerbated in
sdh8D mutants and ameliorated by co-overexpression of
Sdh8. Thus, we conclude that the chaperone activity of Sdh8
protects the cell from potentially damaging effects of unbound
Sdh1, which are likely due to the generation of ROS enabled
by solvent-accessible FAD. Sdh1, which contains a covalently
bound, redox active, FAD cofactor is capable of oxidizing succi-
nate to fumarate independent of the SDH complex. This oxida-
tion of succinate leads to the reduction of FAD, which is then
auto-oxidized bymolecular oxygen to yield superoxide (Messner
and Imlay, 2002; Guzy et al., 2008). The observation that Sdh8
interacts specifically with covalently flavinated Sdh1, but not
with apo-Sdh1, is consistent with Sdh8 acting to prevent this
mechanism of oxidative stress. Further, sdh8D mutant cells
were unable to grow on respiratory medium in the presence of
the superoxide producer paraquat and demonstrate a marked
accumulation of ROS as determined by two independent assays.
Similarly, dSdhaf4 mutant flies are highly sensitive to oxidative
stress induced by hyperoxia. Importantly, overexpression of
two genes involved in the detoxification of ROS —YAP1 and
SOD2—rescued the sdh8D growth defects in yeast without
affecting the SDH activity, SDH assembly, or steady-state
Sdh2 levels. We conclude that, in addition to promoting
Figure 7. Sdh8 Protects the Cell from
Oxidative Stress
(A) Ten-fold serial dilutions of WT and sdh8D
yeast either transformed with an empty vector
or overexpressing Sdh1 were plated on media
containing the indicated carbon source (W303
background).
(B) Ten-fold serial dilutions of WT yeast trans-
formed with an empty vector, WT yeast over-
expressing Sdh1, and WT yeast overexpressing
Sdh1 and Sdh8-His6HA3 were plated on media
containing acetate (W303 background).
(C) Ten-fold serial dilutions of WT yeast trans-
formed with an empty vector, sdh8D cells trans-
formed with an empty vector, and sdh8D cells
expressing Sdh8-His6HA3 were plated on media
containing glycerol with and without 1 mM para-
quat and incubated at 30!C (W303 background)
as in (A).
(D) Aconitase activity was measured in WT and
sdh8D cells grown to stationary phase in syn-
thetic complete media containing 2% glucose and
normalized to total protein (±SEM; n =4 biological
replicates. **p < 0.005).
(E) WT cells (solid line), sdh8D cells (dashed
line), and sdh8D cells expressing Sdh8-His6HA3
(dotted line) transformed with mito-roGFP
were plated on synthetic media containing 2%
acetate, allowed to grow for 48 hr, and analyzed
by flow cytometry. Shown are representative
histograms measuring the ratio of oxidized/
reduced mito-roGFP in 30,000 cells (BY4741
background).
(F) The median value of the ratio of oxidized/
reduced mito-roGFP is plotted for WT cells,
sdh8D cells, and sdh8D cells expressing Sdh8-
His6HA3 (±SEM; n = 4 biological replicates. ****p <
0.0001).
(G) Ten-fold serial dilutions of WT yeast
transformed with an empty vector, sdh8D cells
transformed with an empty vector, and sdh8D cells overexpressing YAP1 were plated on media containing the indicated carbon source and incubated
at 30!C (BY4741 background) as in (A).
(H) SDH activity enzyme assays were performed using mitochondria harvested from WT and sdh8D cells carrying an empty vector or overexpressing YAP1.
Activity was normalized to total protein (±SEM; n = 3 biological replicates. **p < 0.005).
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Sdh2 binding and holocomplex assembly, Sdh1 protects the
redox-active FAD cofactor from potentially deleterious solvent
interactions.
These biochemical aberrations resulted in profound physio-
logical defects in Drosophila lacking dSdhaf4, all of which are
hallmarks of mitochondrial dysfunction and which suggest
possible links to human disease. Most notably, dSdhaf4mutants
display bang sensitivity, a phenotype characterized by a sus-
ceptibility to mechanically induced paralytic seizures, which is
commonly elicited by defects in mitochondrial function (Ferges-
tad et al., 2006; Liu et al., 2007). dSdhaf4 mutants also display
neurodegeneration and reduced lifespan, which often accom-
pany bang sensitivity (Fergestad et al., 2008). In addition, we
observed abnormal wing posture in dSdhaf4 mutants, which is
characteristic of muscular dysfunction (Greene et al., 2003).
Similar phenotypes have been reported in flies harboring muta-
tions in several known disease-causing genes that impact mito-
chondrial function. For example, Pink and Parkinmutants display
abnormal wing posture, andmtATP6mutants are bang sensitive
(Celotto et al., 2006b; Fernandes and Rao, 2011). Human muta-
tions in Pink/Parkin and mtATP6 are known to cause familial
Parkinson’s disease andmitochondrial encephalopathy, respec-
tively (Schapira, 2012). Moreover, as described in more detail
below, some neurodegenerative diseases such as Leigh’s syn-
drome are known to be associated with a loss of SDH activity.
Our studies of dSdhaf4 thus provide a genetic model for better
understanding the pathophysiology of neurodegenerative disor-
ders that are caused by SDH deficiency (Rutter et al., 2010;
Hoekstra and Bayley, 2013).
Similar to dSdhaf4 mutants, SdhB hypomorphic mutants that
retain !40% of normal SDH activity are sensitive to oxidative
stress and display a reduced lifespan (Walker et al., 2006). The
SdhB hypomorphs, however, were not reported to undergo
mechanically induced paralytic seizures or display neurodegen-
erative phenotypes (Walker et al., 2006). This lack of neuronal
phenotypes in SdhB mutants could be due to the higher overall
SDH activity seen in these partial loss-of-function mutants rela-
tive to a complete loss of dSdhaf4 activity. It is also possible,
however, that the neurodegeneration phenotype is driven by
increased ROS production rather than a defect in mitochondrial
ATP production. In support of this model, clones generated us-
ing a lethal null allele of SdhA in the eye display retinal degener-
ation similar to that seen in dSdhaf4 mutants, which was shown
to be specifically caused by increased ROS production (Mast
et al., 2008). This is also consistent with our finding that dSdhaf4
mutants are not depleted of ATP, possibly enabled by metabolic
compensation (Celotto et al., 2011). Thus, our study of dSdhaf4,
and other work characterizing SdhA, SdhB, and dSdhaf3 mu-
tants in Drosophila, suggests that tissue dysfunction induced
by a loss of SDH appears to be largely driven by increased
ROS production. This is consistent with our hypothesis that
SDH assembly factors may have evolved as a mechanism to
protect cells and organisms from ROS production during SDH
assembly.
Mutations in all genes encoding previously published SDH
subunits and assembly factors have been shown to cause
human disease. These include neurodegenerative diseases
(Leigh’s Syndrome, leukodystrophy, and leukoencephalopathy),
which have been linked to mutations in SDHA, SDHB, and
SDHAF1 (Horva´th et al., 2006; Ghezzi et al., 2009; Alston et al.,
2012; Ohlenbusch et al., 2012). Mutations in SDHA, SDHB,
SDHC, SDHD, and SDHAF2 have also been shown to cause par-
agangliomas and pheochromocytomas—two classes of neuro-
endocrine tumors (Astuti et al., 2001; Hao et al., 2009; Fishbein
and Nathanson, 2012). Recently, several cases of WT gastroin-
testinal stromal tumors (WT GIST) have been linked to germline
loss-of-function mutations in SDHA and SDHB (Janeway et al.,
2011; Celestino et al., 2012; Italiano et al., 2012; Oudijk et al.,
2013). This wealth of evidence linking SDH dysfunction to dis-
ease raises the possibility that damaging mutations in SDHAF4
may cause human disease. In fact, several cases of SDH-defi-
cient diseases, including Leigh’s Syndrome and WT GIST,
lack mutations in the genes encoding all known SDH subunits
(Horva´th et al., 2006; Janeway et al., 2011; Jain-Ghai et al.,
2013). Our phenotypic studies raise the important possibility
that SDHAF4 is a candidate gene for these and other dis-
eases characterized by SDH deficiency. Our future efforts will
focus on determining the incidence of these possible causative
SDHAF4 mutations.
On the basis of the data presented in this report, we conclude
that the SDHAF4 gene family encodes an SDH assembly factor.
Insights gained in our studies of this protein have allowed us to
propose a more complete model of SDH assembly (Figure S7H).
Upon import into the matrix by TOM and TIM, apo-Sdh1 is flavi-
nated in a reaction that requires Sdh5 (Hao et al., 2009). Free
flavo-Sdh1 is then bound by Sdh8 to form a !150 kDa sub-
complex. This subcomplex occupies Sdh1, preventing auto-
oxidation and supporting its ability to dimerize with Sdh2. The
Sdh1-Sdh2 soluble dimer is then recruited to the IMMvia interac-
tions with Sdh3 and Sdh4 to form the SDH holocomplex. This
model highlights the importance of subunit-specific chaperones
in the process of assembly. Indeed, failure of SDHAF4 to occupy
free SdhA prevents normal SDH assembly in three eukaryotic
systems and has profound physiological consequences. The
identification and characterization of the SDHAF4 protein family
thus provides important new insights into the process of SDH as-
sembly, the mechanisms by which SDH subunits are protected
for generating ROS, and a new candidate gene to understand
human disease associated with a loss of SDH activity.
EXPERIMENTAL PROCEDURES
Drosophila Metabolomic Analysis and Enzyme Activity Assays
Adult male flies were aged 5–7 days, washed with PBS, and snap frozen
in liquid nitrogen. Metabolites were extracted from frozen flies, and gas chro-
matography-mass spectrometry (GC/MS) was performed as previously
described (Bricker et al., 2012). SDH activity was measured in mitochondrial
extracts, as previously described, by examining the reduction of iodonitrote-
trazolium at 500 nm in the presence of succinate (Celotto et al., 2011). CS
activity was measured in mitochondrial extracts by examining the reduction
of 5,50-5 dithiobis-2-nitrobenzoic acid in the presence of oxaloacetate and
acetyl-CoA, as previously described (Tang et al., 2009). Enzyme activity per
gram of mitochondrial protein was calculated.
Drosophila Paralytic Assays
Bang sensitivity was measured as previously described (Ganetzky and Wu,
1982). Flies were collected in groups of five to eight females per vial and
allowed to recover from CO2 anesthesia for at least 2 hr. Flies were then vor-
texed for 15 s, and the time it takes to return to a standing position was as-
sayed. At least three vials were assayed per condition in each experiment,
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and all experiments were repeated at least twice. Experiments on female flies
are presented, but similar results were observed when assaying males (data
not shown).
Electron Microscopy
Heads were removed from 8- to 12-day-old female flies, the proboscis was
removed, and EM was performed as described in the Supplemental Experi-
mental Procedures.
Mito-roGFP and Flow Cytometry
The protocol used in this investigation has been adapted from Vevea et al.,
2013. For each experiment, an equal number of cells transformed with mito-
roGFP were plated thinly on synthetic media containing 2% acetate or
2% glycerol. Cells were allowed to incubate for approximately 48 hr before
being harvested and analyzed by flow cytometry. Data was collected at the
University of Utah Flow Cytometry Core Facility. Cells were acquired on a
BD FACSCanto II by collecting emission wavelengths of 530/30 from a violet
(405 nm) and blue (488 nm) laser. Postacquisition analysis was accomplished
in Flowjo (Treestar, Inc). After single cells were selected using FSC-W and
FSC-H parameters, GFP+ cells were gated on for further analysis. The fluores-
cence intensity was expressed as a ratio of oxidized (405 nm excitation) to
reduced (488 nm excitation) mito-roGFP.
BN-PAGE
BN-PAGE was performed as described previously (Wittig et al., 2006). Mito-
chondria were resuspended in lysis buffer (50mMNaCl, 5mM 6-aminocaproic
acid, 50 mM imidazole, 1 mM AEBSF, and protease inhibitor cocktail). Yeast
and Drosophilamitochondria were solubilized with 1% digitonin and mamma-
lian mitochondria with 2% digitonin. Lysates were resolved on a 3%–13%
gradient native gel using a PROTEAN II xi Cell gel running system (Bio-Rad).
Western blot performed as described elsewhere using a Trans-blot transfer
cell (Bio-Rad) and PVDF membranes.
Statistics
PRISM software was used to graph all quantitative data and perform statistical
analyses. p values for pairwise comparisons were determined using a Stu-
dent’s t test, and p values for multiple comparisons were calculated using
one-way ANOVA with a Bonferroni correction. Metabolomics data are pre-
sented in box-plot form, where the box represents the 25th–75th percentile,
the line is the median, and the whiskers represent the range of the data. All
other quantitative data are shown as the mean ±SEM. p values for Kaplan-Me-
ier survival curves in Figures 5 and S5 were calculated using a log rank test.
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Supplemental Figures  
Figure S1, related to Figure 1.  Yeast Sdh8 is a conserved matrix protein required 
for maximal SDH activity.   
(A) Sequence alignment of the SDHAF4 protein family (Clustal Omega).  (B) The sdh8Δ 
mutant expressing Sdh8-GFP and MitoRFP were grown to early log phase and imaged by 
fluorescence microscopy.  Sdh8-GFP exhibits a complete co-localization with MitoRFP 
confirming the previously annotated mitochondrial localization (Reinders et al., 2006).  
(C) Intact mitochondria, hypotonic-swollen mitoplasts, and Triton X-100-solubilized 
mitochondria of an sdh8Δ strain expressing Sdh8-His6HA3 were treated either with (+) or 
without (-) proteinase K and analyzed by immunoblot along with the whole-cell lysate 
(WCL) and post-mitochondrial supernatant (PMS).  Fzo1, Cyb2, and Mge1 are outer 
mitochondrial membrane, inner-membrane space, and matrix proteins, respectively.  
Upon biochemical fractionation Sdh8-His6HA3 was readily detected in the whole cell 
lysate but was undetectable in the post-mitochondrial supernatant.  Sdh8-His6HA3 was 
present in purified mitochondria and protected from Proteinase K except in the presence 
of Triton X-100, consistent with localization to the mitochondrial matrix.  (D) 
Mitochondria isolated from sdh8Δ mutant cells expressing Sdh8-His6HA3 were separated 
into soluble and membrane fractions.  Each fraction was assessed by SDS-PAGE and 
immunoblot.  Sdh5 and Porin are used as controls and represent soluble and membrane 
bound proteins, respectively.  Sdh8-His6HA3 can be readily detected in the soluble 
fraction but is excluded from the membrane fraction.   (E) Ten-fold serial dilutions of 
wild-type (WT) yeast transformed with an empty vector (EV), sdh8Δ mutants 
transformed with EV, or sdh8Δ transformed with SDH8-His6HA3, all in a W303 
background, were grown on different carbon sources and incubated at 30°C.  (F-H)  
GC/MS was used to measure the abundance of metabolites in WT and sdh8Δ yeast 
(W303 background). The data is depicted in box plot format, with the box representing 
the lower and upper quartiles, the horizontal line representing the median, and the bars 
representing the minimum and maximum data points. (N=6 biological replicates. 
**p<0.005; *p<0.05). (I) Mitochondria isolated from either WT yeast or sdh8Δ yeast 
expressing Sdh8-His6HA3 were solubilized in digitonin and the resulting extract was 
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Figure S2, related to figure 2.  Mammalian SDHAF4 is required for maximal SDH 
activity.   
(A) Mitochondria extracted from C2C12 cells transfected with AS, si1, or si2 were 
subjected to SDS-PAGE and analyzed by immunoblot of SDHA, SDHB, ATP5A, and 
VDAC.  (B) MDH enzyme activity was measured in mitochondria harvested from C2C12 









































































Figure S3, related to Figure 3: Metabolomic analysis of multiple dSdhaf4 mutants 
reveals changes in several metabolic pathways 
(A) dSdhaf4 alleles generated and used in this study. TALEN induced alleles (dSdhaf41 
and dSdhaf42) are shown in red, while the deletion generated by imprecise excision 
(dSdhaf43) of the pCG7224[KG07581] P element, is shown in blue. The dSdhaf43 allele 
contains a remnant of the pCG7224[KG07581] element that was not excised. Another strain in 
which the pCG7224[KG07581] element was precisely excised (Ex32+) was generated, 
confirmed by PCR, and used as a control for all studies with the dSdhaf43  allele. (B) 
Either LC/MS or GC/MS was used to measure the abundance of metabolites in 
transheterozygous dSdhaf41/3 mutants compared to genetically matched dSdhaf4+/Ex32+ 
controls. (C) Changes in non-TCA cycle metabolites in dSdhaf41/2 or dSdhaf41/3 flies 
compared to their respective controls measured using GC/MS. The data is depicted in box 
plot format, with the box representing the lower and upper quartiles, the horizontal line 
representing the median, and the bars representing the minimum and maximum data 
points. 8-12 biological replicates from two independent experiments were combined per 
genotype.  *p<0.05, **p<0.01 and ***p<0.001. The reduced levels of glutamate, which is 
interconvertible with alpha-ketoglutarate, as well as aspartate and 2-methylcitrate, which 
can be produced using oxaloacetate as a substrate (Gerike et al., 1998; (Jafari et al., 2013) 
suggest that dSdhaf4 mutant cells are utilizing aspartate and glutamate for anapleurosis. 
Conversely, elevated levels of homocysteine and GABA could reflect their 









































































































































































































































































Figure S4, related to Figure 4: dSdhaf4 is required for the stability of SdhA and 
SdhB, but is not a rate limiting factor in SDH assembly 
(A) Mitochondrial extracts from w1118 control (dSdhaf4+) or dSdhaf41/2 (dSdhaf4–) flies 
were resolved by SDS-PAGE, the gel was washed, and then either exposed to ultraviolet 
light to visualize flavinated SdhA (top), or stained with Coomassie Blue (bottom) to 
visualize total protein. Two biological replicates are shown. The reduction in flavinated 
SdhA reflects the overall reduction in SdhA protein levels (Figure 4B), indicating little if 
any effect of the mutation on flavination. (B) Protein from whole-fly homogenates was 
resolved by SDS-PAGE followed by immunoblotting to detect SdhB or tubulin. The 
asterisk denotes a non-specific band. Two biological replicates are shown.  (C) 
Mitochondria were isolated from either control w1118 (dSdhaf4+/+) or heterozygous 
dSdhaf4+/1  (dSdhaf4+/–) flies and SDH enzymatic activity was assayed. (D) Mitochondria 
were isolated from flies carrying a ubiquitous Tubulin-GAL4 driver or a UAS-dSdhaf4 
element alone or in combination, and SDH enzymatic activity was assayed. (E) 
Mitochondria were isolated from flies carrying a ubiquitous Tubulin-GAL4 driver or a 
UAS-dSdhaf4 element alone or in combination, and SdhA, SdhB or ATP∝ subunit levels 
were assayed by western blot analysis. (F) Flies harboring either control (dSdhaf4+) or 
dSdhaf41/2 (dSdhaf4–) mutant chromosomes linked to a hypomorphic SdhB allele or wild 
type SdhB locus over a balancer were crossed to each other in various combinations. The 
resulting progeny from these crosses were then assayed for the absence or presence of the 
marker linked to the balancer chromosome. The proportion of the expected progeny 
eclosed based on Mendelian ratios of the indicated genotype is shown. The n values 
displayed in parentheses in the graph represent the total number of progeny assayed 


















































































































Figure S5, related to Figure 5: dSdhaf4 mutants are sensitive to bang-induced 
paralysis, but not starvation 
(A) Adult dSdhaf4+/Ex32+ (dSdhaf4+) or dSdhaf41/3  (dSdhaf4–) females aged 6-8 hours, 2-4 
days, or 8-12 days were vortexed for 15 seconds and the percentage of paralyzed flies 
was counted. N>35 flies at each age per genotype. ***p<0.001 (ANOVA). (B) The 
percentage of 3-7 day old w1118 control or dSdhaf41/2 females that hold their wings in an 
upright position is shown.  N>180 flies per genotype. ***p<0.001 (Student’s t test). The 
mean±SEM is shown in A and B. (C) Controls or dSdhaf4 mutant flies carrying the 
ubiquitous Daughterless driver (Da-GAL4) or no driver in the presence or absence of 
either a UAS-dSdhaf4 transgene or a UAS-human Sdhaf4 (hSdhaf4) transgene were 
homogenized. Proteins from these homogenates were resolved by SDS-PAGE followed 
by immunoblotting to detect either SdhB or tubulin. Note that UAS-dSdhaf4 is leaky 
since it partially rescues in the absence of a GAL4 driver. (D) The amount of time 8-12 
day old flies paralyzed in Figure 5E take to recover from paralysis was quantified. The 
percentage of flies paralyzed < 2 minutes, 2-6 minutes, 8-10 minutes or >10 minutes are 
shown. The number above each bar represents the total number of flies of the indicated 
genotype paralyzed and is the sample size from which each data set is based. (E) 2-4 day 
old controls or dSdhaf4 mutant females were starved and the number of surviving 
animals was counted every 12 hours. The median lifespan under starvation 3.5 days for 
controls and 3.25 days for dSdhaf4 mutants. Data shown as the percentage of surviving 

























































































































































Figure S6, related to Figure 6. Yeast Sdh8 is a co-chaperone for unbound and 
covalently flavinated Sdh1.   
(A) A large scale HA immunoprecipitation of mitochondria isolated from sdh8Δ cells 
expressing Sdh8-His6HA3 and WT cells as a control.  The final eluates were resolved by 
SDS-PAGE and visualized by silver stain (Thermo Scientific).  The proteins present in 
each band were identified by mass-spectroscopy.  (B) WT, sdh8Δ, and sdh5Δ 
mitochondria were resolved by SDS-PAGE and imaged for covalent FAD (ultra-violet 
light) or immunoblotted for Sdh1.  (C) Sdh8-His6HA3  was immunoprecipitated using 
anti-HA conjugated agarose from digitonin-solublilized mitochondria.  Mitochondria 
were extracted from sdh8Δ cells expressing Sdh8-His6HA3 or sdh1Δsdh8Δ cells 
expressing Sdh8-His6HA3 and Sdh1H90S mutant (BY4741 background).  (D) Sdh8-
His6HA3 was immunoprecipitated from WT and sdh5Δ mitochondria using anti-HA 
conjugated agarose (W303 background).  (E) Mitochondrial lysates isolated from control 
cells (WT), sdh8Δ cells expressing Sdh8-His6HA3, sdh1Δsdh8Δ cells expressing Sdh8-
His6HA3, sdh2Δsdh8Δ cells expressing Sdh8-His6HA3, sdh8Δ cells, sdh2Δsdh8Δ cells, 
and sdh5Δsdh8Δ cells expressing Sdh8-His6HA3 were fractionated by SDS-PAGE.  
Levels of each protein was assessed by immunoblot for Sdh1, Sdh2, and HA (Sdh8-
His6HA3).  Immunoblot of Porin was used as a loading control (W303 background).  (F) 
Sdh2- His6HA3 was immunoprecipitated from digitonin-solubilized mitochondria.  
Mitochondria were extracted from control cells (WT), sdh2Δsdh4Δ cells expressing 
Sdh2-His6HA3, or sdh2Δsdh4Δsdh8Δ cells expressing Sdh2-His6HA3 (BY4741 
background).  (G) Mitochondria isolated from sdh8Δ cells expressing Sdh8-His6HA3 or 
sdh2Δsdh8Δ cells expressing Sdh8-His6HA3 were solubilized in digintonin and the 
resulting extract was fractionated by BN-PAGE.  The left and right panels represent the 
same western blot with a high and low exposure, respectively.  The arrowheads highlight 








































































































































Figure S7, related to Figure 7.  Sdh8 protects the cell from oxidative stress 
(A) Ten-fold serial dilutions of WT yeast transformed with an empty vector, WT yeast 
over-expressing SDH1, sdh8Δ cells transformed with an empty vector, and sdh8Δ cells 
over-expressing SDH1 were plated on media containing the indicated carbon source and 
incubated at 30°C (BY4741 background).  (B) WT yeast cells (W303 background) were 
grown in synthetic media containing 2% glycerol.  Two hours before analysis by flow 
cytometry the cells were either treated with 10mM H2O2 or 10mM DTT or left untreated 
(NT).  Shown are representative histograms of the measurement of the ratio of 
oxidized/reduced mito-roGFP in 30,000 cells from each group.  (C) The median value of 
the ratio of oxidized/reduced mito-roGFP is plotted for WT cells experiencing each 
treatment. (±SEM; N=3 biological replicates. **p < 0.01).  (D) WT and sdh8Δ cells were 
transformed with mito-roGFP and imaged by fluorescence microscopy.  (E) Ten-fold 
serial dilutions of WT yeast transformed with an empty vector, sdh8Δ cells transformed 
with an empty vector, and sdh8Δ cells over-expressing SOD2 were plated on media 
containing the indicated carbon source and incubated at 30°C (BY4741 background).  (F) 
Mitochondria harvested from WT and sdh8Δ cells carrying an empty vector or 
overexpressing YAP1 were solubilized in digitonin and separated by BN-PAGE.  (G) 
Mitochondria harvested from WT and sdh8Δ cells carrying an empty vector or 
overexpressing YAP1 were subjected to western blot analysis to detect Sdh1, Sdh2, and 
Porin. (H) A model for the assembly of SDH is depicted.  (1) Upon entry into the 
mitochondrial matrix, apo-Sdh1 is rapidly flavinated in a reaction that requires Sdh5 
(Hao et al., 2009).  (2) Acting as a co-chaperone, Sdh8 binds to flavinated Sdh1 forming 
an intermediate sub-complex that prevents Sdh1 autoxidation.  (3) Sdh8 may also 
facilitate the formation of Sdh1-Sdh2 soluble dimers.  (4) Finally, the Sdh1-Sdh2 dimer 
can dock on the IMM via interactions with Sdh3 and Sdh4 that have previously 






















































































































Table S1, related to Figure 1. Description of the yeast strains used in this 
investigation. 
 
Strain Genotype Source 
WT (BY4741) Mat A his3 leu2 ura3 met15 Open 
Biosystems 
sdh1Δ Mat A his3 leu2 ura3 met15 
sdh1::his3MX 
This Study 
sdh2Δ Mat A his3 leu2 ura3 met15 
sdh2::kanMX 
This Study 
sdh4Δ Mat A his3 leu2 ura3 met15 
sdh4::natMX 
This Study 
sdh8Δ Mat A his3 leu2 ura3 met15 
sdh8::hygMX 
This Study 
sdh1Δsdh2Δ Mat A his3 leu2 ura3 met15 
sdh1::his3MX  sdh2::kanMX 
This Study 
sdh1Δsdh4Δ Mat A his3 leu2 ura3 met15 
sdh1::his3MX  sdh4::natMX 
This Study 
sdh1Δsdh8Δ Mat A his3 leu2 ura3 met15 
sdh1::his3MX  sdh8::hygMX 
This Study 
sdh2Δsdh4Δ Mat A his3 leu2 ura3 met15 
sdh2::kanMX  sdh4::natMX 
This Study 
sdh2Δsdh8Δ Mat A his3 leu2 ura3 met15 
sdh2::kanMX  sdh8::hygMX 
This Study 
sdh4Δsdh8Δ Mat A his3 leu2 ura3 met15 
sdh4::natMX  sdh8::hygMX 
This Study 
sdh1Δsdh2Δsdh4Δ Mat A his3 leu2 ura3 met15 
sdh1::his3MX  sdh2::kanMX  sdh4::natMX 
This Study 
sdh1Δsdh2Δsdh8Δ Mat A his3 leu2 ura3 met15 
sdh1::his3MX  sdh2::kanMX  sdh8::hygMX 
This Study 
sdh1Δsdh4Δsdh8Δ Mat A his3 leu2 ura3 met15 
sdh1::his3MX  sdh4::natMX  sdh8::hygMX 
This Study 
sdh2Δsdh4Δsdh8Δ Mat A his3 leu2 ura3 met15 
sdh2::kanMX  sdh4::natMX  sdh8::hygMX 
This Study 
sdh1Δsdh2Δsdh4Δsdh8Δ Mat A his3 leu2 ura3 met15 
sdh1::his3MX  sdh2::kanMX  sdh4::natMX  sdh8::hygMX 
This Study 
WT (W303) Mat A his3 leu2 ura3 met15 trp1 David 
Stillman 
sdh1Δ Mat A his3 leu2 ura3 met15 trp1 
sdh1::kanMX   
This Study 
sdh2Δ Mat A his3 leu2 ura3 met15 trp1 
sdh2::kanMX 
This Study 
sdh5Δ Mat A his3 leu2 ura3 met15 trp1 
sdh5::kanMX 
This Study 
sdh8Δ Mat A his3 leu2 ura3 met15 trp1 
sdh8::hygMX 
 
sdh1Δsdh8Δ Mat A his3 leu2 ura3 met15 trp1 
sdh1::kanMX sdh8::hygMX 
This Study 
sdh2Δsdh8Δ Mat A his3 leu2 ura3 met15 trp1 
sdh2::kanMX  sdh8::hygMX 
This Study 
sdh5Δsdh8Δ Mat A his3 leu2 ura3 met15 trp1 




Supplemental Experimental Procedures 
Drosophila strains 
The following stocks were obtained from the Bloomington Stock Center: ElaV-Gal4 (Luo 
et al., 1994), Daughterless-Gal4 (Wodarz et al., 1995), Frt82B,CoVatend/TM6B (Mandal 
et al., 2005), SdhB[12081]/CyO (Walker et al., 2006) and SdhA[HP21216]/CyO . Sdhaf4 mutants 
and transgenic lines were generated as described below. All fly stocks were maintained at 
25˚C on standard cornmeal/molasses/agar food ambient O2 concentrations unless 
otherwise noted. 
Generation of dSdhaf4 mutant lines 
DSdhaf4 mutants were generated by targeting the second exon of dSdhaf4 using 
TALENs, as described (Cermak et al., 2011; Dahlem et al., 2012; Hu et al., 2013). The 
specificity of potential TALEN target sequences was determined using Target Finder 
(https://tale-nt.cac.cornell.edu) and a BLAST analysis. TALEN pairs were designed and 
constructed by the Mutation Generation and Detection Core Research Facility at the 
University of Utah (http://www.cores.utah.edu/) with the following specifications: Left 
binding site – 5’-CGAGATCAAGGAACCAAA-3’; Right binding site – 5’-
AATGGCCTTCCAGAAGA-3’; Spacer – 5’-GACGCGCACCGAGAAGCT-3’. The 
TALEN Golden Gate kit described by Cermak et al was used with modifications and 
TALENs were assembled as described by Dahlem et al and Hu et al. Plasmid DNAs 
carrying the dSdhaf4 TALEN construct were then purified with a Qiagen maxi-prep kit 
and concentrated by ethanol precipitation. RNAs were generated by digesting the 
TALEN construct with NotI, repurifying, and directing in vitro transcription using the 
AmpliScribe SP6 High Yield Transcription Kit (Epicentre), followed by the ScriptCap 
m7G Capping System (Epicentre). The TALEN RNAs were concentrated and 250 µg/ml 
of each RNA was combined in 0.1X PBS. We used the obligate heterodimer architecture 
DDD/RRR and injected ~200 Canton S embryos. ~35 surviving injected G0 animals were 
crossed individually to a strain carrying a CyO balancer. ~5 F1 progeny males from each 
cross were then outcrossed to a strain carrying a CyO balancer marked with GFP, and 





resolution melt analysis (Dahlem et al., 2012). Two putative mutant strains (dSdhaf41 and 
dSdhaf42) were verified by DNA sequencing. Flies carrying a wild type dSdhaf4 locus 
derived from the same G0 animals as the dSdhaf41 and dSdhaf42 alleles were carried 
through the same series of crosses and used as genetically matched controls. This control 
is labeled dSdhaf4+ or dSdhaf4+/+ in all figures. The transposable P-element insertion 
pCG7224KG07581 was also used to generate a dSdhaf4 allele by imprecise excision. The 
dSdhaf43 allele, which was verified by Southern blotting, PCR and DNA sequencing, 
contains an unexcised fragment of the pCG7224KG07581 element (Supplemental Figure 
3A). A precise excision was also isolated (dSdhaf4Ex32+) and is used as a control for 
dSdhaf43 in all relevant experiments.  All mutant and control genotypes analyzed are in a 
w1118 background. 
 
Generation of transgenic fly lines 
To generate UAS-dSdhaf4 rescue construct, the CG7224 cDNA (GH 06541) was excised 
using XhoI and BglII and inserted into a pUAST vector. To generate the UAS-hSdhaf4 
construct, the hSdhaf4 cDNA was PCR amplified from pJR3455A, which contains an 
hSdhaf4 cDNA amplified from HepG2 cells using the primers 5’-
CGAGATCTATGACCCCATCGAGGCTT-3’ and 5’-
CGCTCGAGTTAAAAATCAATACAGCGTCCTTTT-3’. This amplicon was then cut 
with BglII and XhoI and cloned into an pUAST-AttB plasmid. All plasmids used to 
generate transgenic lines were verified by restriction digestion and DNA sequencing. 
UAS-dShdaf4 transgenic lines were generated using standard P-element mediated 
transformation, and UAS-hSdhaf4 transgenic lines were targeted to AttP2 by site-directed 
transformation (Bateman et al., 2006; Pfeiffer et al., 2010). elav-Gal4, UAS-dSdhaf4 and 
UAS-hSdhaf4 on the third chromosome were crossed into the dSdhaf41 or dSdhaf42 
background using balanced crossing schemes. Da-Gal4 on the third chromosome was 
recombined onto the same chromosome as the dSdhaf42 allele. The presence of the 
dSdhaf4 mutant alleles in transgenic lines was verified by DNA sequencing and 
complementation tests.  
 





To assay whether combining the lethal allele of SdhA or the viable hypomorphic allele of 
SdhB with dSdhaf4 mutations affects viability, the SdhA[HP21216] or SdhB[12081] insertions 
were recombined with the either dSdhaf41 or dSdhaf42 alleles. Flies carrying these 
recombinant chromosomes, dSdhaf41 allele alone, Sdh allele alone, or a wild type 
chromosome over an SM5 balancer marked with Cy– were intercrossed in various 
combinations. All crosses were performed in triplicate. The number of expected progeny 
resulting from these crosses was calculated based on mendelian ratios. To determine if 
the expected number of progeny of non-SM5 chromosomes reached adulthood, the total 
number of eclosed Cy+ adult flies was counted, and that number was compared to 1/2 or 
1/3 of the total number of progeny depending on whether a 1:1 or 1:2 ratio was expected. 
The N values shown in Figure 4C and Supplemental figure 4F concerning the genetic 
interactions between dSdhaf4 and SdhA/B represent the total number of progeny counted 
from the pertinent cross. Since CoVa[tend] mutation is on the third chromosome, 
dSdhaf41/SM5;CoVa[tend]/TM3 or dSdhaf4+/SM5;CoVa[tend]/TM3 flies were crossed to 
dSdhaf42/dSdhaf42 or dSdhaf4+/dSdhaf4+ flies, respectively. A normal 1:1 distribution of 
Cy–:Cy+  flies were observed (Data not shown), so only the Cy+ flies were counted. Since 
TM3 is marked with Sb–, the total number of Cy+;Sb– or Cy+;Sb+ flies was counted and 
compared to the 1:1 ratio expected. The N values shown in Figure 4C concerning the lack 
of a genetic interaction between dSdhaf4 and CoVa represent the total number of Cy+ 
progeny assayed.  
 
Drosophila lifespan analyses 
For lifespan measurements, flies were allowed to eclose for one day, and were separated 
into vials containing ~20 flies. Every 2-4 days dead flies were counted/removed and 
surviving flies transferred to new food vials. >100 flies were assayed for each genotype. 
For starvation assays, 2-4 day old females were transferred to starvation media (1% agar 
in H2O) and the number of surviving flies was assayed every 12 hours. >90 flies were 
assayed per genotype. To measure sensitivity to hyperoxia, vials containing 2-4 day old 
females were placed in polyethylene bags (Scienceware 12”x16”), which were 
subsequently filled with 100% O2 and sealed using a Quick Seal bag sealer. Bags were 
refilled with fresh O2 2-3 times daily and the number of surviving flies was assayed every 
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24 hours. >40 flies were assayed per genotype. A similar degree of hyperoxia sensitivity 
was observed in dSdhaf mutants placed in a styrofoam box with a continuous flow of 
100% O2 as described (Walker et al., 2006), however, we could not maintain this 
experimental paradigm long enough to assay the full lifespan of controls (data not 
shown). Survival during hyperoxia was assayed at room temperature, whereas flies for all 
other lifespan experiments were kept at 25˚C. Experiments on female flies are presented 
for all survival curves, but similar results were observed when assaying males (data not 
shown).  
Electron microscopy 
Heads were removed from 8-12 day old female flies, the was proboscis removed, and 
heads were fixed overnight in EM grade 3% glutaraldehyde/3% paraformaldehyde in 
PBS at 4˚C. After fixation, heads were rinsed three times in 10mM cacodylate buffer and 
postfixed in 2% OsO4 for 2 hours at room temperature. The heads were then washed in 
the same buffer, followed by a wash in dH2O, and then post stained in 1% uranyl acetate 
for 1 hour at room temperature. After washing with dH2O, heads were dehydrated in a 
graded series of acetone (25%, 50%, 75%, 90% and 3x100% for 20 min each step), and 
then infiltration was conducted over 3 days followed by embedding in epoxy resin 
(Embed 812, Electron Microscopy Sciences). For the infiltration step, specimens were 
incubated in 30% resin and acetone for 6 hours, then in placed in 70% resin and acetone 
overnight. The next day, the specimens were placed into 90% resin and acetone for 8 hrs 
and 100% resin for another overnight incubation. On the following day, after two 
incubations in freshly prepared 100% resin over 6 hrs, specimens were embedded and 
polymerized at 60°C for 48 hrs. Ultrathin (70nm) sections were obtained with diamond 
knife (Diatome) and an ultratome Leica UC6  (Leica Microsystems, Bannockburn,IL). 
Grids with sections were post stained with saturated uranyl acetate in dH2O for 20 min 
and with lead citrate for 10 min and imaged at 120kV using a Technai T 12 electron 
microscope. N=3 flies assayed per genotype. 
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Immunoblotting 
Antibodies used for immunoblotting: anti-SdhA (Abcam 137756; rabbit polyclonal to 
human SdhA), anti-SdhB (Abcam 14714; mouse monoclonal to human SdhB), anti-Atp 
synthase a (Abcam 14748; mouse monoclonal to bovine Atp5) and anti-beta Tubulin 
(Chemicon MAB380; mouse monoclonal), anti-VDAC (Abcam 15895), anti-Sdh1 (rabbit 
polyclonal to yeast Sdh1; was a generous gift from Dennis Winge), anti-Sdh2 (rabbit 
polyclonal to yeast Sdh2; was a generous gift from Dennis Winge), anti-Porin (Abcam 
110326). 
SdhA/Sdh1 flavination assay 
To visualize flavinated SdhA, mitochondrial extracts were fractionated by SDS-PAGE 
and the gel was incubated for 20 minutes in 10% acetic acid. Auto-fluorescent flavo-
SdhA was imaged using an ethidium bromide filter, as previously described (Hao et al., 
2009). The gel was stained with Coomassie Blue to visualize total protein as a control for 
loading in Drosophila experiments.  In yeast experiments, immunoblot for Sdh1 was used 
to control for loading. 
Yeast strains and growth conditions 
Saccharomyces cerevisiae (BY4741 MATa, his3 leu2 met15 ura3) and Saccharomyces 
cerevisiae (W303a MATa, his3 leu2 met15 trp1 ura3) were used as the wild-type strains 
where indicated.  Each mutant was derived from a BY4741 or W303 diploid using a 
standard PCR-based homologous recombination method.  Each haploid was generated by 
sporulation and tetrad dissection.  The genotypes of all strains used in this study are listed 
in Supplemental Table 1.  Yeast transformation was performed by the standard TE/LiAc 
method and transformed cells were recovered and grown in synthetic complete glucose 
(SD) medium lacking the appropriate amino acid(s) for selection purposes.  Medium used 
in this study includes YPA and synthetic minimal medium supplemented with 2% 




Growth assays were performed using synthetic minimal media supplemented with the 
appropriate amino acids and indicated carbon source.  Overnight cultures were back-
diluted equivalent ODs and spotted as 10-fold serial dilutions.   
 
Plasmid construction 
The plasmids expressing internal His6HA3 or GFP tagged Sdh8 were generated by PCR 
amplification of SDH8 (NC_001134.8) flanked by its upstream promoter and 
downstream terminator regions off genomic DNA.  The untagged gene along with its 
regulatory elements was ligated into pRS415 using XhoI and SpeI.  Sewing PCR was 
used to add NheI and SalI restriction sites between the codons encoding residues N82 and 
S83 of SDH8.  The His6HA3 tag, which was chemically synthesized, and the GFP tag, 
which was amplified by PCR, were each ligated between N82 and S83 using the NheI 
and SalI yielding the final SDH8-His6HA3 and SDH8-GFP constructs.  The sequence of 
each construct was confirmed by sequencing (Genewiz).       
 
Human and Drosophila SDHAF4 were cloned such that the expression of each gene was 
under the control of the SDH8 promoter.  Sewing PCR was used to clone the SDH8 
promoter and terminator separated by NheI and SalI restriction sites into pRS415.  
SDHAF4 from each species was PCR amplified from cDNA and ligated between the 
SDH8 promoter and terminator using NheI and SalI.   
 
Sdh1H90A and Sdh1H90S  constructs were generated by sewing PCR.  The mutants were 
ligated into pRS416 using XhoI and XmaI.  Both constructs were expressed under the 
control of the native SDH1 promoter and terminator.   
 
Isolation of Yeast Mitochondria 
Yeast cells were harvested in mid-log phase.  Preparation of crude mitochondria was as 
described previously .(Boldogh and Pon, 2007)  Cell pellet was washed once with ddH2O 
and incubated in TD buffer (100 mM Tris-SO4, pH 9.4 and 100 mM DTT) for 15 min at 
30°C.  Spheroplasts were obtained by incubating cells in SP buffer (1.2 M Sorbitol and 




at 30°C to remove the cell wall.  Spheroplasts were gently washed once and homogenized 
in ice-cold SEH buffer (0.6 M sorbitol, 20 mM HEPES-KOH, pH 7.4, 2 mM MgCl2, 
1mM EGTA) using a dounce homogenizer applied with 30-40 strokes.  Crude 
mitochondria were further purified using differential centrifugation. When needed, pure 
mitochondria were isolated by ultracentrifugation through a continuous nycodenz 
gradient.   
 
Fluorescence Microscopy 
The sdh8 mutant strain transformed with plasmids expressing Sdh8-GFP and MtRFP was 
grown in SD medium overnight.  Cells were back-diluted in fresh media to 0.1 OD and 
allowed to grow for several hours.  Images wee captured using a Zeiss Axioplan 2 
Imaging microscope (Carl Zeiss). 
 
Steady-State Protein Analysis 
Yeast mitochondria were solubilized in Laemmli buffer.  Samples were resolved by SDS-
PAGE and assessed by immunoblot.  Drosophila extracts from either 20 µg isolated 
mitochondria or the equivalent of ½ of a fly were analyzed in each lane of a Western blot. 
 
Immunoprecipitation of Sdh8-His6HA3 and Sdh2-His6HA3 
Crude mitochondria were isolated and resuspended to a concentration of 5 mg/mL in 
XWA buffer.  Soluble proteins were extracted by sonication and centrifugation at 20,000 
x g for 20 mins.  Membrane proteins were extracted in buffer containing 0.7% digitonin 
for 1 hr. and and centrifugation at 20,000 x g for 20 mins.  Cleared mitochondrial lysates 
were incubated with anti-HA antibody conjugated agarose (Sigma) for 2 hrs. at 4°C.  The 
agarose was washed 3-5 times and eluted in buffer containing 1 mg/mL HA peptide.  
Elution samples were precipitated in 20% TCA, resolved by SDS-PAGE, and assessed by 
mass spectroscopy and/or immunoblot.   
 
Assessment of Submitochondrial Localization and Solubility 
Submitochondrial fractionation was performed using a protocol adapted from (Boldogh 
and Pon, 2007).  Mitochondria were incubated in the isotonic SH buffer (20mM HEPES-
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KOH, pH 7.4, 0.6M Sorbitol) of hypotonic H buffer (20mM HEPES-KOH, pH 7.4) with 
and without 1% Tritin-X100. Samples were treated with Protease K (New England 
BioLabs) on ice for 30 min.  Addition of PMSF to each sample was used to terminate 
protease digestion.  Samples were resolved by SDS-PAGE and assessed by immunoblot. 
Solubility of Sdh8 was assessed by ultracentrifugation.  Mitochondria was suspended in 
SH buffer and subjected to sonication.  Mitochondrial membranes were isolated by 
ultracentrifugation at 100,000 x g for 30 min (MLA-130, Beckman Coulter).  The 
membrane (membrane fraction) was resuspended in 2X Laemmli buffer.  The supernatant 
(soluble fraction) was precipitated in 20% TCA and resuspended in 2X Laemmli buffer.  
Samples were resolved by SDS-PAGE and assessed by immunoblot.   
Yeast Enzyme Activity Assays 
SDH and MDH activity assays were performed as described in Hao et al., 2009.  
Aconitase Activity Assay 
Yeast cells were grown in SD medium well into stationary phase and resuspended in lysis 
buffer (50 mM Tris-HCl, 50 mM KCl, 2 mM sodium citrate dihydrate, 10% glycerol, 1 
mM PMSF, and 7 mM β-mercaptoethanol), and stored at –80°C overnight. After thawing 
on ice, cells were homogenized by vortexing with glass beads and cleared lysate was 
collected by centrifugation. Aconitase activity was measured by coupling with NADP+-
dependent isocitrate dehydrogenase activity. 30 μl of crude lysate was mixed with 150 μl 
of reaction mixture (1 M Tris-Cl pH 8.0, 10 mM MgCl2, 10 mM NADP+, 0.32 units of 
NADP+- dependent Isocitrate Dehydrogenase), and 10 μl of 50 mM citrate. The reaction 
mixture was recorded at 340nm for 2 minutes (15 sec intervals).  Aconitase activity was 
normalized to total protein concentration. 
Yeast Metabolomic Analysis 
Metabolomic analysis was carried out in the Metabolomics Core Research Facility at the 
University of Utah School of Medicine.  Yeast cultures were grown to an OD of 1 in 
synthetic media containing 2% glycerol and 2% ethanol. 
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Mammalian Cell Culture 
C2C12 myoblasts (ATCC CLR-1772) were maintained in DMEM with 10% FBS, 2mM 
Glutamax (Gibco), and 1% Primocin (Invitrogen).  All knockdowns were performed by 
treating cells with 5 nM total siRNA, using the Lipofectamine RNAiMax tranfection 
reagent (Invitrogen).  The All-Stars non-targeting siRNA (Qiagen) was used as a control 
for siRNAs targeting SDHAF4 (NM_026503) which were designed using Dharmacon 
siDesign Center tool (http://www.dharmacon.com/designcenter/DesignCenterPage.aspx).  
Sequences of the sense strands of targeting siRNAs, which include a 3’ tt DNA overhang, 
are as follows: (si1) UGAGUUAUCAGGAAGGAAA and (si3) 
UCUCACAACUGCAGAAUCA. Cells were subjected to knockdown on day 0, again on 
day 3, and harvested for analysis on day 6.  Total RNA was isolated with the RNeasy 
Mini Kit (Qiagen) and reverse transcribed to cDNA using the High Capacity cDNA 
Reverse Transcriptase Kit (Applied Biosystems).  Quantitative PCR was performed on 
cDNA with a Roche 480 LightCycler using LightCycler 480 SYBR Green 1 Master Mix 
(Roche) to confirm knockdown.   
Isolation of Mammalian Mitochondria 
The procedure was adapted from (Bozidis et al., 2007). C2C12 cells were trypsinized, 
washed twice with ice cold PBS and pelleted.  The cell pellet was resuspended in 2 mL 
ice cold MTE buffer and lysed by sonication (Branson Model 250, continuous pulse, 
power setting 3.5, 3 cycle, 10 s. each).  Cell debris and nuclei were pelleted at 1,400 x g 
for 10 min.  Mitochondria were recovered from the supernatant by centrifugation at 
10,000 x g for 10 min.  Mitochondria were resuspended in MTE.  Protein concentration 
was determined by Advanced Protein Assay Reagent (Cytoskeleton).    
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Abstract Mitochondrial fatty acid synthesis (FASII) and iron sulfur cluster (FeS) biogenesis are
both vital biosynthetic processes within mitochondria. In this study, we demonstrate that the
mitochondrial acyl carrier protein (ACP), which has a well-known role in FASII, plays an unexpected
and evolutionarily conserved role in FeS biogenesis. ACP is a stable and essential subunit of the
eukaryotic FeS biogenesis complex. In the absence of ACP, the complex is destabilized resulting in
a profound depletion of FeS throughout the cell. This role of ACP depends upon its covalently
bound 4’-phosphopantetheine (4-PP)-conjugated acyl chain to support maximal cysteine
desulfurase activity. Thus, it is likely that ACP is not simply an obligate subunit but also exploits the
4-PP-conjugated acyl chain to coordinate mitochondrial fatty acid and FeS biogenesis.
DOI: 10.7554/eLife.17828.001
Introduction
The mitochondrial acyl carrier protein (ACP; Figure 1—figure supplement 1) plays a critical role in
the evolutionarily conserved type II fatty acid biosynthesis pathway (FASII; Figure 1—figure supple-
ment 2A). Unlike the cytosolic fatty acid biosynthesis pathway (FASI), the mitochondrial FASII sys-
tem, which is homologous to the prokaryotic fatty acid biosynthesis pathway, utilizes a set of
monofunctional enzymes that interact transiently with ACP to catalyze the initiation and elongation
of nascent acyl chains (Hiltunen et al., 2010). To facilitate FASII, ACP utilizes a 4’-phosphopante-
theine prosthetic group (4-PP), which is covalently bound to an invariant Ser residue (Majerus et al.,
1965; Stuible et al., 1998). As such, ACP serves as a soluble scaffold for acyl intermediates during
the stepwise process of de novo fatty acid synthesis. Currently, it is thought that the primary product
of ACP-dependent FASII is octanoate, which is cleaved from ACP and further processed to generate
lipoic acid. Lipoic acid is an obligate cofactor of the pyruvate dehydrogenase and a-ketoglutarate
dehydrogenase complexes as well as the branched chain a-keto acid dehydrogenase and glycine
cleavage complex (Hiltunen et al., 2010; Brody et al., 1997). In addition, a FASII-derived acyl chain
other than lipoic acid is required for RNase P function in tRNA maturation (Schonauer et al., 2008).
Biochemical analyses of mammalian FASII enzymes demonstrate that this pathway is capable of
generating ACP-bound acyl chains as long as fourteen carbons (Zhang et al., 2005). Since lipoic
acid biosynthesis requires an acyl chain of just eight carbons, it is likely that these extended FASII-
synthesized fatty acids serve an alternative function in mitochondria (Brody et al., 1997). Indeed,






proteomic and structural studies have demonstrated that ACP is a stable accessory subunit of mito-
chondrial respiratory Complex I (CI) (Sackmann et al., 1991; Angerer et al., 2014). Furthermore,
the pool of ACP associated with CI contains a 4-PP-conjugated 3-hydroxymyristic acid, however, the
functional importance of this 14-carbon acyl chain has never been investigated in the context of CI
activity or assembly (Carroll et al., 2003).
In Saccharomyces cerevisiae, ACP1, the gene encoding ACP, is essential for cell viability in multi-
ple strain backgrounds, while the genes required for lipoic acid biosynthesis and ligation are not
(Figure 1A, Figure 1—figure supplement 2B,C) (Schonauer et al., 2008; Brody et al., 1997). This
is consistent with reports demonstrating that ACP is essential for viability in Yarrowia lipolytica
(Dobrynin et al., 2010) and in mammalian cells (Yi and Maeda, 2005; Feng et al., 2009). Moreover,
S. cerevisiae mitochondria do not have CI or any structurally similar analog of it. Since neither known
function explains the essentiality of ACP1, we reasoned that ACP must perform a distinct, unknown,
and essential mitochondrial function.
Results and conclusions
To begin to define the essential function of Acp1, we purified endogenously expressed and fully
functional Acp1-HA (Figure 1A) from purified mitochondria to discover interacting proteins that
might explain the acp1D phenotype. We were particularly intrigued by the co-purification of three
subunits of the ISU complex—Nfs1, Isd11, and Isu1—each of which is required for FeS biogenesis
and essential for viability. The cysteine desulfurase (Nfs1) and Isd11 form the core of the ISU com-
plex and catalyze the conversion of cysteine to alanine thereby generating a persulfide intermediate,
which is the source of sulfide ions that combine with ferrous iron on the Isu1 scaffold protein to form
[2Fe-2S] clusters (Garland et al., 1999; Mu¨hlenhoff et al., 2004; Adam et al., 2006;
Wiedemann et al., 2006). To confirm these interactions, we immunoprecipitated Acp1-HA from iso-
lated mitochondria and analyzed the eluates by immunoblot. Indeed, Nfs1, Isd11, and Isu1 all specif-
ically co-immunoprecipitate with Acp1, although Isu1 appears to interact less avidly than Nfs1 or
Isd11 (Figure 1B). In addition to SDS-PAGE, the resultant eluates were also resolved by blue native
(BN)-PAGE, which demonstrated that Acp1 co-purifies with the intact core Nfs1-Isd11 complex
(Figure 1B). Finally, Nfs1-V5 and Isd11-V5 were each immunoprecipitated from isolated
eLife digest Like animals and plants, yeast cells contain structures called mitochondria. These
structures are commonly referred to as the powerhouses of the cell because they provide much of
the energy that cells need to survive. All mitochondria contain a protein called acyl carrier protein
(ACP), which cells need in order to live. The ACP protein has a number of known roles including
manufacturing the molecules that make up certain fats and helping to organise other proteins that
are important for energy production. However, neither of these roles explain why yeast cells require
ACP because the other proteins required for these processes are not required for survival.
Mitochondria are also the sites where iron and sulfur atoms are joined together to make the iron
sulfur clusters that many proteins need in order to carry out their roles. Van Vranken, Jeong et al.
now show that the ACP protein associates with a molecular machine that makes iron sulfur clusters
in the mitochondria of budding yeast cells. The experiments show that this interaction is needed to
produce iron sulfur clusters, and without it the other proteins involved in the process are not able to
work together. Since iron sulfur clusters are essential for life, this could explain why cells cannot
survive without ACP. Van Vranken et al. also showed that ACP is only able to efficiently produce iron
sulfur clusters when a chemical called a “4-PP-conjugated acyl chain” is attached to it.
It is possible to separate the activity of ACP in making iron sulfur clusters from its previously
known roles. Van Vranken et al. suggest that the addition of the 4-PP-conjugated acyl chain to ACP
may help to balance the use of ACP between its different activities. Moving forward, Van Vranken
et al. hope to determine the structure of ACP in more detail to understand how it contributes to
iron sulfur cluster formation, and why this single protein has evolved to perform so many distinct
roles.
DOI: 10.7554/eLife.17828.002





mitochondria. As expected, Acp1-HA was detected in the eluates of each immunoprecipitation (Fig-
ure 1—figure supplement 3). These results are further supported by proteomics-based interaction
studies, which identify human ACP, NFS1, and ISD11 as mutually interacting proteins in mammalian
cells (Huttlin et al., 2015). Taken together these data demonstrate that Acp1 is a stable and evolu-
tionarily conserved subunit of the ISU complex with Nfs1, Isd11, and Isu1.
FeS biogenesis is an essential function of mitochondria and is absolutely dependent on the ISU
complex with which Acp1 stably interacts (Lill et al., 1999). Thus, we hypothesized that the essential
function of Acp1 might relate to FeS biogenesis. We engineered inducible ACP1 knockdown strains
(Acp1KD) using two distinct strategies and strain backgrounds—TetO7-ACP1 in the BY4741 back-
ground and Gal-ACP1 in the DY150 background, in which ACP1 expression is suppressed by doxy-
cycline and galactose withdrawal, respectively. As expected, Acp1KD cells from each background
displayed attenuated growth upon ACP1 shutdown, which is particularly evident on respiration-
requiring glycerol medium (Figure 2—figure supplement 1A–C). Importantly, viability could be
restored in each of these strains by episomal expression of the Acp1-HA at endogenous levels. In
addition to the expected loss of lipoic acid-containing subunits of pyruvate dehydrogenase and a-
ketoglutarate dehydrogenase in the Acp1KD cells, we also observed a specific destabilization of the
FeS-containing subunits of Complex II (Sdh2) and Complex III (Rip1) and loss of those assembled
respiratory complexes (Figure 2A and Figure 2—figure supplement 2A). A similar destabilization
of these complexes occurs in cells depleted for Nfs1 and Isu1 (Adam et al., 2006;
Wiedemann et al., 2006). Importantly, Complex III biogenesis stalls in Acp1KD cells at the final stage
of assembly – incorporation of the Rieske FeS protein (Rip1) (Figure 2A; IB: Rip1)–resulting in the
accumulation of a stable assembly intermediate of Complex III lacking Rip1 (Figure 2A; III2*; IB:
Figure 1. Acp1 is a stable subunit of the ISU complex. (A) acp1D heterozygous diploids were dissected with and
without a plasmid expressing Acp1-HA (BY4741) and spores were grown on YPAD medium for 2 days. Sporulation
of the heterozygous deletion strain failed to generate haploid ACP1 deletion strains unless a vector borne ACP1
gene was present. (B) Purified mitochondria from cells either expressing Acp1-HA or not were solubilized by
digitonin (input) and then subjected to anti-HA immunoprecipitation. The resulting eluates and input samples
were subjected to SDS-PAGE and BN-PAGE and immunoblot.
DOI: 10.7554/eLife.17828.003
The following figure supplements are available for figure 1:
Figure supplement 1. Protein sequence alignment of ACP from eukaryotes.
DOI: 10.7554/eLife.17828.004
Figure supplement 2. Eukarotic mitochondrial fatty acid biosynthesis (FASII) pathway.
DOI: 10.7554/eLife.17828.005
Figure supplement 3. Acp1 is a stable subunit of the ISU complex.
DOI: 10.7554/eLife.17828.006
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Qcr7). The presence of the late stage intermediate III2* indicates that mitochondrial translation of
the Cob cytochrome b subunit is normal in Acp1KD cells (Atkinson et al., 2011; Cui et al., 2012).
Likewise, translation of the mitochondrial subunits of ATP synthase is normal as seen by the assem-
bled F1F0 complex (Figure 2A). We also observed a loss of activity of aconitase, a mitochondrial
enzyme with an obligate FeS cofactor (Figure 2B and Figure 2—figure supplement 2B).
Figure 2. Acp1 is required for FeS biogenesis. (A) Isolated mitochondria from the indicated strains were resolved by SDS-PAGE (upper panel) or
solubilized in 1% digitonin and resolved by BN-PAGE (lower panel). The time course indicates the time following addition of 10 mg/mL doxycycline to
the cultures, which suppresses expression from the TetO7-ACP1 allele. The indicated proteins and protein complexes were assessed by immunoblot.
LA indicates lipoic acid-conjugated Lat1 (PDH complex subunit; upper band) and Kgd2 (a-ketoglutarate dehydrogenase complex subunit; lower band).
(B) Aconitase activity was measured in whole cell lysates from the indicated strains containing the indicated plasmids 18 hr post-addition of 10 mg/mL
doxycycline (± SEM; N = 3 biological replicates. ***p<0.0005, ****p<0.00005). (C) qPCR was used to measure the expression of ACP1, FIT2, and FIT3 in
the indicated strains. The Gal-ACP1 strain was harvested at 28 hr post-transfer to raffinose medium to suppress ACP1 expression. The mrs3/4D strain
lacks both Mrs3 and Mrs4 mitochondrial iron transporters. BPS (80 mM) is a Fe(II) chelator that causes depletion of bioavailable iron. FIT2 and FIT3 are
components of the iron regulon that is induced upon loss of cytosolic FeS (± SEM; N = 3 biological replicates. *p<0.05, **p<0.005, ***p<0.0005).
DOI: 10.7554/eLife.17828.007
The following source data and figure supplements are available for figure 2:
Source data 1. Source data for Figure 2.
DOI: 10.7554/eLife.17828.008
Figure supplement 1. ACP1 expression is required for cell proliferation.
DOI: 10.7554/eLife.17828.009
Figure supplement 2. Acp1 is essential for FeS biogenesis.
DOI: 10.7554/eLife.17828.010





The mitochondrial ISU complex is essential for the production of FeS that act in the cytosol as
well as ribosome assembly (Kispal et al., 2005). In addition, mitochondrial FeS synthesis is important
to attenuate the transcriptional activity of two partially redundant iron-responsive factors Aft1 and
Aft2. In Acp1KD cells the expression of Aft1-target genes FIT2 and FIT3 was elevated consistent with
impaired mitochondrial FeS synthesis (Figure 2C) (Chen et al., 2004; Rutherford et al., 2005).
Figure 3. ACP promotes FeS biogenesis by maintaining the stability of the ISU (Nfs1-Isd11) complex. (A) Purified mitochondria from the indicated
strains were either resolved by SDS-PAGE (lower panels) or solubilized in 1% digitonin and resolved by BN-PAGE (upper panels). Cells were grown for
18 hr in the presence of 10 mg/mL doxycycline. The indicated proteins and protein complexes were assessed by immunoblot. (B) Mitochondria purified
from the indicated strains 18 hr post-addition of 10 mg/mL doxycycline were solubilized with 1% Triton X-100. Soluble (S) and pellet (P) fractions were
separated by centrifugation at 100,000 g. The fractions, along with the total input (T) were resolved by SDS-PAGE and assessed by immunoblot. (C)
C2C12 mouse myoblasts were transfected with a pool of siRNA targeting NDUFAB1 (ACP) or a scrambled control. Isolated mitochondria was resolved
by SDS-PAGE and assessed by immunoblot. (D) Isolated mitochondria from the WT and Gal-ACP1 strains expressing the indicated gene via a 2 m
plasmid at 28 hr post-transfer to raffinose-containing medium were either resolved by SDS-PAGE (lower panels) or solubilized in 1% digitonin and
resolved by BN-PAGE (upper panels). The indicated proteins and protein complexes were assessed by immunoblot.
DOI: 10.7554/eLife.17828.011
The following source data and figure supplement are available for figure 3:
Source data 1. Source data for Figure 3.
DOI: 10.7554/eLife.17828.012
Figure supplement 1. ACP promotes FeS biogenesis by maintaining the stability of the ISU (Nfs1-Isd11) complex.
DOI: 10.7554/eLife.17828.013





Figure 4. Acp1 requires a 4-PP-conjugated acyl chain to fully stabilize the ISU complex. (A) Isolated mitochondria from the indicated strains expressing
the indicated genes by plasmid were either resolved by SDS-PAGE (upper panels) or solubilized in 1% digitonin and resolved by BN-PAGE (lower
panels). The indicated proteins and protein complexes were assessed by immunoblot. Cells were grown for 18 hr in the presence of 10 mg/mL
doxycycline. (B) Aconitase activity was measured in whole cell lysates from the indicated strains grown for 18 hr in the presence of 10 mg/mL doxycycline
(± SEM; N = 3 biological replicates. *p<0.05, **p<0.005, ***p<0.0005). (C) Isolated mitochondria from the indicated strains were either resolved by SDS-
PAGE (upper panels) or solubilized in 1% digitonin and resolved by BN-PAGE (lower panels). The indicated proteins and protein complexes were
assessed by immunoblot. (D) Aconitase activity was measured in whole cell lysates from the indicated strains (± SEM; N = 3 biological replicates.
***p<0.0005). (E) Sulfite reductase activity was measured in whole cell lysates from the indicated strains (± SEM; N = 3 biological replicates. **p<0.005).
DOI: 10.7554/eLife.17828.014
The following source data and figure supplement are available for figure 4:
Source data 1. Source data for Figure 4.
DOI: 10.7554/eLife.17828.015
Figure supplement 1. Acp1 requires a 4-PP-conjugated acyl chain to fully stabilize the ISU complex.
DOI: 10.7554/eLife.17828.016





These Aft1 target genes are also induced in cells lacking the two mitochondrial iron transporters
Mrs3 and Mrs4 (Figure 2C). To further assess the perturbation of cytosolic FeS function, we quanti-
fied the activity of the cytosolic FeS-containing enzyme sulfite reductase and observed a diminution
in Acp1KD cells (Figure 2—figure supplement 2C). Combined with the essential nature of ACP1,
these data demonstrate that Acp1 is essential for FeS biogenesis.
We next sought to define the mechanism underlying the observed necessity of Acp1 for FeS bio-
genesis, focusing specifically on the ISU complex. Acp1KD cells exhibited a marked diminution of the
assembled Nfs1-Isd11 complex, similar to depletion of the other ISU complex subunits (Figure 3A,
Figure 3—figure supplement 1A,B). Importantly, the Nfs1 and Isd11 protein that remain in these
cells is found only in insoluble aggregates in contrast to WT cells where Nfs1 and Isd11 are soluble
(Figure 3B). Thus, in the absence of Acp1, the Nfs1-Isd11 complex is destabilized, most likely caus-
ing a loss of cysteine desulfurase activity. To determine if mammalian ACP is also necessary for main-
taining steady state levels of the FeS biogenesis complex in mammalian cells, C2C12 mouse
myoblasts were transfected with a pool of siRNAs targeting NDUFAB1 (the gene encoding mamma-
lian ACP) or a control siRNA. While our methods were unable to detect the mammalian Nfs1-Isd11
complex by BN-PAGE, depletion of ACP in these cells was accompanied by a clear destabilization of
the subunits of the mammalian FeS biogenesis machinery, NFS1, ISD11, and ISCU2, which is the
mammalian version of Isu1 (Figure 3C). Thus, ACP plays an evolutionarily conserved role in stabiliz-
ing the ISU complex thereby enabling FeS biogenesis.
Interestingly, overexpression of the MRS3 iron transporter resulted in robust stabilization of the
Nfs1-Isd11 complex in Acp1KD cells, while not restoring lipoic acid biosynthesis (Figure 3D). Ele-
vated Mrs3 expression also restored Sdh2 and Rip1 protein abundance and complex assembly as
well as aconitase activity in Acp1KD cells (Figure 3D and Figure 3—figure supplement 1C). We
tested whether overexpression of other components of the ISU complex stabilized the Nfs1-Isd11
complex in cells depleted of Acp1. Elevated levels of Isu1 yielded a modest stabilization and
restored aconitase activity (Figure 3D and Figure 3—figure supplement 1C), while overexpression
of Yfh1, the yeast frataxin homologue, had no effect (Figure 3—figure supplement 1D). We specu-
late that elevated Mrs3 may increase the Fe(II) occupancy of Isu1, which enables it to more effec-
tively stabilize the ISU complex.
Acp1 requires a 4-PP prosthetic group to support mitochondrial fatty acid synthesis. The gene
encoding 4-PP transferase, PPT2, is not essential, but the haploid deletion strain exhibits no growth
in respiration-requiring medium and impaired growth on glucose, which does not require respiration
(Figure 1—figure supplement 2C and Figure 4—figure supplement 1A). The growth impairment
on glucose is not explained by any known function of ACP and therefore may relate to defects in
FeS biogenesis.
To directly test the role of the 4-PP prosthetic group and the acyl chain that is conjugated to it,
we investigated the ability of apo-Acp1 lacking 4-PP to support FeS biogenesis. Apo-Acp1 can be
generated in vivo by mutating the invariant Ser (S82) to which 4-PP is conjugated (Stuible et al.,
1998). While re-expression of WT Acp1 could fully restore the steady state abundance of the Nfs1-
Isd11 complex in Acp1KD cells, expression of Acp1S82A had only modest effects (Figure 4A). These
modest effects were sufficient to enable the Acp1KD cells expressing Acp1S82A to retain viability,
albeit with impaired grow rate, and to exhibit a modest recovery of aconitase activity compared to
Acp1KD cells (Figure 4B, Figure 4—figure supplement 1B). Thus, the apparent absence of the
Nfs1-Isd11 complex on BN gels is likely the result of a severely destabilized complex that is not
capable of surviving the stringent detergent conditions of BN-PAGE and not the complete loss of
the complex in vivo.
To further investigate the role of the 4-PP-conjugated acyl chain in FeS biogenesis we interro-
gated the effects of PPT2 deletion on the function of Acp1 in FeS biogenesis. Like Acp1KD cells
expressing Acp1S82A, the Nfs1-Isd11 complex was severely depleted in ppt2D cells (Figure 4C). Fur-
thermore, these cells exhibit a clear diminution in activity of FeS-containing enzymes in both the
mitochondria and cytosol as represented by aconitase and sulfite reductase activity, respectively
(Figure 4D,E). We also interrogated the ability of Acp1 to interact with Nfs1 in WT and ppt2D cells.
While the steady state levels of Acp1 are not affected in ppt2D cells (Figure 4C), we observed a
clear defect in the ability of Acp1 to interact with Nfs1 in this strain (Figure 4—figure supplement
1C). Therefore, the Acp1-conjugated 4-PP plays an important role in the interaction of Acp1 with
the core Nfs1-Isd11 complex and in FeS biogenesis. Importantly, lip5D cells, which cannot synthesize
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lipoic acid but remain competent for Acp1-dependent fatty acid synthesis (Hiltunen et al., 2010),
maintain normal abundance of the Nfs1-Isd11 complex and aconitase and sulfide reductase activity
(Figure 4C–E). Thus, the defects in FeS biogenesis observed in cells expressing apo-Acp1 are a
result of the inability to generate an acyl-conjugated Acp1 species and not a defect in lipoic acid
biosynthesis.
The data presented herein define a new and unexpected role of ACP in FeS biogenesis. ACP
functions as a stable subunit of the ISU complex where it acts to stabilize the complex in part by
exploiting a 4-PP-conjugated acyl chain. Unlike ACP, however, the acyl chain is not absolutely
required for FeS biogenesis and viability, which raises the intriguing possibility that ACP is not simply
an obligate subunit, but may exploit this unique interaction modality to provide additional structural
or regulatory functions on FeS biogenesis. It is particularly intriguing to speculate that ACP may
serve to coordinate mitochondrial fatty acid synthesis and FeS biogenesis, which represent two criti-
cal biosynthetic processes performed by mitochondria.
Materials and methods
Yeast strains and growth conditions
Saccharomyces cerevisiae BY4741 (MATa, his3 leu2 met15 ura3), Saccharomyces cerevisiae R1158
(BY4741 derivative; MATa, URA3::CMV-tTA, his3 leu2 met15), Saccharomyces cerevisiae W303a
(MATa, his3 leu2 met15 trp1 ura3), and Saccharomyces cerevisiae DY150 (MATa ade2-1 his3-11
leu2-3,112 trp1-1 ura3-52 can1-100(oc)) were used as the wild-type strains where indicated. Each
mutant was generated using a standard PCR-based homologous recombination method. The geno-
types of all strains used in this study are listed in Supplementary file 1. Yeast transformation was
performed by the standard TE/LiAc method and transformed cells were recovered and grown in syn-
thetic complete glucose (SD) medium lacking the appropriate amino acid(s) for selection purposes.
Medium used in this study includes YPA and synthetic minimal medium supplemented with 2% glu-
cose, 2% raffinose, or 2% glycerol.
Growth assays were performed using synthetic minimal media supplemented with the appropri-
ate amino acids and indicated carbon source. For plate-based growth assays, overnight cultures
were back-diluted to equivalent ODs and spotted as 10-fold serial dilutions. For liquid culture
growth assays, overnight cultures were back-diluted to equivalent ODs and grown at 30˚C. Growth
was monitored by absorbance at 600 nm.
To shut down expression of ACP1 in TetO7-ACP1, over-night cultures were used to inoculate syn-
thetic media containing either 2% glucose or 2% raffinose and 10 mg/mL DOX to an approximate
OD600 of 0.05 and incubated for 16–24 hr as indicated. To shut down the expression in Gal-ACP1,
Gal-NFS1, Gal-ISD11, Gal-ISU1, and Met3-YFH1, over-night cultured cells were used to inoculate in
synthetic media containing 2% raffinose to an approximate OD600 of 0.05 and incubated from 24 to
32 hr as indicated. For YFH1 shut down 2.5 mM methionine was added in the media.
Isolation of yeast mitochondria
Cell pellet was washed once with ddH2O and incubated in TD buffer (100 mM Tris-SO4, pH 9.4 and
100 mM DTT) for 15 min at 30˚C. Spheroplasts were obtained by incubating cells in SP buffer (1.2 M
Sorbitol and 20 mM potassium phosphate, pH 7.4) supplemented with 0.3 mg/mL lyticase for 1 hr at
30˚C to remove the cell wall. Spheroplasts were gently washed once and homogenized in ice-cold
SEH buffer (0.6 M sorbitol, 20 mM HEPES-KOH, pH 7.4, 2 mM MgCl2, 1 mM EGTA) using a dounce
homogenizer applied with 30–40 strokes. Crude mitochondria were then isolated by differential
centrifugation.
Immunoprecipitation
Crude mitochondria were isolated and resuspended to a concentration of 5 mg/mL. Mitochondria
was solubilized in 0.7% digitonin for 30 min. Followed by centrifugation at 20,000 !g for 20 min.
Cleared mitochondrial lysates were incubated with anti-HA antibody conjugated agarose (Sigma) for
2 hr. at 4˚C. The agarose was washed 3–5 times and eluted in Laemmli buffer (65˚C, 10 min). Elutions
were resolved by SDS-PAGE and assessed by immunoblot.






Yeast mitochondria were solubilized in Laemmli buffer. Samples were resolved by SDS-PAGE and
assessed by immunoblot.
Blue native polyacrylamide gel electrophoresis (BN-PAGE)
BN-PAGE was performed as described previously (Wittig et al., 2006). Mitochondria were resus-
pended in lysis buffer (Invitrogen) and solubilized with 1% digitonin. Lysates were resolved on a 4%–
16% gradient native gel (Invitrogen).
Protein aggregation assays
Mitochondria were solubilized in Triton-X100 lysis buffer (0.5% Triton-X100, 20 mM HEPES-KOH, pH
7.4, 150 mM KCl). The samples were incubated on ice for 30 min. and centrifuged at 30,000 !g for
10 min.
Aconitase activity assays
Yeast cells were grown in SD medium to early log phase, resuspended in lysis buffer (50 mM Tris-
HCl, 50 mM KCl, 2 mM sodium citrate dihydrate, 10% glycerol, 1 mM PMSF, and 7 mM b-mercap-
toethanol), and stored at –80˚C overnight. After thawing on ice, cells were homogenized by vortex-
ing with glass beads and cleared lysate was collected by centrifugation. Aconitase activity was
measured by coupling with NADP+- dependent isocitrate dehydrogenase activity. 30 ml of crude
lysate was mixed with 150 ml of reaction mixture (1 M Tris-Cl pH 8.0, 10 mM MgCl2, 10 mM NADP
+,
0.32 units of NADP+- dependent Isocitrate Dehydrogenase), and 10 ml of 50 mM citrate. The reac-
tion mixture was recorded at 340 nm for 2 min (15 s intervals). Aconitase activity was normalized to
total protein concentration.
Sulfite reductase assays
To measure cytosolic iron, cells (50 ml cultures) were grown in SC –Met (To avoid repression of the
enzyme expression by methionine) medium containing 2% glucose or raffinose as a carbon source
till 1 of OD600 nm. Total cell lysate preparation and the enzyme assay was performed as described in
(Rutherford et al., 2005) with modifications. Briefly, cell pellets were resuspended in buffer A
(0.1 M Tris-Cl pH7.4, 10% glycerol, 1 mM EDTA pH 8.0, 1 mM phenylmethlysulfony fluoride (PMSF))
with lyticase and incubated 30˚C for 45 min. After disruption using glass beads, 50 ml of cell lysates
were mixed with 400 ml of assay mix with or without sulfite. After incubation at 37˚C for 20 min,
100 ml of N,N-diethyl-p-phenylenediamine sulfate (DPD) and 100 ml of ferric chloride were added to
the reaction mix to stop the reaction and incubated in the dark to develop the color for 20 min. The
production of methylene blue was measured at 669 nm.
qPCR analysis
To quantify the expression of Fe regulon genes, total RNAs were extracted from yeast spheroplasts
using RNeasy mini kit (QIAGEN). cDNA were synthesized from 1 mg of total RNA using High-Capac-
ity cDNA Reverse Transcription Kit (Applied Biosystems). 2 ml of 10X diluted cDNA reaction mix
were mixed with SYBR Green real-time PCR master mix (Thermo Fisher) with primers and the PCR
reaction were performed using the Mastercycler ep realplex (Eppendorf). Expression of genes of
interesting was normalized to actin and fold changes was analyzed using the 2"DDCt method.













PRISM software was used to graph all quantitative data and perform statistical analyses. p values for
pairwise comparisons were determined using a Student’s t test.
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Figures and figure supplements
The mitochondrial acyl carrier protein (ACP) coordinates mitochondrial fatty acid
synthesis with iron sulfur cluster biogenesis
Jonathan G Van Vranken et al






Figure 1—figure supplement 1. Protein sequence alignment of ACP from eukaryotes. (A) Protein sequence alignment of the ACP proteins from the
indicated species (Clustal Omega). D.m. – Drosophila melanogaster, D.r. – Danio rerio, H.s. – Homo sapiens, M.m. – Mus musculus, S.c. –
Saccharomyces cerrevisiae, N.c. – Neuropsora crassa. The invariant Ser residue to which 4-PP is conjugated is indicated.
DOI: 10.7554/eLife.17828.004






Figure 1—figure supplement 2. Eukarotic mitochondrial fatty acid biosynthesis (FASII) pathway. (A) Eukaryotic cells have maintained two distinct fatty
acid synthesis pathways—the canonical cytoplasmic FASI and the mitochondrial FASII, which is homologous to the prokaryotic fatty acid synthesis
pathway. FASII, which is dependent on ACP, is comprised of a set of monofunctional enzymes that catalyze the various steps in fatty acid synthesis. In
order to facilitate mitochondrial fatty acid synthesis, apo-ACP must first be converted to holo-ACP by a 4’-phosphopanthetheine transferase (Ppt2),
which catalyzes the covalent attachment of the 4-phosphopantetheine prosthetic group (4-PP) to an absolutely conserved Ser residue on ACP. The 4-PP
contains a terminal thiol that serves as the attachment site to enable Acp1 to scaffold de novo fatty acid synthesis. The enzymes of FASII use malonyl-
coA to initiate the fatty acid chain and acetyl-coA for acyl chain elongation. The canonical product of FASII is octanoate, which is the precursor for lipoic
acid, an important mitochondrial cofactor. Following ACP-dependent octanoate synthesis, Lip2, Lip3, Lip5, and Gcv3 support the synthesis of lipoic
acid and ligation to its target proteins including the E3 component of pyruvate dehydrogenase and a-ketoglutarate dehydrogenase. Ppt2 –
4’phophopantetheine transferase; MCT – malonyl-coA transferase; KAS – ketoacyl synthetase; KAR – ketoacyl reductase; HTD2 – hydroxyacyl-thioester
reductase type 2; ETR – enoyl-thioester reductase; Lip2, Lip3, Lip5, Gcv3 – lipoic acid biosynthesis and ligation. (B) acp1D heterozygous diploids in the
W303 strain background were dissected with and without a plasmid expressing Acp1-V5 and spores were grown on YPAD medium for 2 days. (C)
ppt2D, lip5D, lip2D, lip3D, and gcv3D heterozygous diploids were dissected and spores were grown on YPAD medium for 2 days.
DOI: 10.7554/eLife.17828.005







Figure 1—figure supplement 3. Acp1 is a stable subunit of the ISU complex. (A) Isd11-V5 and Acp1- HA were expressed from their endogenous loci
and Isd11-V5 was immunoprecipitated from digitonin-solubilized mitochondria followed by the indicated immunoblots. (B) Nfs1-V5 and Acp1- HA were
expressed from their endogenous loci and Nfs1-V5 was immunoprecipitated from digitonin-solubilized mitochondria followed by the indicated
immunoblots.
DOI: 10.7554/eLife.17828.006
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Figure 2—figure supplement 1. ACP1 expression is required for cell proliferation. (A) Ten-fold serial dilutions of
WT, TetO7-ACP1, and TetO7-ACP1 cells expressing Acp1-HA were plated on synthetic media containing the
indicated carbon source with and without 10 mg/mL doxycycline (BY4741 background). (B) Liquid cultures (2%
raffinose) with and without 10 mg/mL doxycycline were inoculated to an OD. 025 with either WT or TetO7-ACP1
cells. Growth was monitored by absorbance at 600 nm. (C) Ten-fold serial dilutions of WT, Gal-ACP1, and Gal-
ACP1 cells expressing Acp1-HA were serially diluted and plated on synthetic media containing the indicated
carbon source. With pre-growth of the Gal-ACP1 strain on glucose medium, subsequent plating of the cells on
glucose shows moderate growth impairment. The depletion of Acp1 in TetO7-ACP1 cells is more efficient
compared to Gal-ACP1 cells.
DOI: 10.7554/eLife.17828.009








Figure 2—figure supplement 2. Acp1 is essential for FeS biogenesis. (A) Isolated mitochondria from WT, TetO7-ACP1, or TetO7-ACP1 cells
expressing Acp1-HA were harvested at the indicated times post addition of doxycycline were resolved by SDS-PAGE (upper panels) or solubilized in 1%
digitonin and resolved by BN-PAGE (lower panels). (B) Aconitase activity was measured in mitochondrial lysates from WT and Gal-ACP1 cells at 28 hr
post-transfer to raffinose-containing medium (± SEM; N = 3 biological replicates. ***p<0.0005). (C) The cytosolic FeS-containing sulfite reductase
activity was measured in whole cell lysates from WT and Gal-ACP1 cells at 28 hr post-transfer to raffinose-containing medium (± SEM; N = 3 biological
replicates. **p<0.005).
DOI: 10.7554/eLife.17828.010






   
Figure 3—figure supplement 1. ACP promotes FeS biogenesis by maintaining the stability of the ISU (Nfs1-Isd11) complex. (A) Isolated mitochondria
from WT and TetO7-ACP1 cells harvested at the indicated time points post-addition of doxycycline were resolved by SDS-PAGE (upper panel) or
solubilized in 1% digitonin and resolved by BN-PAGE (lower panel). (B) Indicated strains were grown in raffinose for 32 hr to repress expression of the
indicated genes. YFH1 was depleted in a Met3-YFH1 strain cultured in the presence of 2.5 mM methionine. Isolated mitochondria from each strain was
either resolved by SDS-PAGE (upper panel) or solubilized in 1% digitonin and resolved by BN-PAGE (lower panel). Depletion of ISD11, but not ISU1
subunit destabilizes Nfs1-Isu11 complex on BN-PAGE as ACP1 depletion does, suggesting Acp1 acts through Isd11 to destabilize Nfs1. (C) Aconitase
activity was measured in mitochondrial lysates from WT and Gal-ACP1 cells overexpressing MRS3 or ISU1 harvested at 28 hr post-transfer to raffinose-
containing medium (± SEM; N = 3 biological replicates. *p<0.05, ***p<0.0005). (D) Isolated mitochondria from the WT and Gal-ACP1 strains expressing
the indicated gene via a 2 m plasmid at 28 hr post-transfer to raffinose-containing medium were either resolved by SDS-PAGE (lower panels) or
solubilized in 1% digitonin and resolved by BN-PAGE (upper panels). The indicated proteins and protein complexes were assessed by immunoblot. *
indicates non-specific band.
DOI: 10.7554/eLife.17828.013







Figure 4—figure supplement 1. Acp1 requires a 4-PP-conjugated acyl chain to fully stabilize the ISU complex. (A) Ten-fold serial dilutions of the
indicated strains plated on synthetic medium with either glucose or glycerol. (B) Ten-fold serial dilutions of the indicated strains expressing the
indicated plasmids were plated on synthetic media containing 10 mg/mL doxycycline and either glucose, raffinose, or glycerol. (C) Purified mitochondria
from WT and ppt2D cells expressing Acp1-HA were solubilized by digitonin (input) and then subjected to anti-HA immunoprecipitation. The resulting
eluates and input samples were subjected to SDS-PAGE.
DOI: 10.7554/eLife.17828.016
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Table 4-S1. Yeast strains used in this study. 
Strain Genotype Source 
WT (BY4741) MATa, his3 leu2 met15 ura3 Open Biosystems 
acp1Δ + Acp1-HA MATa, his3 leu2 met15 ura3 
acp1::hygMX ACP1-HA (plasmid) 
This study 
ppt2Δ MATa, his3 leu2 met15 ura3 
ppt2::natMX 
This study 
WT (W303) MATa, his3 leu2 met15 trp1 ura3 This Study 
acp1Δ + Acp1-V5 MATa, his3 leu2 met15 trp1 ura3 
acp1::hygMX ACP1-V5 (plasmid) 
This Study 
WT (R1158; BY4741 
derivative) 
MATa, URA3::CMV-tTA, his3 leu2 met15 GE Dharmacon 
TetO7-ACP1 MATa, URA3::CMV-tTA, his3 leu2 met15 
acp1::KanRTetO7-CYC1TATA-ACP1 
This study 
TetO7-NFS1 MATa, URA3::CMV-tTA, his3 leu2 met15 
nfs1::KanRTetO7-CYC1TATA-NFS1 
GE Dharmacon 
TetO7-ISD11 MATa, URA3::CMV-tTA, his3 leu2 met15 
isd11::KanRTetO7-CYC1TATA-ISD11 
This study 


















WT (DY150) MATa ade6 his3-11 leu2-3,112 trp1-1 ura3-
52 can1-100(oc) 
This study 
Gal-ACP1 MATa ade6 his3-11 leu2-3,112 trp1-1 ura3-
52 can1-100(oc) KanMX::pGal-ACP1 
This study 
Gal-NFS1 MATa ura3-52 lys2-801_amber ade2-
101_ochre trp1-Δ63 his3-Δ200 leu2-Δ1 cyh2 
nfs1::HIS3 URA3::pGal-NFS1 
Andrew Dancis 
Gal-ISD11 MATa ura3-52 lys2-801_amber ade2-
101_ochre trp1-Δ63 his3-Δ200 leu2-Δ1 cyh2 
HIS3MX6::pGal-ISD11 
Andrew Dancis 
Gal-ISU1 MATa ura3-52 lys2-801_amber ade2-
101_ochre trp1-Δ63 his3-Δ200 leu2-Δ1 
pRS406-gamma isu2 (URA3) 
HIS3MX6::pGal-ISU1 
Andrew Dancis 
Met-YFH1 MATa ade2-1 his3-11 leu2-3,112 trp1-1 ura3-
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Abstract 
The electron transport chain (ETC) is an important player in cellular energy 
conversion, but can also generate potentially damaging derivatives when not carrying a 
steady flux of reducing equivalents. Therefore, the cell must balance the metabolic 
capacity of mitochondria with the availability of substrate. In addition to being the major 
fuel of the TCA cycle and ETC, acetyl-CoA is also the carbon donor for mitochondrial 
fatty acid synthesis (FASII). We demonstrate that, in the presence of mitochondrial 
acetyl-CoA, FASII-synthesized acyl chains accumulate on the acyl carrier protein and 
signal ETC biogenesis through direct physical interactions with the LYR protein family 
of ETC assembly factors. By coupling acetyl-CoA levels with ETC assembly, this system 
provides an elegant mechanism for coordinating the assembly of each ETC complex with 
one another and with substrate availability. Thus, ETC biogenesis is suppressed and 
mitochondrial metabolic homeostasis is maintained even in the absence of substrate. 
Introduction 
Mitochondrial acetyl-CoA is the primary substrate that fuels oxidative 
phosphorylation. It is oxidized by the TCA cycle to provide the reducing equivalents 
(NADH and FADH2) that feed the electron transport chain (ETC). These complexes, 
comprised of subunits encoded by both the nuclear and mitochondrial genomes, couple 
the passing of electrons through numerous redox-active cofactors to the establishment of 
an electrochemical gradient across the inner mitochondrial membrane, which ATP 
synthase (complex V; CV) exploits to generate adenosine triphosphate. While this system 
provides an efficient source of cellular energy, it can also generate potentially deleterious 
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reactive oxygen species, particularly when electron availability and ETC capacity are not 
maintained in balance (1). Therefore, the cell must coordinate the assembly and activity 
of ETC complexes with substrate availability. Herein, we demonstrate that acetyl-CoA 
coordinates the biogenesis of the ETC through acylation of the mitochondrial acyl carrier 
protein (ACP). 
Eukaryotic mitochondria have maintained a prokaryote-like fatty acid synthesis 
pathway (FASII) that is structurally and functionally distinct from the FASN-dependent 
cytosolic pathway (2). This pathway employs a number of mono-functional enzymes that 
transiently interact with ACP—the soluble scaffold for fatty acid synthesis—to catalyze 
the step-wise elongation of nascent acyl chains (Figure 5-1A,B). In order to support this 
pathway, ACP utilizes a 4’-phosphopantetheine prosthetic group (4’-PP), which is 
covalently attached to an invariant Ser residue and provides the terminal thiol upon which 
fatty acid synthesis is initiated and elongated (Figure 5-1A,B) (3, 4). It has been thought 
that the primary function of FASII was the synthesis of octanoate, the eight-carbon 
precursor of lipoic acid, which is a required cofactor for mitochondrial enzymes (5). 
Curiously, FASII can synthesize ACP-bound acyl chains significantly longer than eight 
carbons however no functional importance has yet to be attributed to these extended acyl 
chains (6). 
Results 
To begin to understand the role of mitochondrial FASII in the maintenance of 
mitochondrial physiology, we sought to interrogate the consequences of MCT1 deletion 
on the cellular proteome using quantitative tandem mass spectrometry after isobaric 
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labeling (Figure 5-1C,D). Mct1 is the malonyl-CoA transferase that is required to initiate 
FASII and thus cells lacking this enzyme are devoid of ACP acylation (7). We compared 
the steady state abundance of over 4700 proteins and found notable changes not only 
within mitochondria but also in other cellular compartments (Figure 5-1E and Figure 5-
2A). The most obvious change was a profound and specific depletion of proteins 
involved in cellular respiration and oxidative phosphorylation (Figure 5-2A-C). In fact, 
almost all ETC complex subunits were lost in FASIIΔ cells, while other membrane-
associated mitochondrial complexes were unaffected (Figure 5-2C). Consistent with these 
results, ETC complexes were also undetectable by immunoblot after blue-native- or SDS-
PAGE in FASIIΔ strains (mct1Δ and oar1Δ; Figure 5-2D).  
Having recently discovered that ACP supports iron-sulfur cluster (FeS) biogenesis 
through a direct physical interaction with the FeS biogenesis complex (8), we 
hypothesized that ACP may promote ETC assembly using a related mechanism. To test 
this hypothesis, fully functional Acp1HA/FLAG, expressed at endogenous levels, was 
immunoprecipitated from digitonin-solubilized mitochondrial extracts. The resulting 
eluates were analyzed by mass spectrometry to identify interacting proteins, which 
revealed a number of candidates connecting ACP to ETC biogenesis. Of these candidates, 
we first confirmed a physical interaction between Acp1 and Rpm2, the protein subunit of 
mitochondrial RNase P (Figure 5-3A). It has been previously reported that FASII is 
required to support mitochondrial translation by promoting maturation of RNase P (9). 
Thus, in the absence of ACP acylation, RNase P activity is lost and translation of the 
mitochondrial genome is prevented. Consistent with these reports, the mitochondria-
encoded proteins of the ETC that were detectable by mass spectrometry (Cox1, Cox2, 
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Cox3, and Atp6) were among the most severely depleted proteins in mct1Δ cells (Figure 
5-4A). Furthermore, the steady state abundance of Rpm2 itself was severely decreased 
(Figure 5-3G). Combined with previous findings, these data suggest that acylated ACP 
supports mitochondrial translation and ETC biogenesis, likely through a physical 
interaction with RNase P.  
In addition to Rpm2, Acp1 also co-purified with each member of the 
evolutionarily conserved LYR protein family—Sdh6, Sdh7, Mzm1, Fmc1, and Isd11 
(Figure 5-4B,C). In general, these proteins, which are named for a highly conserved 
tripartite Leu-Tyr-Arg (LYR) motif, function as complex-specific late stage ETC 
assembly factors (10-15). Sdh6 and Sdh7, Mzm1, and Fmc1, support the assembly of 
complex II, complex III, and complex V, respectively, whereas Isd11 is an essential 
component of the FeS biogenesis machinery (10-15). In higher eukaryotes, this family 
has expanded considerably to include, in addition to direct orthologues of Sdh6, Sdh7, 
Mzm1, and Isd11, two stable accessory subunits of complex I and several others with 
unclear functions (16). Fmc1 is not conserved in mammals and seems to be atypical in its 
function (see below). ACP-LYR interactions were confirmed by immunoprecipitation of 
Acp1HA/FLAG from mitochondria expressing Sdh6V5, Sdh7V5, Mzm1V5, Fmc1V5, and 
Isd11V5 fusion proteins (Figure 5-3B-F). This family-wide interaction with ACP is 
corroborated by large scale mass spectrometry interaction studies (17-19) and recent 
high-resolution structures of ACP-LYR complexes, which demonstrate that the LYR 
motif is critical for mediating the interaction (20, 21). We also found that the 4’-PP 
prosthetic group of ACP is critical for the majority of ACP-LYR interactions, as an 
Acp1S82A mutant protein, which cannot bind 4’-PP, was incapable of interacting with 
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Sdh6, Sdh7, Mzm1, and Isd11 (Figure 5-4D-G). Interestingly, Fmc1 was still able to 
interact with Acp1S82A, however the implications of this discrepancy remain unclear 
(Figure 5-4H). Finally, deletion of MCT1 depleted most, but not all, of the LYR proteins, 
suggesting that ACP not only interacts with these proteins but that its acylation is 
important for supporting their stability and function (Figure 5-3G). Taken together, these 
results demonstrate that acylated ACP interacts with a network of ETC assembly factors 
with the potential to coordinate complex biogenesis. 
Because FASIIΔ cells have such profound defects in mitochondrial translation, it 
is difficult to use this system to study the impact of ACP acylation on LYR-dependent 
assembly of the ETC. Instead, we sought to investigate the role of ACP in supporting the 
function of each LYR independently. Deletion of each member of this family results in 
the specific destabilization of certain complexes, which can be rescued by reexpression of 
the deleted gene (Figure 5-3H). In order to independently prevent the interaction of each 
LYR family member with ACP, mutant proteins were generated in which the LYR motif 
was substituted with three Ala residues. Even when over-expressed, Sdh6ΔLYR, Sdh7ΔLYR, 
and Mzm1ΔLYR were unable to complement their respective mutant strains (Figure 5-3H 
and Figure 5-4I-K,M). Fmc1ΔLYR, on the other hand, rescued growth and ETC assembly, 
further contributing to the notion that Fmc1 is unique among the yeast LYR protein 
family (Figure 5-3H and Figure 5-4L,M). Taken together these data demonstrate that the 
LYR proteins require the LYR motif, which mediates the ACP interaction, to function as 
complex-specific assembly factors. 
ETC biogenesis is dependent on FASII-catalyzed acylation of ACP (Figure 5-2). 
ACP also interacts with an entire family of ETC assembly factors (Figure 5-3). 
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Therefore, we hypothesized that ACP acylation may serve as a signal to activate ETC 
assembly and sought to identify the relevant acyl-ACP species. In WT cells, Acp1HA/FLAG 
can be resolved by SDS-PAGE into three clearly defined bands (identified as 1, 2, and 3), 
each of which represents a different Acp1 species (Figure 5-5A and Figure 5-6B). Band 
1, which accumulates in FASIIΔ cells, likely represents deacyl/holo-ACP, which is 
bound to 4’-PP but devoid of acylation (Figure 5-5A). Band 2 co-migrates with Acp1S82A 
and is likely to be apo-ACP lacking 4’-PP (Figure 5-5A and Figure 5-6A). Finally, 
because the accumulation of band no. 3 is dependent on FASII and holo-ACP, it is likely 
an acylated form of ACP, which we will define as acyl-ACP (Figure 5-5A and Figure 5-
6A,B) (22). A number of other ACP-containing species that migrate higher than 
deacyl/holo-ACP accumulate reproducibly in FASIIΔ cells (Figure 5-5A). These bands 
are sensitive to reducing agents like β-mercaptoethanol (Figure 5-6B) and thus, likely 
represent spurious ACP disulfide-linked species. Because the mature form of ACP 
contains no Cys residues, the only free thiol capable of participating in disulfide bonds is 
the terminal thiol of the 4’-PP prosthetic group. Since these higher molecular weight 
species can only form when this thiol is unmodified, these disulfide species are markers 
of ACP deacylation.   
It has been reported that ectopic mitochondria-targeted expression of a 
peroxisomal medium-chain fatty acyl-CoA ligase (mito-FAA2) can restore respiratory 
growth in FASIIΔ cells (23, 24). We confirmed this (Figure 5-6C) and demonstrated that 
mito-Faa2 almost completely rescued the defects in ETC complex assembly and subunit 
accumulation (Figure 5-5B). Importantly, mutants competent for FASII but deficient in 
lipoic acid synthesis and ligation (lip5Δ) also have severe defects in ETC complex 
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assembly (Figure 5-5B) and ACP acylation (Figure 5-5A), which likely results from a 
loss of pyruvate dehydrogenase (PDH) activity (see below). Expression of mito-FAA2 
augmented ETC complex assembly in these cells, however, because these mutants still 
cannot synthesize lipoic acid, they remain respiratory deficient (Figure 5-6C). Thus, the 
severe phenotype observed in FASIIΔ strains cannot be explained by a defect in lipoic 
acid synthesis but likely result from a failure to generate acyl-ACP.  
Having demonstrated that mito-Faa2 can restore respiratory growth and ETC 
biogenesis in FASIIΔ cells, we next wanted to understand the mechanism underlying this 
rescue. Expression of mito-FAA2 failed to restore respiratory growth in ppt2Δ cells, 
demonstrating that holo-ACP is required for this construct to rescue FASIIΔ defects 
(Figure 5-6D). This suggests that mito-Faa2 may restore ETC biogenesis in FASIIΔ cells 
through FASII-independent re-acylation of ACP. Indeed, expression of mito-FAA2 
partially restored acyl-ACP in mct1Δ cells and also decreased the abundance of the high 
molecular weight disulfide linkages, which serve as marks of ACP deacylation (Figure 5-
5C). These data suggest that acylation of ACP is sufficient to promote ETC biogenesis 
independent of FASII.  
Upon identifying acyl-ACP as the ACP species required for supporting ETC 
biogenesis, we wanted to determine if it was sufficient to activate the LYR network to 
initiate ETC assembly. To that end, Sdh6V5 and Mzm1V5 were immunoprecipitated from 
cells and the bound ACP species were assessed by immunoblot. Consistent with the 
ability of acyl-ACP to facilitate ETC biogenesis, Sdh6 and Mzm1 both exhibited a clear 
preference for binding to acyl-ACP over deacyl/holo-ACP (Figure 5-5D and Figure 5-
6E). Despite this preference, however, ACP acylation and FASII are not necessarily 
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required for all ACP-LYR interactions as LYR proteins that remain stable in FASIIΔ 
cells can still bind ACP (Figure 5-6F-J). Taken together, these data suggest that ACP 
acylation is not simply required for the ACP-LYR physical interactions but instead serves 
as a signal to activate the assembly network driven by the LYR proteins. This conclusion 
is further supported by high-resolution structural studies of three distinct ACP-LYR 
complexes (20, 21). In all cases, an acylated form of ACP (likely acyl-ACP/band 3) binds 
the LYR protein and embeds its acyl chain deep within the hydrophobic core of the LYR. 
As such, the position of the ACP-bound acyl chain is ideal for allosterically signaling to 
activate the assembly function of the LYR proteins.  
In addition to the profound depletion of the ETC subunits, mct1Δ cells displayed 
an increased abundance of proteins involved in mitochondrial acetyl-CoA generation 
(Figure 5-7A). This could suggest that the cell perceives loss of FASII and the resulting 
ACP deacylation as indicators of mitochondrial acetyl-CoA depletion. Therefore, we 
hypothesized that ACP acylation might regulate ETC assembly in coordination with 
mitochondrial acetyl-CoA levels. To test this hypothesis, an mpc1Δ strain was employed 
as a genetic model of mitochondrial acetyl-CoA depletion. Mpc1 is an essential subunit 
of the mitochondrial pyruvate carrier and deletion of this gene prevents the import of 
pyruvate into mitochondria, thereby preventing PDH-dependent generation of 
mitochondrial acetyl-CoA (25). Indeed, depletion of mitochondrial acetyl-CoA through 
MPC1 deletion results in a significant diminution of ETC complexes and respiratory 
growth (Figure 5-7B and Figure 5-8A), which is coincident with a depletion of acyl-ACP 
and corresponding accumulation of deacyl/holo-ACP (Figure 5-7B). This phenotype is 
reminiscent of lip5Δ cells, which have reduced levels of ACP acylation (Figure 5-5A) 
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and ETC complex assembly (Figure 5-5B). This is consistent with acetyl-CoA depletion, 
as defects in lipoic acid synthesis will inhibit PDH, thereby preventing pyruvate-derived 
acetyl-CoA synthesis.  
In order to better understand the mechanisms underlying this phenotype, the 
whole cell proteomic profile of mpc1Δ cells was quantified and compared to WT and 
mct1Δ cells. Like mct1Δ, mpc1Δ cells also exhibited increased abundance of proteins 
involved in generating mitochondrial acetyl-CoA (Figure 5-7A), however, the steady 
state abundance of ETC complex subunits was considerably different in these two strains. 
In fact, the majority of the ETC subunits were unaffected in the mpc1Δ mutant (Figure 5-
7C). Importantly, acetyl-CoA-depleted mitochondria displayed no defects in 
mitochondrial translation as evidenced by normal abundance of mitochondria-encoded 
proteins, Cox1, Cox2, Cox3 and Atp6 as well as Rpm2 (Figure 5-7D and Figure 5-8B). 
Thus, the mitochondrial translation defect observed in mct1Δ cells is likely an extreme 
effect of complete FASII deletion and not a typical response to normal variations in 
mitochondrial acetyl-CoA.  
On the other hand, the LYR proteins, which were depleted in the mct1Δ strain, 
were also lost in the mpc1Δ mutant (Figure 5-7D). Consistent with this observation, the 
ETC complex subunits that are the most depleted in the mpc1Δ strain are Rip1 and Sdh2, 
the direct binding partners of LYR proteins (LYR targets), Mzm1 and Sdh6/Sdh7, 
respectively (Figure 5-7C & Figure 5-8C). Focusing on complex III assembly, it is 
possible to gain further insights into the ACP-LYR network. Deletion of the complex III-
specific LYR protein, Mzm1, causes a phenotype in which a sub-assembly of complex III 
lacking Rip1 and Qcr10 accumulates (11, 12). Because all other complex III subunits 
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remain stable in mpc1Δ cells (Figure 5-8C), it is likely that this subcomplex assembles 
but deacyl/holo-ACP fails to activate Mzm1 to incorporate Rip1 and Qcr10. This 
suggests that in mitochondrial acetyl-CoA-depleted conditions, ACP deacylation prevents 
the activation of complex III, and presumably other complexes. By restricting the 
incorporation of LYR target proteins, this network provides the cell a mechanism by 
which assembly of these complexes can be tuned to acute substrate depletion.  
Finally, we hypothesized that augmenting ACP acylation in mpc1Δ cells could 
stimulate ETC biogenesis independent of mitochondrial acetyl-CoA abundance. 
Therefore, we expressed mito-FAA2 in mpc1Δ cells and assayed ETC biogenesis. Mito-
FAA2 increased respiratory growth and restored complex II and complex III assembly to 
WT levels by supporting the incorporation of LYR target proteins, Sdh2 and Rip1, into 
their respective complexes (Figure 5-7E,D). Taken together, these data demonstrate that 
mitochondrial acetyl-CoA depletion causes ACP deacylation, which prevents ETC 
assembly and activation.  
Conclusion 
The data presented herein define a novel and unexpected role of mitochondrial 
fatty acid synthesis in regulating ETC assembly. It carries out this function through the 
acetyl-CoA-dependent synthesis of ACP-bound fatty acyl chains. Acyl-ACP then directly 
interacts with each member of the LYR protein family and, in an acyl chain-dependent 
manner, stimulates their ETC complex assembly function. In addition to ETC biogenesis, 
acetyl-CoA, FASII and ACP are also required for the activity of the TCA cycle enzymes 
PDH and α-ketoglutarate dehydrogenase through the synthesis of lipoic acid. As such, 
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this pathway provides an elegant mechanism whereby the primary substrate of 
mitochondrial metabolism signals the assembly and activation of the two main systems of 
mitochondrial catabolism. It is clear that one of the most damaging mediators of 
mitochondrial dysfunction is an imbalance of metabolic activities, which leads to 
inappropriate accumulation of reduced or oxidized electron carriers and other 
intermediary metabolites. We propose that by coordinating assembly of the ETC 
complexes with one another and with the availability of substrate, this newly uncovered 
regulatory role for FASII maintains a balanced and healthy mitochondrial metabolism. 
Materials and Methods 
Yeast strains and growth conditions 
Saccharomyces cerevisiae BY4741 (MATa, his3 leu2 met15 ura3) was used as the 
wild-type strains where indicated. Each mutant was generated in diploid cells using a 
standard PCR-based homologous recombination method. The genotypes of all strains 
used in this study are listed in Table 5-1. Yeast transformation was performed by the 
standard TE/LiAc method and transformed cells were recovered and grown in synthetic 
complete glucose (SD) medium lacking the appropriate amino acid(s) for selection 
purposes. Medium used in this study includes YPA and synthetic minimal medium 
supplemented with 2% glucose or 2% raffinose. Growth assays were performed using 
synthetic minimal media supplemented with the appropriate amino acids and indicated 
carbon source. For plate-based growth assays, overnight cultures were back-diluted to 
equivalent ODs and spotted as 10-fold serial dilutions. Cells were allowed to grow for 2-
3 days at 30°C. 
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Isolation of yeast mitochondria 
Cell pellet was washed once with ddH2O and incubated in TD buffer (100 mM 
Tris-SO4, pH 9.4 and 100 mM DTT) for 15 min at 30°C. Spheroplasts were obtained by 
incubating cells in SP buffer (1.2 M Sorbitol and 20 mM potassium phosphate, pH 7.4) 
supplemented with 0.3 mg/mL lyticase for 1 hour at 30°C to remove the cell wall. 
Spheroplasts were gently washed once and homogenized in ice-cold SEH buffer (0.6 M 
sorbitol, 20 mM HEPES-KOH, pH 7.4, 2 mM MgCl2, 1mM EGTA) using a dounce 
homogenizer applied with 30-40 strokes. Crude mitochondria were then isolated by 
differential centrifugation. In order to reliably maintain ACP acylation during the 
mitochondrial isolation 10mM N-ethylmaleimide was added to the SEH buffer. 
Steady-state protein analysis 
Yeast mitochondria were solubilized in Laemmli buffer. Samples were resolved 
by SDS-PAGE and assessed by immunoblot. In order to maintain ACP acylation during 
electrophoresis, 10 mM NEM was added to the Laemmli buffer.  
Immunoprecipitation 
Crude mitochondria were isolated and resuspended to a concentration of 5 mg/mL 
in XWA buffer. Mitochondria was solubilized in 0.7% digitonin for 30 mins. Followed 
by centrifugation at 20,000 x g for 20 mins.  Cleared mitochondrial lysates were 
incubated with anti-HA antibody conjugated agarose (Sigma) for 2 hrs. at 4°C. The 
agarose was washed 3-5 times and eluted in Laemmli buffer (65°C, 10 mins). Elutions 
were resolved by SDS-PAGE and assessed by immunoblot. In order to reliably maintain 
 95 
ACP acylation during the mitochondrial isolation, 10mM N-ethylmaleimide was added to 
IP buffers. 
 
Blue native polyacrylamide gel electrophoresis (BN-PAGE) 
BN-PAGE was performed as described previously (26).  Mitochondria were 
resuspended in lysis buffer (Invitrogen) and solubilized with 1% digitonin. Cleared 
mitochondrial lysates were prepared by centrifugation at 20,000xg for 15-20 mins. 
Lysates were resolved on a 3%-12% or 4%-16% gradient native gel (Invitrogen).  
 
Proteomics 
In order to fully use the sample multiplexing ability, an 11-plex experiment was 
designed containing the following proteome-wide comparisons: wt (n=3), mct1Δ (n=3), 
mpc1Δ (n=30), and wt_extra (samples for an unrelated experiment) (n=2).  Cell pellets 
from each condition were resuspended at 4°C in buffer containing 8M urea, 50mM EPPS 
pH 8.5, 50mM NaCl, and protease inhibitors. Chilled zirconium oxide beads were added 
to cell slurries. Cells were lysed using a MiniBeadbeater (Biospec products, Bartlesville, 
OK) at 4°C in 2mL screw cap tubes for 5 cycles of 30 seconds each, with 1 min pauses 
between cycles to avoid overheating. After centrifugation, clarified lysates were 
transferred to new tubes. Bicinchoninic acid (BCA) protein assay (Thermo Fischer 
Scientific) was performed to determine protein concentration. Proteins were then 
subjected to disulfide reduction with 5mM tris (2 carboxyethyl) phosphine (TCEP), 
(room temperature, 30 min) and alkylation with 10 mM iodoacetamide (room 
temperature, 30 min in the dark). 15 mM dithiotreitol was used to quench excess 
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iodoacetamide (room temperature, 15 min in the dark). Proteins (200ug) were then 
chloroform/methanol precipitated and washed with methanol prior to air drying. Samples 
were resuspended in 8 M urea, 50 mM EPPS, pH 8.5, and then diluted to <1M urea with 
50mM EPPS, pH 8.5. Proteins were digested for 16 hours with LysC (1:100 
enzyme:protein ratio) at room temperature, followed by trypsin (1:100 enzyme:protein 
ratio) for 6 hours at 37°C. Peptides were quantified using Pierce Quantitative 
Colorimetric Peptide Assay. TMT-11 reagents (0.8mg) were dissolved in 40uL 
anhydrous acetonitrile, and 7uL was used to label 70ug peptides in 30% (v/v) acetonitrile. 
Labeling proceeded for 1 hour at room temperature, until reaction was quenched using 
7uL 5% hydroxylamine. TMT-labeled peptides were then pooled, vacuum centrifuged to 
dryness, and cleaned using 50mg Sep-Pak (Waters). The pooled TMT-labeled peptide 
sample was fractionated using BPRP HPLC. We used an Agilent 1260 Infinity pump 
equipped with a degasser and a single wavelength detector (set at 220 nm). Peptides were 
subjected to a 50 min linear gradient from 8% to 40% acetonitrile in 10 mM ammonium 
bicarbonate pH 8 at a flow rate of 0.6 mL/min over an Agilent 300Extend C18 column 
(3.5 µm particles, 4.6 mm ID and 250 mm in length). We collected a total of 96 fractions, 
then consolidated those into 24 and vacuum centrifuged to dryness. Twelve of the 24 
fractions were resuspended in a 5% acetonitrile, 1% formic acid solution. Fractions were 
desalted via StageTip, dried via vacuum centrifugation, and reconstituted in 5% 
acetonitrile, 5% formic acid for LC-MS/MS processing. Mass spectrometry data were 
collected using an Orbitrap Fusion Lumos mass spectrometer (Thermo Fischer Scientific) 
equipped with a Proxeon EASY-nLC 1000 liquid chromatography (LC) system (Thermo 
Fisher Scientific). Peptides were separated on a 100 µm inner diameter microcapillary 
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column packed with ~35 cm of Accucore C18 resin (2.6 µm, 150 Å, Thermo Fisher 
Scientific). Approximately 2ug peptides were separated using a 2.5 h gradient of acidic 
acetonitrile. We used the multinotch MS3-based TMT method (27). The scan sequence 
began with a MS1 spectrum (Orbitrap analysis; resolution 120,000; mass range 
400−1400 Th). MS2 analysis followed collision-induced dissociation (CID, CE = 35) 
with a maximum ion injection time of 150 ms and an isolation window of 0.5 Da. The 10 
most abundant MS1 ions of charge states 2-6 were selected for MS2/MS3 analysis. To 
obtain quantitative information, MS3 precursors were fragmented by high-energy 
collision-induced dissociation (HCD, CE = 55) and analyzed in the Orbitrap (resolution 
was 50,000 at 200 Th) with a maximum ion injection time of 150 ms and a charge state-
dependent variable isolation window of 0.7 to 1.2 Da (28). MS2 mass spectra were 
processed using a SEQUEST-based software pipeline (27, 29, 30). Spectra were 
converted to mzXML using a modified version of ReAdW.exe. Database searching used 
the yeast proteome downloaded from Uniprot (Magrane and Consortium, 2014) in both 
forward and reverse directions, along with common contaminating protein sequences. 
Searches were performed using a peptide mass tolerance of 20 ppm, and a fragment ion 
tolerance of 0.9 Da. These wide-mass-tolerance windows were chosen to maximize 
sensitivity in conjunction with SEQUEST searches and linear discriminant analysis (29, 
31). TMT tags on lysine residues and peptide N termini (+229.163 Da) and 
carbamidomethylation of cysteine residues (+57.021 Da) were set as static modifications, 
while oxidation of methionine residues (+15.995 Da) was set as a variable modification. 
Peptide-spectrum matches (PSMs) were adjusted to a 1% false discovery rate (FDR) (32). 
Linear discriminant analysis was used to filter PSMs, as described previously (29), while 
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considering the following parameters: XCorr, ΔCn, missed cleavages, adjusted PPM, 
peptide length, fraction of ions matched, charge state, and precursor mass accuracy. 
PSMs were identified, quantified, and collapsed to a 1% peptide false discovery rate 
(FDR) and then collapsed further to a final protein-level FDR of 1%. PSMs were 
quantified from MS3 scans; those with poor quality, MS3 spectra with total TMT reporter 
signal-to-noise ratio that is <200, or no MS3 spectra were excluded from quantitation. 
Protein quantitation was performed by summing the signal-to-noise values for all 
peptides for a given protein. Each TMT channel was summed across all quantified 
proteins and normalized to enforce equal protein loading. Each protein’s quantitative 
measurement was then scaled to 100. In Figure 5-2, the first 6 channels were used (wt vs 





The signal-to-noise ratios for each of the six channels were scaled to represent the 
percent of total signal in the six channels.  Student’s t tests were performed in Excel (2-
tailed).  P values were adjusted using the Benjamini-Hochberg approach for the 4,716 
proteins that were tested.  Significance was determined based on an adjusted P-value of 
<0.01.  Heat maps and dendrograms in Figure 5-1, D to E were generated using JMP.  
Heat maps in Figures 5-2C, 5-7A, and 5-7C were generated using R. The Volcano plot 
was generated in Excel. PRISM software was used to graph all quantitative data and 
perform statistical analyses. P values for pairwise comparisons were determined using a 
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Figure 5-1. FASII is required for oxidative metabolism and ETC assembly. A. Model 
of mitochondrial fatty acid synthesis (FASII). B. Model of various ACP species. Apo-
ACP is converted to deacyl/holo-ACP by Ppt2-dependent addition of 4’-PP to Ser82 of 
ACP. Deacyl/holo-ACP is acylated by FASII. C. Proteomic workflow for WT vs. MCT1 
deletion. D. Dendrogram plot demonstrating that replicates cluster as expected. E. Heat 
map for significantly changing proteins (corrected p value < 0.01 and fold-change >1.5). 
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Figure 5-2. FASII is required for cellular respiration and ETC biogenesis. A. 
Volcano plot highlighting proteins that are significantly altered in expression in mct1Δ 
cells. Significantly depleted proteins involved in oxidative phosphorylation are 
emphasized in red. B. Gene set enrichment analysis of the 245 proteins depleted in in 
mct1Δ cells compared to WT. Indicated are gene ontologies and associated p-values. C. 
Heat map showing the fold change of the indicated proteins in mct1Δ cells compared to 
WT. Proteins indicated in red are encoded by the mitochondrial genome. D. 
Mitochondrial lysates were separated by BN-PAGE (upper panel) or SDS-PAGE (lower 
panel). Indicated antibodies were used to assess abundance of complexes and subunits.  
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Figure 5-3. ACP coordinates a mitochondrial network that is required for ETC 
assembly. A-F. Acp1HA/FLAG was immunoprecipitated from mitochondrial lysates 
expressing the indicated proteins. Inputs and eluates were resolved by SDS-PAGE and 
immunoblotted for HA (Acp1HA/FLAG) and V5 (Rpm2V5 and LYRV5 fusions). G. Relative 
abundance of the indicated proteins in WT and mct1Δ cells (N=3). H. Mitochondrial 
lysates expressing the indicated plasmids were separated by BN-PAGE and 
immunoblotted with the indicated antibodies. I. Error bars represent the standard 
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Figure 5-4. ACP coordinates the LYR assembly network. A. Relative abundance of 
the indicated proteins in WT and mct1Δ cells (N=3). B. Sequence alignment of the LYR 
protein family is Saccharomyces cerevisiae. The LYR motif in each protein is indicated. 
C. Table describing the function and target of each LYR protein family member.
Indicated is the complex associated with each LYR protein and the specific LYR target.
LYR target proteins are the complex subunits to which an LYR protein directly binds. D-
H. WT and S82A Acp1HA/FLAG were immunoprecipitated from mitochondrial lysates
expressing the indicated proteins. Inputs and eluates were resolved by SDS-PAGE and
immunoblotted for HA (Acp1HA/FLAG) and V5 (LYRV5 fusions). I-L. Ten-fold serial
dilutions of the indicated strains harboring the indicated plasmids were plated on
synthetic medium with either glucose or glycerol and grown for 2-3 days. L.
Mitochondrial lysates expressing the indicated plasmids were separated by SDS-PAGE
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1 2 3 4 5 6 7 8 9 10 11 12 13
Fmc1     1 -----------------MDRPRTLRTYRGLIRAILKYERPSKIVNWGNLRKAMITKLEYAKKQ-NQRDSHENINRQLEKW
Mzm1     1 ----------------MSTRTKALNAYRHGLRATRIAFRNDAE-----VLLAA--RAKMRSGMLCPPDPKLTTEDQIQHL
Sdh7     1 MNNKLIYRSVRFATHNSQLLLPPLVLYRRILRQHKLLPGPQREMGDQYVRNEF--KL----HK-DIDNPLHI-VGFLASW
Sdh6     1 -----------MPKRLSGLQKEVLHLYRASIRTAHTKPKENQVNFVNYIHEEF---GKY-RNL-PRKDFTT---------
Isd11    1 -----------MPGFTAPTRRQVLSLYKEFIKNANQF---NNYNFREYFLSKT--RTTFRKNM-NQQDPKV---------
Fmc1    63 KKLDPVSDRSLNLFIADSKSLRSILQNDIKWEKKVAQGQNVDEIFEHALDIIKFLDNQREYEELVDRYNPGNKLTQDEKV
Mzm1    58 EDVAVFL---RRNLV------------QGKKVDGSSTKEPR-------------YH---------LNIHKDTELGDNETI
Sdh7    73 QDY-------LHMIS------------NGKWKDATLSSETLEKLSPEQ--TVQLYELMK---ET-QKLHQDNEIESSKDV
Sdh6    56 --I-------EHLLR------------VGNKKIATFSHPEL------------------------TNIH-----------
Isd11   55 --L-------MNLFK------------EAKNDLGVLKRQSV---------ISQMYTFDR---LVVEPLQGR------KH-
Fmc1   143 KRTANVVGLD---VPT-------
Mzm1   101 ADPTARVKTNLKARPFKCSDKKQ
Sdh7   128 K-------RNNKD----------
Sdh6       -----------------------












































Figure 5-5. ACP acylation is sufficient to stimulate ETC assembly. A. Mitochondrial 
lysates expressing Acp1HA/FLAG were separated by SDS-PAGE in the presence of 10mM 
NEM and immunoblotted for HA to identify Acp1-containing bands. B. Mitochondrial 
lysates expressing the indicated plasmids were separated by BN-PAGE (upper panel) or 
SDS-PAGE (lower panel) and immunoblotted with the indicated antibodies. While mito-
Faa2 only weakly restores protein lipoylation in FASII mutant cells, this appears to be 
sufficient to support respiratory growth C. Acp1HA/FLAG was immunoprecipitated from 
mitochondrial lysates, separated by SDS-PAGE in the presence of 10mM NEM, and 
immunoblotted for FLAG to identify Acp1-containing bands D. Acp1HA/FLAG or GPD-
Sdh6V5 were immunoprecipitated from mitochondrial lysates expressing the indicated 
proteins, separated by SDS-PAGE in the presence of 10 mM NEM, and immunoblotted 
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Figure 5-6. ACP acylation is required for ETC assembly. A. WT of S82A 
Acp1HA/FLAG were immunoprecipitated from mitochondrial lysates, separated by SDS-
PAGE in the presence of 10mM NEM, and immunoblotted for FLAG. B. Mitochondrial 
lysates expressing Acp1HA/FLAG were separated by SDS-PAGE in the presence of 10mM 
NEM or 1% β-mercapoethanol and immunoblotted for HA. C. Ten-fold serial dilutions of 
the indicated strains harboring the indicated plasmids were plated on synthetic medium 
with either glucose or glycerol and grown for 2-3 days. D,E. acp1Δ (D) and ppt2Δ (E) 
heterozygous diploids harboring the indicated plasmids were dissected and spores were 
grown on YPAD medium for 2 days. F. Ten-fold serial dilutions of the indicated strains 
harboring the indicated plasmids were plated on synthetic medium with either glucose or 
glycerol and drown for 2-3 days. G. Acp1HA/FLAG or GPD-Mzm1V5 were 
immunoprecipitated from mitochondrial lysates expressing the indicated proteins, 
separated by SDS-PAGE in the presence of 10 mM NEM, and immunoblotted for HA 
(Acp1HA/FLAG) and V5 (Mzm1V5).  H-L. Acp1HA/FLAG was immunoprecipitated from 
mitochondrial lysates expressing the indicated proteins, separated by SDS-PAGE, and 
immunoblotted for HA (Acp1HA/FLAG) and V5 (LYRV5 fusions). * indicates nonspecific 
bands in A and B. 
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Figure 5-7. Mitochondrial acetyl-CoA is required for ETC assembly. A. Heat map 
showing the fold change of the indicated proteins in mct1Δ and mpc1Δ cells compared to 
WT. B. Mitochondrial lysates were separated by BN-PAGE (upper panel) or SDS-PAGE 
(lower panel) in the presence of 10mM NEM and immunoblotted with the indicated 
antibodies. C. Heat map showing the fold change of the indicated proteins in mct1Δ and 
mpc1Δ cells compared to WT. Proteins in red are encoded by the mitochondrial genome. 
Proteins with * are direct LYR target proteins. D. Relative abundance of the indicated 
proteins in WT, mct1Δ, and mpc1Δ cells (N=3). E. Mitochondrial lysates expressing the 
indicated plasmids were solubilized in 1% digitonin, separated by BN-PAGE, and 
immunoblotted with the indicated antibodies. Error bars represent the standard deviation. 
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Figure 5-8. Mitochondrial acetyl-CoA is required for ETC biogenesis. A. Ten-fold 
serial dilutions of the indicated strains harboring the indicated plasmids were plated on 
synthetic medium with either glucose or glycerol and grown for 2-3 days. B,C. Relative 
abundance of the indicated proteins in WT, mct1Δ, and mpc1Δ cells (N=3). D. 
Mitochondrial lysates expressing the indicated plasmids were separated by SDS-PAGE 
and immunoblotted with the indicated antibodies. Error bars represent the standard 
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Table 5-1. Yeast strains used in this study. 
Strain Genotype Source 
WT (BY4741) MATa, his3 leu2 met15 ura3 Open Biosystems 
mct1Δ MATa, his3 leu2 met15 ura3 
mct1::natMX 
This study 
oar1Δ MATa, his3 leu2 met15 trp1 ura3 
oar1::natMX 
This Study 
lip5Δ MATa, his3 leu2 met15 trp1 ura3 
sdh6::natMX  
This Study 
sdh6Δ MATa, his3 leu2 met15 trp1 ura3 
sdh6::natMX  
This Study 
sdh7Δ MATa, his3 leu2 met15 trp1 ura3 
sdh7::natMX  
This study 
mzm1Δ MATa, his3 leu2 met15 trp1 ura3 
mzm1::natMX 
This Study 
fmc1Δ MATa, his3 leu2 met15 trp1 ura3 
fmc1::natMX 
This study 
mpc1Δ MATa, his3 leu2 met15 trp1 ura3 
mpc1::hygMX 
This study 





Mitochondria play important roles in numerous aspects of cell biology. As a 
result, dysfunction in this organelle is associated with many forms of human disease. In 
order to better understand the etiology of these pathologies, we initiated a project to 
interrogate previously uncharacterized mitochondrial proteins. In particular, we focused 
on proteins and protein families with a high degree of conservation throughout eukaryotic 
evolution. These studies have significantly enhanced our understanding of numerous 
aspects of mitochondrial biology, including the biogenesis of the electron transport chain 
(ETC). This dissertation describes the identification and characterization of a novel 
succinate dehydrogenase (SDH) assembly factor, as well as a novel nutrient-responsive 
ETC biogenesis network. Together, these studies shine new light on the fundamental 
process of ETC assembly and, furthermore, raise important questions regarding the role 
of ETC biogenesis in the maintenance of cellular physiology. 
Using three eukaryotic model systems—yeast, Drosophila, and mammalian cell 
lines—we characterized the function of the SDHAF4/Sdh8 protein family. Yeast SDH8 
and Drosophila Sdhaf4 mutants both present with classical metabolomics phenotypes of 
SDH deficiency, which is characterized by an accumulation of succinate and 
corresponding depletion of fumarate and malate. This defect in SDH activity resulted 
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from a decrease in the steady state abundance of individual subunits, as well as the fully 
assembled holocomplex.  
 Yeast was used as the primary model to interrogate the molecular function of 
Sdh8. Consistent with the observed defects in SDH activity and assembly, Sdh8 interacts 
directly with Sdh1, the catalytic subunit of SDH. Importantly, Sdh8 does not interact with 
the SDH holocomplex or any other SDH subunits. Disruption of the SDH complex, by 
deleting genes encoding the other structural subunits, results in the emergence and 
accumulation of a subassembly that contains both Sdh1 and Sdh8. Thus, Sdh8 likely acts 
as a chaperone for Sdh1 prior to its association with Sdh2 and integration into the SDH 
complex. Free Sdh1 is capable of oxidizing succinate outside of the SDH complex, which 
results in the spurious generation of reactive oxygen species. By interacting with free 
Sdh1, Sdh8 prevents the production of these deleterious byproducts and helps maintain 
mitochondrial homeostasis.  
 To garner a better understanding of the role of this protein family in the 
maintenance of mitochondrial health, we used Drosophila to interrogate the physiological 
consequences of Sdhaf4 deletion. Consistent with human SDH deficiency, flies lacking 
Sdhaf4 present with severe progressive neurodegeneration and reduced lifespan.  
Importantly, there remain numerous reports of SDH-deficient pathologies with no 
mutations in any of the SDH core subunits or known assembly factors. The molecular 
and phenotypic insights gained from the characterization of the SDHAF4 gene family 
raise the intriguing possibility that mutations in this gene may explain this discrepancy. In 
the end, these studies have not only revealed important insights into the SDH assembly 
pathway, but have also further established SDH deficiency in disease. 
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The ETC chain complexes are not simple enzymes but, rather, highly intricate 
membrane-bound complexes. As such, assembly of these complexes requires the 
coordinated synthesis of the individual subunits and redox-active cofactors. Furthermore, 
the assembly process must also be capapble of responding to nutrient availability. The 
data presented herein firmly establish mitochondrial fatty acid synthesis (FASII) and the 
acyl carrier protein (ACP) in the regulation and coordination of ETC biogenesis.  
ACP1, the gene encoding yeast ACP, is essential for cell viability, while the genes 
encoding the FASII enzymes are not. Thus, we hypothesized that ACP must perform a 
function independent of FASII and sought to define this novel function. ACP interacts 
with the core subunits of the iron sulfur cluster (Fes) biogenesis machinery, each of 
which is also required for cell viability. Furthermore, ACP is absolutely required for the 
synthesis of FeS.  
Next we wanted to further interrogate the role of FASII in the maintenance of 
mitochondrial physiology. Indeed, FASII is known to catalyze the synthesis of acyl 
chains as long as 12-14 carbons; however, no functional importance has ever been 
attributed to these extended acyl chains. Our data demonstrate that synthesis of these 
ACP-bound fatty acids serve as a signal to activate ETC biogenesis. As such, ACP 
acylation is necessary and sufficient to support ETC assembly through direct physical 
interaction with a network of ETC assembly factors, known as the LYR protein family. 
This protein family interacts preferentially with acyl-ACP and this interaction is required 
to activate the LYR network.  
Because this system uses posttranslational acylation of ACP to activate ETC 
biogenesis, we hypothesized that FASII may coordinate ETC assembly with the levels of 
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mitochondrial acetyl-CoA. Indeed, depletion of mitochondrial acetyl-CoA results in a 
stark diminution in the steady state abundance of the ETC complexes. Furthermore, these 
cells exhibit a significant decrease in the abundance of acyl-ACP, suggesting that ACP 
acylation is sensitive to fluctuations in nutrient availability. Thus, upon depletion of 
mitochondrial acetyl-CoA, ACP becomes deacylated thereby inhibiting the LYR network 
of ETC assembly factors. In the end, we propose that by coordinating assembly of the 
ETC complexes with one another and with the availability of substrate, this newly 
uncovered regulatory role for FASII maintains a balanced and healthy mitochondrial 
metabolism. 
Finally, in addition to ETC biogenesis, ACP, FASII, and acetyl-CoA are all 
required to activate the TCA cycle. As such, this pathway provides an elegant mechanism 
whereby the primary substrate of mitochondrial metabolism signals the assembly and 
activation of the two main systems of mitochondrial catabolism. 
Biology is infinitely complex and despite the best efforts of generations of 
scientists, there remain enormous gaps in our understanding of the most basic aspects of 
cell biology. Motivated by this, we sought to focus our attention on identifying and 
characterizing novel aspects of mitochondrial biology. This strategy has resulted has 
significantly enriched our understanding of fundamental biological processes from 
mitochondrial quality control to metabolite transport. This dissertation has focused on the 
process of ETC biogenesis, an essential process in cellular energy generation. The 
discovery of multiple new pathways that both support and regulate the assembly of these 
complexes highlight the importance searching for new and unexpected aspects of 
biology.  
